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ABSTRACT 
Chemistry of Oxomolybdenum Complexes with ON- and ONO- Donor Ligands 
Sagarika Pasayat 
Department of chemistry, National Institute of Technology, Rourkela-769008, Odisha, India 
 
Chapter 1: In this chapter the scope of the present investigation is delineated briefly along with 
the aim of the work. 
 
Chapter 2: Reaction of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L) with [MoO2(acac)2] 
proceeds smoothly in refluxing ethanol to afford an orange complex [MoO2L(C2H5OH)] (1). The 
substrate binding capacity of complex (1) has been demonstrated by the formation and isolation 
of two mononuclear [MoO2L(Q)] {where Q = imidazole (2a) and 1-methylimidazole (2b)} and 
one dinuclear [(MoO2L)2(Q)] {Q = 4,4'-bipyridine (3)} mixed- ligand oxomolybdenum 
complexes. All the complexes have been characterized by elemental analysis, electrochemical 
and spectroscopic (IR, UV–Vis and NMR) measurements. Molecular structures of all the 
oxomolybdenum(VI) complexes (1, 2a, 2b and 3) have been determined by X-ray 
crystallography. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. The minimum inhibitory 
concentration of these complexes and antibacterial activity indicates the compound 2a and 2b as 
the potential lead molecule for drug designing.  
 
Chapter 3: Reaction of the salicyloylhydrazone of 2-hydroxy-1-naphthaldehyde (H2L
1),  
anthranylhydrazone of 2-hydroxy-1-naphthaldehyde (H2L
2), benzoylhydrazone of 2-hydroxy-1-
acetonaphthone (H2L
3) and anthranylhydrazone of 2-hydroxy-1-acetonaphthone (H2L
4; general 
abbreviation H2L) with [MoO2(acac)2] afforded a series of  5- and 6- coordinate Mo(VI) 
complexes of the type [MoO2L
1–2(ROH)] [where R = C2H5 (1) and CH3 (2)], and [MoO2L
3–4] (3 
and 4). The substrate binding capacity of 1 has been demonstrated by the formation of one 
mononuclear mixed- ligand dioxomolybdenum complex [MoO2L
1(Q)] {where Q = γ-picoline 
(1a)}. Molecular structure of all the complexes (1, 1a, 2, 3 and 4) is determined by X-ray 
crystallography, demonstrating the dibasic tridentate behavior of ligands. All the complexes have 
been characterized by elemental analysis, electrochemical and spectroscopic (IR, UV–Vis and 
vi 
 
NMR) measurements. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis, Proteus vulgaris and Klebsiella pneumoniae. The minimum 
inhibitory concentration of these complexes and antibacterial activity indicates 1 and 1a as the 
potential lead molecule for drug designing. Catalytic potential of these complexes was tested for 
the oxidation of benzoin using 30% aqueous H2O2 as an oxidant in methanol. At least four 
reaction products benzoic acid, benzaldehyde-dimethylacetal, methylbenzoate and benzil were 
obtained with the 95-99% conversion under optimized reaction conditions. Oxidative 
bromination of salicylaldehyde, a functional mimic of haloperoxidases, in aq ueous H2O2/KBr in 
the presence of HClO4 at room temperature has also been carried out successfully.  
 
Chapter 4: Report of synthesis and characterization of two novel dimeric [(Mo VIO2)2L] (1) and 
tetrameric [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) dioxomolybdenum(VI) complexes with             
N,N'-disalicyloylhydrazine (H2L), which is formed by the self combination of salicyloyl 
hydrazide. Both the complex was characterized by various spectroscopic techniques (IR, UV–
Vis and NMR) and also by electrochemical study. The molecular structures of both the 
complexes have been confirmed by X-ray crystallography. All these studies indicate that the 
N,N'-disalicyloylhydrazine (H2L) has the normal tendency to form both dimeric and tetrameric 
complexes coordinated through the dianionic tridentate manner.  
 
Chapter 5: Two novel dioxomolybbdenum(VI) complexes containing the MoO2
2+ motif are 
reported where unexpected coordination due to ligand rearrangement through metal mediated 
interligand C–C bond formation is observed. The ligand transformations are probably initiated 
by molybdenum assisted C–C bond formation in the reaction medium. The ligands (H2L
1–2) are 
tetradentate C–C coupled O2N2– donor systems formed in situ during the synthesis of the 
complexes by the reaction of bis(acetylacetonato)dioxomolybdenum(VI) with Schiff base 
ligands of 2-aminophenol with 2-pyridine carboxaldehyde (HL1) and 2-quinolinecarboxaldehyde 
(HL2). The reported dioxomolybdenum(VI) complexes [MoO2L
1] (1) and [MoO2L
2] (2) 
coordinated with the O2N2– donor rearranged ligand are expected to have better stability of the 
molybdenum in +6 oxidation state than the corresponding ON2–donor ligand precursor. Both the 
complexes are fully characterized by several physicochemical techniques and the novel structural 
features through single crystal X-ray crystallography. 
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Chapter 6: In this chapter we present a detailed account of the synthesis, structure, 
spectroscopic, electrochemical properties and study of biological activity of some 
oxomolybdenum(VI) complexes with special reference to their H–bonded molecular and 
supramolecular structures. Reaction of bis(acetylacetonato)dioxomolybdenum(VI) with three 
different hydrazides (isonicotinoyl hydrazide, anthraniloyl hydrazide and 4-nitrobenzoyl 
hydrazide) afforded two di-oxomolybdenum(VI) complexes {[MoO2L
1(CH3OH)] (1) and 
[MoO2L
3] (3)} and one mono-oxomolybdenum(VI) complex {[MoOL2(O–N)] (2)} (where L = 
Intermediate in situ ligand formed by the reaction between acetyl acetone and the corresponding 
acid hydrazide, and O–N = 4-nitrobenzoylhydrazide). All the complexes have been characterized 
by elemental analysis, electrochemical and spectroscopic (IR, UV–Vis and NMR) 
measurements. Molecular structures of all the complexes (1, 2 and 3) have been determined by 
X-ray crystallography. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. The Minimum inhibitory 
concentration of these complexes and antibacterial activity indicates 1 as the potential lead 
molecule for drug designing.  
 
Keywords: Aroylhydrazones / Schiff bases / Dioxomolybdenum(VI) complexes / X-ray crystal 
structure / Biological activity / Catalytic oxidation of benzoin / Oxidative bromination  
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Preface 
 
The present dissertation describes the design, synthesis, full characterization and the exploration 
of chemical, electrochemical, catalytic and biological reactivity of a series of  
oxomolybdenum(VI) complexes of some selected multidentate NO- and/or ONO- donor ligands. 
Structures of seventeen important oxomolybdenum(VI) complexes are determined by single 
crystal X-ray analysis. Structure-reactivity relations are discussed and implications of structure 
determination on the design of new complexes using the structurally characterized compounds as 
precursors are elaborated. All the complexes described in this dissertation are characterized by 
various physicochemical techniques such as elemental analysis, measurement of magnetic 
susceptibility at room temperature in solid state, measurement of conductivity in solution and by 
various spectroscopic techniques (UV-Vis, IR, NMR). Electrochemical characteristics of the 
complexes were studied by cyclic voltammetry and, as pointed out before, single crystal X-ray 
crystallography is used to find out crystal and molecular structure of all the compounds of 
oxomolybdenum(VI) complexes. Biological (antimicrobial activity) and catalytic activities of 
some of the above complexes particularly oxidation of alkenes, aromatic alcohols and oxidative 
bromination of aromatic aldehydes were also studied. The subject matter of this dissertation is 
divided into six chapters containing the chemistry of oxomolybdenum(VI) ligated to selected 
NO- and/or ONO- donors ligands and a brief resume of the work embodied in this dissertation 
and concluding remarks.  
   Chapter 1 is a general introduction to the entire work described in the present dissertation and 
spells out the objectives of the thesis. The objectives of the works are placed at the end of the 
general introduction. The entire subject matter of this dissertation is organized as follows: 
    Chapter 2 contains synthesis and characterization of the oxomolybdenum(VI) complex 
[MoO2L(C2H5OH)] (1) of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L). The substrate 
binding capacity of 1 has been demonstrated by the formation and isolation of two mononuclear 
[MoO2L(Q)] {where Q = imidazole (2a) and 1-methylimidazole (2b)} and one dinuclear 
[(MoO2L)2(Q)] {Q = 4,4'-bipyridine (3)} mixed- ligand oxomolybdenum(VI) complexes. All the 
complexes have been characterized by elemental analysis, spectroscopic (IR, UV–Vis and NMR) 
and cyclic voltammetry measurements. Molecular structures of all the oxomolybdenum(VI) 
complexes (1, 2a, 2b and 3) have been determined by X-ray crystallography. The complexes 
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have been screened for their antibacterial activity against Escherichia coli, Bacillus subtilis and 
Pseudomonas aeruginosa. The minimum inhibitory concentration of these complexes and 
antibacterial activity indicates the compound 2a and 2b as the potential lead molecule for drug 
designing.  
   Chapter 3 deals with the synthesis, characterization and reactivity of a series of 5- and 6- 
coordinated oxomolybdenum(VI) complexes of the type [MoO2L
1–2(ROH)] [where R = C2H5 (1) 
and CH3 (2)], and [MoO2L
3–4] (3 and 4) of four different ONO donor ligands: 
salicyloylhydrazone of 2-hydroxy-1-naphthaldehyde (H2L
1), anthranylhydrazone of 2-hydroxy-
1-naphthaldehyde (H2L
2), benzoylhydrazone of 2-hydroxy-1-acetonaphthone (H2L
3) and 
anthranylhydrazone of 2-hydroxy-1-acetonaphthone (H2L
4; general abbreviation H2L). The 
substrate binding capacity of 1 has been demonstrated by the formation of one mononuclear 
mixed- ligand dioxidomolybdenum complex [MoO2L
1(Q)] {where Q = γ-picoline (1a)}. 
Molecular structure of all the complexes (1, 1a, 2, 3 and 4) is determined by X-ray 
crystallography, demonstrating the dibasic tridentate behavior of ligands. The complexes have 
been screened for their antibacterial activity against Escherichia coli, Bacillus subtilis, Proteus 
vulgaris and Klebsiella pneumoniae. The minimum inhibitory concentration of these complexes 
and antibacterial activity indicates 1 and 1a as the potential lead molecule for drug designing. 
Catalytic potential of these complexes was tested for the oxidation of benzoin using 30% 
aqueous H2O2 as an oxidant in methanol. At least four reaction products benzoic acid, 
benzaldehyde-dimethylacetal, methylbenzoate and benzil were obtained with the 95-99% 
conversion under optimized reaction conditions. Oxidative bromination of salicylaldehyde, a 
functional mimic of haloperoxidases, in aqueous H2O2/KBr in the presence of HClO4 at room 
temperature has also been carried out successfully.  
   Chapter 4 describes the report of synthesis and characterization of two novel dimeric 
[(MoVIO2)2L] (1) and tetrameric [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) 
dioxomolybdenum(VI) complexes with N,N'-disalicyloylhydrazine (H2L), which is formed by 
the self combination of acid hydrazide. Both the complex was characterized by various 
spectroscopic techniques (IR, UV–Vis and NMR) and also by electrochemical study. The 
molecular structures of both the complexes have been confirmed by X-ray crystallography. All 
these studies indicate that the N,N'-disalicyloylhydrazine (H2L) has the normal tendency to form 
both dimeric and tetrameric complexes coordinated through the dianionic tridentate manner.  
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   In chapter 5 two novel dioxomolybbdenum(VI) complexes containing the MoO2
2+ motif are 
reported where unexpected coordination due to ligand rearrangement through metal mediated 
interligand C–C bond formation is observed. These ligand transformations are probably initiated 
by molybdenum assisted C–C bond formation in the reaction medium. It is checked and 
confirmed that, the reactions using other metal precursors [VO(acac)2 or Cu(acac)2] do not 
initiate this type of ligand rearrangement. The ligands (H2L ) are tetradentate C–C coupled O2N2– 
donor systems formed in situ during the synthesis of the complexes from 
bis(acetylacetonato)dioxomolybdenum(VI) with Schiff base ligands of 2-aminophenol with       
2-pyridinecarboxaldehyde (HL1) and 2-quinolinecarboxaldehyde (HL2). The reported 
dioxomolybdenum(VI) complexes [MoO2L
1] (1) and [MoO2L
2] (2) coordinated with the O2N2– 
donor rearranged ligand are expected to have better stability of the +6 oxidation state of 
molybdenum than the corresponding ONN– donor ligand precursor. Both the complexes are 
fully characterized by several physicochemical techniques and the novel structural features 
through single crystal X-ray crystallography. 
The essence of the work presented in chapter 6 is the detailed account of the synthesis, structure, 
spectroscopic, electrochemical properties and study of biological activity of some 
oxomolybdenum(VI) complexes with special reference to their H-bonded molecular and 
supramolecular structures. Reaction of bis(acetylacetonato)dioxomolybdenum(VI) with three 
different hydrazides (isonicotinoyl hydrazide, anthraniloyl hydrazide and 4-nitrobenzoyl 
hydrazide) afforded two dioxomolybdenum(VI) complexes {[MoO2L
1(CH3OH)] (1) and 
[MoO2L
3] (3)} and one mono-oxomolybdenum(VI) complex {[MoOL2(O-N)] (2)} (where L = 
Intermediate in situ ligand formed by the reaction between acetyl acetone and the corresponding 
acid hydrazide, and O–N = 4-nitrobenzoylhydrazide). All the complexes have been characterized 
by elemental analysis, electrochemical and spectroscopic (IR, UV–Vis and NMR) 
measurements. Molecular structures of all the complexes (1, 2 and 3) have been determined by 
X-ray crystallography. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. The minimum inhibitory 
concentration of these complexes and antibacterial activity indicates 1 as the potential lead 
molecule for drug designing. 
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Chapter 1 
Scope of the present investigation 
Abstract: In this chapter the scope of the present investigation is delineated briefly along with 
the aim of the work. 
1.1 Review on oxomolybdenum complexes with ON- and ONO- donor ligands 
The studies described in the present thesis involve coordination complexes of molybdenum 
featuring ON- and/or ONO- donor ligands in relation to their biological and catalytic activities. 
The coordination chemistry of metal complexes with Schiff base ligands has attracted continuing 
attention for the synthetic chemist due to their ease of synthesis and stability under a variety of 
oxidative and reductive conditions. Molybdenum is one of the versatile transition metal with a 
large number of stable and accessible oxidation states ranging from –2 to +6 [1]. Within the 
second series of transition metals only molybdenum represents a biometal, important for 
microorganisms, plant and animals. Co-ordination numbers of Mo are from 4 to 8. Mo 
complexes show varied stereochemistry. It can form compounds with inorganic and organic 
ligands, with particular preference for oxygen, sulphur, fluorine and chlorine donor atoms. 
Again, coordination chemistry of molybdenum(VI) assumed special importance due to the 
following reasons: 
1) Molybdenum complexes have long standing application in the catalysis of chemical and 
petrochemical processes in various industries like ammoxidation of propene [2], epoxidation 
of olefin [3], olefin metathesis [4], isomerization of allylic alcohols [5], oxidative 
bromination of salicylaldehyde etc. [6].  
2) Mo(VI) complexes have played a versatile role in biology [6]. Molybdenum(VI) is found to 
be present at the active centers of oxotransfer molybdoenzymes and nitrogen fixing enzymes 
- the nitrogenases [7]. It is the heaviest metal which is essential for life and its biological 
importance was first recognized in the field of agriculture.  
3) The discovery of several oxotransferase enzymes like xanthine oxidase and DMSO reductase 
[8, 9] containing NSO donor points around the Mo(VI) center .  
4) Unlike most transition metals, molybdenum(VI) is relatively harmless to the environment 
[10]. 
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5) Molybdenum(VI) with Schiff base complexes are of significant interest and attention because 
of their biological activity including anticancer [11], antibacterial [12], antifungal [13] and 
antitumor [14] properties. 
 
In this context, role of the coordination environment around the central metal (molybdenum) ion 
is most important. Variation in the coordination environment can only bring about corresponding 
variation in the properties of the complexes. Chemistry of oxomolybdenum(VI) by ligands of 
various types has been of significant importance in this regard. Review on some of the recent 
reports of the oxomolybdenum complexes with ON-donor environments, which are drawing 
much current attention, are highlighted below. 
 
R. Sillanpää and coworkers reported the synthesis and characterization of few monomeric cis 
dioxomolybdenum(VI) complexes of some tridentate Schiff base ligands obtained by condensing 
salicylaldehyde with substituted aminoalcohols [15]. These ligands were fo und to coordinate 
through the deprotonated phenolate oxygen, the azomethine nitrogen and the deprotonated 
alkoxide oxygen. Structures of four complexes were determined and each one showed that the 
sixth coordination position around the Mo(VI) center is taken up by a MeOH  molecule, which is 
used as solvent for the preparation of the complexes (Fig.1.1). The complexes are reported to act 
as inhibitors in the oxidation of aldehydes by oxygen.  
 
Fig.1.1 
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B. Modec and his coworkers [16] have reported the preparation and structure of the two cluster 
species of [Mo8O16(OCH3)8Py4]·2CH3OH (Py = pyridine, C5H5N) (1) and [Mo8O16(OCH3)8(4-
MePy)4] (4-MePy = 4-methylpyridine, C6H7N) (2). Both products were synthesized by the 
solvothermal reactions. The two distinct geometries of [Mo8O16(OCH3)8Py4], one encountered in 
complex (1) and the other being the cyclic [Mo8O16(OCH3)8Py4], make a pair of structural 
isomers whose differences can be interpreted in terms of different arrangement of constituent 
{Mo2O4}
2+ blocks and connectivity among them. 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.2 
 
These cluster (Fig.1.2) complexes are formed by the reactions of (PyH)2[MoOCl5] with methanol 
and pyridine or alkyl-substituted pyridines (R-Py). Its reactivity is a further demonstration of the 
propensity of molybdenum in the +5 oxidation state to hydrolyze with the formation of dimers, 
i.e. {Mo2O3}
4+ or {Mo2O4}
2+, through one or two bridging oxygen atoms, with or without the 
metal–metal bond respectively.  
 
In 2002 M. Cindric et al. reported [17] the synthesis and characterization of three acetato 
complexes of Mo(VI) (along with other related Mo(V) and Mo(IV) complexes). They are 
[MoO2(OCOCH3)2] (1), Na2[Mo2O4(OCOCH3)6].CH3COONa·CH3COOH (2) and 
K[MoO2(OCOCH3)3]· CH3COOH (3). Crystal structures of (2) and (3) were determined by 
single crystal X-ray diffraction analysis.  
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In the same year (2002) H. K. Lee and his group reported [18] the synthesis and catalytic activity 
of dioxomolybdenum(VI) alkyl complex supported by a N2O-type ancillary ligand. Initially they 
synthesized a series of cis-dioxomolybdenum(VI) complexes MoO2(L
n)Cl (n = 1-5) (Fig.1.3) by 
the reaction of MoO2Cl2(DME) (DME = 1,2-dimethoxyethane) with 2-N-(2-
pyridylmethyl)aminophenol (HL1) or its N-alkyl derivatives (HLn) (n = 2-5) in the presence of 
triethylamine. 
 
 
 
 
 
 
 
 
                                           Fig.1.3                                                              Fig.1.4 
 
The dioxomolybdenum(VI) alkyl complexes (Fig.1.4) were prepared by the treatment of 
MoO2(L
1)Cl or [MoO2(L
1)]2O with the Grignard reagent Me3SiCH2MgCl. They have also 
reported the catalytic properties of selected dioxo-Mo(VI)-chloro and μ-oxo complexes towards 
epoxidation of styrene by tert-butyl hydroperoxide (TBHP).  
 
An interesting report on the synthesis and characterization of three non-oxo molybdenum(VI) 
complexes by Jeong et al. appeared in 2002 [19]. These three non-oxo-molybdenum(VI) 
bis(imido) complexes are [Tp Mo(Nmes)2Cl] (1), [Tp Mo(Nmes)2(CH3)] (2) and                      
[Tp Mo(Nmes)2(OH)] (3), where Tp  = hydrotris (3,5- dimethyl –1-pyrazolyl) borate. Structures 
of (1) (Fig.1.5) and (3) were solved by single crystal X-ray analyses. Structure of (1) reveals that 
the non-oxo Mo(VI) centre is present in a distorted octahdral N5Cl coordination. High reactivity 
of complex (1) centered at the coordinated Cl indicates that (1) may be used as the precursor of 
new non-oxo Mo(VI) complexes. 
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Fig.1.5 
 
Rana et al. has published the synthesis and crystal structure of cis-dioxomolybdenum(VI) 
complexes of some potentially pentadentate but functionally tridentate (ONS) donor ligands [20]. 
These complexes, MoO2LH(R-/OH) (R-/CH3) (where LH = L
1–4H) (Fig.1.6) were synthesized by 
the reaction of the thiocarbodihydrazone of substituted salicylaldehyde (ONSNO donor, H3L
1–4) 
with MoO2(acac)2. All the complexes were characterized by IR, UV–Vis and 
1H NMR 
spectroscopy, magnetic susceptibility measurement, molar conductivities in solution and by 
cyclic voltammetry. Two of the complexes [MoO2(L
2H)(MeOH)] (Fig.1.7) and 
[MoO2(L
4H)(MeOH)] were crystallographically characterized.  
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Fig.1.6 
Oxomolybdenum(IV) complexes of the formula [MoO(LH)]n (1–4) were prepared by a general 
method of refluxing the appropriate [MoVIO2(LH)(R-OH)] complexes with PPh3 in 1:1.5 molar 
proportions in dry degassed CH3CN under dry dinitrogen atmosphere. The oxo-abstraction 
property of these Mo(IV) complexes from substrates like triphenylphosphine oxide and pyridine 
N-oxide was demonstrated by the formation and the isolation of the precursor Mo(VI) 
complexes. Such reactions are reminiscent of MoIVO+2 complexes, which mimic the active 
centers of the reduced forms of oxidoreductase molybdoenzymes.  
 
 
  
 
 
 
 
 
 
 
Fig.1.7 
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In 2004, A. Lehtonen and V.G. Kessler published the synthesis and characterization of 
dioxomolybdenum(VI) complexes of two equivalents of tris(2-hydroxy-3,5-
dimethylbenzyl)amine (H3Lig) with the alcoholic solution of MoO2(acac)2 [21]. A yellow 
crystalline anionic complex LigH4[MoO2Lig] was formed and characterized by the single crystal 
X-ray crystallography. The structure of the complex (Fig.1.8) revealed that the asymmetric unit 
of metal complex consists of one [MoO2Lig]
– anion, one HLig+ cation and two molecules of 
MeOH. In the Mo centered unit, the phenoxide groups of the tetradentate ligand are bonded to 
cis-MoO2
2+ ion in xy-plane, while the amino nitrogen completes the distorted octahedral 
coordination.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.8 
 
A. Lehtonen and R. Sillanpää also prepared several oxomolybdenum(VI) complexes with tri- and 
tetradentate ligand derived from aminobis(phenolate) [22]. Tridentate aminobis(phenol) ligands 
can form monomeric dioxomolybdenum(VI) complex in which the sixth coordination site is 
occupied by solvent methanol. In the absence of methanol, the coordination sphere around 
oxophilic Mo(VI) ion was completed by dimerization through oxygen bridges (Fig.1.9).  
12 
 
 
 
 
 
 
 
 
 
 
 
                                                                          
Fig.1.9 
 
Potentially tetradentate aminobis(phenol) ligands (H2L
n), which carry either a dimethylamino, a 
pyridyl or a methoxy sidearm donor were used in the preparation of new tungsten and 
molybdenum complexes [23]. The spectral analyses and crystal structure investigations revealed 
that the dianionic aminobis(phenolate) backbones of the ligands have coordinated as ONO 
donors (Fig.1.10).  
 
 
 
 
 
 
 
 
 
 
                                                                    Fig. 1.10 
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M. Masteri-Farahani and his coworkers published a paper on the synthesis and characterization 
of molybdenum complexes with bidentate Schiff base ligands supported on MCM-41 
mesoporous material [24]. Characterization of these materials was carried out with FT-IR, 
atomic absorption spectroscopy, powder X-ray diffraction (XRD) and BET nitrogen adsorption–
desorption methods. Reaction of amine groups of AmpMCM-41 and carbonyl groups of 
aldehyde or ketone are condensed to formed ON- and NN-donor Schiff base ligands. Reaction of 
the supported Schiff base ligands with MoO2(acac)2 in refluxing absolute ethanol formed the 
corresponding molybdenum complexes on MCM-41 surface. Catalytic activities of the prepared 
molybdenum catalysts were also investigated in the epoxidation of cyclooctene, cyclohexene, 1-
octene and 1-hexene with TBHP. The ON– donor type catalyst (MoO2acacAmpMCM-41) 
mostly exhibits more epoxidation activity than NN– donor type catalyst (MoO2pycaAmpMCM-
41).  
 
S. N. Rao and their group reported [25] the catalytic air oxidation of olefins by using 
molybdenum dioxo complexes with dissymmetric tridentate ONS donor Schiff base ligands 
derived from o-hydroxyacetophenone and S-benzyldithiocarbazate or S-methyldithiocarbazate. 
The corresponding metal complexes oxidized 1-hexene, cyclohexene and styrene at 60ºC and 1 
atm O2 in DMF with a high percentage conversion in the range 86–98%, which obey pseudo-first 
order kinetics.  
 
 
 
 
 
 
 
 
 
 
 
Fig.1.11 
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Another interesting report on the synthesis and structure (Fig.1.11) of one-dimensional chain 
oxomolybdenum polymer [Mo4O12(2,2′-bpy)3] with three {MoO4N2} octahedral and one 
{MoO4} tetrahedral unit [26]. This reaction was carried out by the hydrothermal reaction of 
(NH4)6Mo7O24.4H2O, MnCl2.4H2O, 2,2′-dipyridyl N,N´-dioxide, and H2O in the mole ratio 
1.00:1.67:3.33:3333 at 200 ºC for 6 days.  
 
The new complexes, [(μ-CO)2Cr2(η
4-H2L)2], (1); [(μ-CO)M2(CO)2(η
4-H2L)2], [M = Mo; (2), W; 
(3)]; [(μ-CO)2Cr2(η
4-H2L')2], (4) and [(μ-CO)M2(CO)2(η
4-H2L')2], [M = Mo; (5), W; (6)] were 
synthesized by Karahan et al. in 2008 [27]. All the complexes were synthesized by the 
photochemical reactions of M(CO)5THF (M = Cr, Mo, W) with tetradentate Schiff base ligands, 
{N,N′-bis(2-hydroxynaphtalin-1-carbaldehydene)-1,2-bis(p-aminophenoxy)ethane (H2L) and 
N,N′-bis(2-hydroxynaphtalin-1-carbaldehydene)-1,4-bis(p-aminophenoxy)butane (H2L')}. The 
complexes were characterized by elemental analyses, LC-mass spectrometry, magnetic studies, 
FTIR, and 1H-NMR spectroscopy. The mass spectra fragmentations showed good accordance 
with the expected structures of all the complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.12 
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A series of homologous mononuclear dioxomolybdenum complexes were reported [28]. The 
ligands were derived from the prototype 2-hydroxybenzaldehyde-4-
triphenylmethylthiosemicarbazone (H2L) (Fig.1.12) behave as a tridentate ONS donor set to the 
central metal atom. X-ray crystal structures of [MoO2(LR
n)(dmf)] and [MoO2(LR
n)(MeOH)] 
were determined. From the variation of substituents in this ligand library, the influences of 
electronic ligand effects on the spectroscopic, electrochemical, and functional properties of these 
biomimetic model complexes for molybdenum-containing oxotransferases were reported.  
 
 
 
Fig. 1.13 
 
Molybdenum(VI) complexes of the ligands were prepared by the condensation of 4,6-dimethyl 
2-hydrazino pyrimidine with salicylaldehyde (for HL1) and o-hydroxy acetophenone (for HL2) 
respectively. When MoO2(acac)2 was used as a metal precursor in acidic medium, HL1 yielded 
the normal ligand exchange product [MoO2(L1)Cl] (1) (Fig.1.13). In the same reaction medium 
HL2 produced two bis chloro dioxomolybdenum(VI) complexes [MoO2(L3)Cl2] (2) and 
[Mo2O5(L3)Cl2] (3) (Fig.1.14), where L3 is a bidentate neutral ligand 2-(3, 5-dimethyl-1-
pyrazolyl) 4,6-dimethyl pyrimidine, which was afforded by an organic transformation of the used 
ligand.  
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Fig. 1.14 
 
The complexes were characterized by elemental analyses, electronic spectra, IR, 1H NMR, 
magnetic measurements, EPR and by cyclic voltammetry. Another pyrimidine derived hydrazone 
ligand (H2L′1) (Fig.1.15) was employed for complexation with MoO2(acac)2, a similar ligand 
transformation occurred and the complex [MoO2(L4)Cl] (4) (Fig.1.16) was produced. Complexes 
(1–4) as well as the ligand HL2, have been crystallographically characterized. From X-ray 
crystallography it is revealed that during complex formation, the ligand transformations were 
initiated by a metal mediated C=N bond cleavage of the used ligands in the reaction medium 
[29].  
 
 
 
                                                                    
 
  
 
 
                              Fig.1.15                                                                    Fig.1.16     
 
O
N
HNN
N
N
N
CH3
H3C
Mo
O
OCl
[MoO2(L4)Cl] (4)
OH
N NH
N
N NH
N
HO
H2L
'
1
17 
 
The synthesis of a new Mo complex [MoO2(L)-(CH3OH)] with 2-{(2-
hydroxypropylimino)methyl}phenol ligand (H2L) was reported and prepared by the reaction 
between 2-{(2-hydroxypropylimino)} methyl]phenol and dioxo-molybdenum(VI) 
acetylacetonate [30]. The [MoO2(L)(CH3OH)] was structurally characterized by single-crystal X-
ray crystallography, having a monoclinic structure with a space group P21/c (Fig.1.17). 
Conversion of sulfides to both sulfoxides and sulfones by using UHP was efficiently enhanced 
under the influence of [MoO2(L)(CH3OH)] catalyst in ethanol under mild conditions and high 
turnover rates were obtained in the oxidation reactions, which highlighted the novelty of this new 
Mo-catalyst. 
 
 
 
Fig.1.17 
 
V. Vrdoljak and his coworkers have reported [31] some oxomolybdenum(VI) (monomeric 
[MoO2L
1(CH3OH)] or polymeric [MoO2L
1–3]) complexes, which were prepared by the reaction 
of [MoVIO2(acac)2] or (NH4)2[Mo
VOCl5] with different N-substituted pyridoxal 
thiosemicarbazone ligands (H2L
1 = pyridoxal 4-phenylthiosemicarbazone; H2L
2 = pyridoxal 4-
methylthiosemicarbazone, H2L
3 = pyridoxal thiosemicarbazone). In all the complexes 
molybdenum was coordinated with a tridentate doubly-deprotonated ligand, but in the 
oxomolybdenum(V) complexes [MoOCl2(HL
1–3)] (Fig.1.18) the pyridoxal thiosemicarbazonato 
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ligands are tridentate monodeprotonated. Crystal and molecular structures of the pyridoxal 
thiosemicarbazone ligand and complexes were determined by the single crystal X-ray diffraction 
method.  
 
 
 
 
 
Fig.1.18 
Nair and Thankamani have reported some new oxomolybdenum(V) and dioxomolybdenum(VI) 
with a Schiff base, 3-methoxysalicylaldehydeisonicotinoylhydrazone derived from                     
3-methoxysalicylaldehyde and isonicotinoylhydrazide [32]. The complexes have been 
characterized by elemental analyses, molar conductance, magnetic susceptibility data, IR, 
UV-Vis, EPR, 1H NMR and FAB mass spectral studies. The FAB mass and X-band EPR 
spectra indicate that the pentavalent Mo in the complex [MoO(MSINH)Cl2] (Fig.1.19) is 
monomeric in nature. The anticancer and antibacterial activities of ligand, [MoO(MSINH)Cl2] 
and [MoO2(MSINH)Cl] were also investigated. The complex [MoO(MSINH)Cl2] exhibits 
much higher activity than the ligand (MSINH) and its dioxo complex [MoO2(MSINH)Cl].  
 
 
 
 
 
 
 
     
Fig.1.19 
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The tetradentate Schiff base N,N′-bis(salicylidene)4,5-dichloro-1.2-phenylenediamine (H2L) 
with M(CO)6 (M = Cr and Mo) under different conditions formed [Cr(CO)2(H2L)] and 
[Mo(CO)2(L)] under reduced pressure, and the oxo complex [Cr(O)(L)] and the dioxo complex 
[Mo(O2)(L)] (Fig.1.20) in air condition were reported by A. A. Abdel Aziz [33]. The catalytic 
activities of all the complexes were investigated in the epoxidation of cyclooctene, cyclohexene, 
1-octene and 1-hexene with TBHP and methylene chloride as a solvent at different temperatures. 
The results showed that the reported molybdenum complexes have higher catalytic activity than 
chromium complexes. The antibacterial and antifungal activities of the new compounds were 
also investigated.  
 
 
 
 
 
 
 
 
 
 
Fig.1.20 
The oxo imido molybdenum(VI) compounds [MoO(N-t-Bu)L2] (Fig.1.21) were reported by 
Nadia C. Mösch-Zanetti and his coworkers [34]. Reaction of [MoO(N-t-Bu)Cl2(dme)] (dme = 
dimethoxyethane) with 2 equiv of the potassium salts of Schiff base ligands 
{KArNC(CH3)CHC(CH3)O} afforded oxo imido molybdenum(VI) compounds [MoO(N-t-
Bu)L2] (1) {with Ar = phenyl (LPh) (Fig.1.22), (2) with Ar = 2-tolyl (LMePh), (3) with Ar = 2,6-
dimethylphenyl (LMe2Ph) and (4) with Ar = 2,6-diisopropylphenyl (Li-Pr2Ph), (5) with (L = LPh), 
(6) with (L = LMePh), and (7) with (L = LMe2Ph)}. The complexes (1, 3, 5, and 6) were 
characterized by single crystal X-ray diffraction.  
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Fig. 1.21 
The oxo imido complexes (1 and 3) also introduced oxygen atom transfer (OAT) by trimethyl 
phosphine. This oxygen transfer was analyzed kinetically by UV-Vis spectroscopy under 
pseudo-first order conditions. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.22 
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The synthesis and catalytic performance of novel cis-dioxo-Mo(VI) complexes containing simple 
ONO tridentate Schiff base ligands in the epoxidation of various olefins using tert-butyl 
hydroperoxide in desired times with excellent chemo- and stereoselectivity have been described 
by A. Rezaeifard et al. [35]. The study of turnover numbers and the UV–Vis spectra of the Mo 
complexes in the epoxidation system indicate well the high efficiency and stability of the 
catalysts during the reaction. The electron-deficient and bulky groups on the salicylidene ring of 
the ligand promote the effectiveness of the catalyst.  
 
 
 
 
 
 
 
 
 
 
 
Fig.1.23 
 
Synthesis, characterization and study of antitumor activity of some new thiosemicarbazonato 
dioxomolybdenum(VI) complexes have been reported by V. Vrdoljak and his coworkers [36]. 
The dioxomolybdenum(VI) [MoO2L(CH3OH)] complexes (Fig.1.23) were obtained by the 
reaction of [MoO2(acac)2] with thiosemicarbazone ligands derived from 3-thiosemicarbazide 
and 4-(diethylamino)salicylaldehyde (H2L
1), 2-hydroxy-3-methoxybenzaldehyde (H2L
2) or   
2-hydroxy-1-naphthaldehyde (H2L
3). All the complexes were characterized by means of 
chemical analyses, IR spectroscopy, TGA and NMR measurements. The molecular structures 
of the ligand H2L
2 and complex [MoO2L
2(CH3OH)]·CH3OH (2a) have been determined by 
single crystal X-ray crystallography.  
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Fig.1.24 
 
Z. Hu et al. has published the olefin epoxidation of Schiff base molybdenum(VI) complexes 
immobilized onto zirconium poly (styrene-phenylvinylphosphonate)-phosphate. Schiff base 
molybdenum(VI) complexes were immobilized onto a novel polymer–inorganic hybrid support, 
zirconium poly(styrene-phenylvinylphosphonate)-phosphate (ZPS-PVPA) [37]. The catalysts 
were characterized by IR, BET, XPS, SEM and TEM. Compared with other heterogeneous 
catalysts known from the relative literatures, the as-prepared heterogeneous catalysts showed 
comparable or even higher conversion and chemical selectivity, which was mainly attributed to 
the special structure and composition of ZPS-PVPA. Moreover, the supported catalysts were 
easily recovered by simple filtration and could be reused at least ten times with little loss of 
activity.  
 
Chakravarthy and his co-workers have reported six new cis-dioxomolybdenum(VI) complexes 
(Fig.1.24) of chiral Schiff-base ligands, derived from condensation of various amino alcohols 
and substituted salicylaldehydes [38]. All the complexes were characterized by NMR, IR, ESI-
MS and single crystal X-ray diffraction techniques. The octahedral geometry of the cis-
dioxomolybdenum center was completed by a coordinated labile solvent molecule. In some 
complexes the sixth site is found to be vacant where the relatively bulky substituents hinder the 
coordination of the solvent. These complexes were tested for catalytic enantioselective 
sulfoxidation reactions using hydrogen peroxide as oxidant at low temperature which shows high 
23 
 
selectivity along with good to moderate enantiomeric excess. The formation of oxoperoxo 
Mo(VI) complexes was studied by ESI-MS from the reaction mixture during catalysis.  
 
 
 
 
 
 
 
 
 
 
 
Fig.1.25 
M. Kooti and M. Afshari published a paper on the molybdenum Schiff base complex which was 
covalently anchored with silica-coated cobalt ferrite nanoparticles and used as a heterogeneous 
catalyst for the oxidation of alkenes [39]. The prepared catalyst was characterized by X-ray 
powder diffraction, transmission electron microscopy, vibrating sample magnetometry, 
thermogravimetric analysis, Fourier transform infrared, and inductively coupled plasma atomic 
emission spectroscopy. The molybdenum complex was shown to be an efficient heterogeneous 
catalyst for the oxidation of various alkenes using t-BuOOH as oxidant.  
 
M. E. Judmaier and his coworker reported [40] a series of new [MoO2(L
X)2] (Fig. 1.25) 
complexes with Schiff base ligands using the uncommon η2 coordinated [MoO2(η
2-tBu2pz)2] 
complex as starting material. All ligands coordinate through phenolic O atom and the imine N 
atom in a bidentate manner to the metal center.  
 
 
 
24 
 
 
 
 
 
 
 
                        
 
 
 
Fig.1.26 
With the more sterically demanding tBu substituent on the aryl ring (complexes 1, 3 and 5), a 
mixture of two isomers in solution was obtained, whereas only one isomer in solution was 
detected for methyl substituted complexes (2) and (4). Complexes (1) (Fig.1.26) and (3) were 
characterized by X-ray diffraction analyses. All the complexes were used as catalyst in the 
epoxidation of various alkenes where TBHP was used as oxidant. Among them, complexes (1) 
and (2) were highly selective in the epoxidation of styrene and the yield was very high. Co mplex 
(3), (4) and (5) were significantly less selective in the epoxidation of styrene.  
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Jun Feng and his coworkers have reported the synthesis and characterization of a series of 
oxomolybdenum complexes with polyhydroxyl phenols [41], where two of them are tri-oxo-
molybdenum complexes (Fig.1.27), in relation to their in vitro anticancer activities against 
human cancer cells. The structural features of all the complexes were investigated by X-ray 
diffraction. MTT assay tests indicated that their anticancer activities against human cancer cells 
decreased when the chelation number of the ligand increased.  
 
1. 2. Aim of the present work 
The primary aim of the present work has been to study the chemistry of oxomolybdenum(VI) 
complexes with ON- and/or ONO- donor ligand systems. The different ligands that have been 
used for this purpose are shown below along with their observed coordination modes.  
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1.3. The main objectives of the present study:    
1. To develop some ON- and/or ONO- donor mono- and binucleating ligand systems, 
(especially aroylhydrazones and Schiff bases) inspired by the paradigm of biologically and 
catalytically important oxomolybdenum complexes.  
 
2. To develop versatile, new-generation mono- and dinuclear oxomolybdenum(VI) systems, 
for use as reagents in some bio- and catalytic reactions. This work uses synthetic and 
analytical approaches to generate and study mono- and binuclear molybdenum complexes, 
relying upon current mechanistic understanding of their mode of action.  
 
3. Study the properties of these metal complexes, such as spectral, magnetic and redox 
behavior. Solve the X-ray structure of these complexes and develop the structure-reactivity 
correlation.  
 
4. Exploration of biological (antibacterial activity) and catalytic activities of some of the above 
complexes particularly oxidation of alkenes, aromatic alcohols and oxidative bromination of 
aromatic aldehydes.  
 
 
 
 
 
 
 
 
 
 
29 
 
References 
1. C.L. Rollinson, Inorg. Chem. 21 (1973) 691; Cotton and Wilkinson, 6th edition Wiley-
Interscience, N. Y. (1999) 920. 
2. R.K. Grasselli, Catal. Today 49 (1999) 141.  
3. R.J. Cross, P.D. Newman, R.D. Peacock, D. Stirling, J. Mol. Catal. 144 (1999) 273.  
4. K.J. Ivin, J.C. Mol, Olefin metathesis polymerisation, Academic Press, London (1997). 
5. J. Belgacem, J. Kress, J.A. Osborn, J. Am. Chem. Soc. 114 (1992) 1501.  
6.  M.R. Maurya, S. Sikarwar, T. Joseph, S.B. Halligudi, J. Mol. Catal. A: Chem. 236 
(2005) 132. 
7. D. Collison, C.D. Garner, J.A. Joule, Chem. Soc. Rev. 25 (1996).  
8. R. Hill, Chem. Rev. 96 (1996) 2757. 
9. Nitrogen Fixation: The chemical- Biochemical Genetic Interface, A. Miller, W.E. 
Newton,(Eds), Plenum Press, NY, (1983). Advance in Nitrogen Fixation Research, C. 
Veeger, W.E. Newton, (Eds.), Nijhoff / Junk, Wageningen, (1984).  
10. G.C. Tucci, J.P. Donahue, R.H. Holm, Inorg. Chem. 37 (1998) 1602.  
11. B.E. Schultz, S.F. Gheller, M.C. Muetterties, M. J. Scott, R.H. Holm, J. Am. Chem. Soc. 
115 (1993) 2714. 
12. S.K. Sridhar, M. Saravanan, A. Ramesh, Eur. J. Med. Chem. 36 (2001) 615. 
13. S.N. Pandeya, D. Sriram, G. Nath, E. De Clercq, Eur. J. Pharm. Sci. 9 (1999) 25. 
14. R. Mladenova, M. Ignatova, N. Manolova, T.S. Petrova, I. Rashkov, Eur. Polym. J. 38 
(2002) 989. 
15.  J. Liimatainen, A. Lehtonen, R. Sillanpää, Polyhedron 19 (2000) 1133.  
16. B. Modec, J.V. Brenčič, R.C. Finn, R.S. Rarig, J. Zubieta, Inorg. Chim. Acta. 322 (2001) 
113. 
17. B. K. Colig, M. Cindric, D. M. Calogovic, V. Vrdoljak, B. Kamenar, Polyhedron 21 
(2002) 147. 
18. Y. Wong, D. K. P. Ng, H. K. Lee, Inorg. Chem. 41 (2002) 5276. 
19. H. Y. Cho, S. G. Roh, J. H. Jeong, Polyhedron 21 (2002) 1211. 
20. A. Rana, R. Dinda, P. Sengupta, L.R. Falvello, S. Ghosh, Polyhedron 21 (2002) 1023.  
21. A. Lehtonen, V.G. Kessler, Inorg. Chem. Commun. 7 (2004) 691.  
22. A. Lehtonen, R. Sillanpää, Polyhedron 24 (2005) 257.  
30 
 
23. A. Lehtonen, M. Wasberg, R. Sillanpää, Polyhedron 25 (2006) 767. 
24. M. Masteri-Farahani, F. Farzaneh, M. Ghandi, J. Mol. Catal. A: Chem.248 (2006) 53.  
25. S. N. Rao, N. Kathale, N.N. Rao, K.N. Munshi, Inorg. Chim. Acta 360 (2007) 4010. 
26. J. Kim, W.T. Lim, B.K. Koo, Inorg. Chim. Acta 360 (2007) 2187. 
27. S. Karahan, P. Köse, E. Subasi, H. Temel, Synth. React. Inorg., Met.-Org., Nano-Met. 
Chem. 38 (2008) 615. 
28. D. Eierhoff , W. C. Tung, A. Hammerschmidt, B. Krebs, Inorg. Chim. Acta 362 (2009) 
915. 
29. S. Gupta, S. Pal, A.K. Barik, S. Roy, A. Hazra, T.N. Mandal, R.J. Butcher, S.K. Kar, 
Polyhedron 28 (2009) 711. 
30. I. Sheikhshoaie, A. Rezaeifard, N. Monadi, S. Kaafi, Polyhedron 28 (2009) 733. 
31.  V. Vrdoljak, J. Pisk, B. Prugovečki, D. Matković-Čalogović, Inorg. Chim. Acta 362 
(2009) 4059. 
32. M.L.H. Nair, D. Thankamani, Indian J. Chem. 48 (2009) 1212.  
33. A.A.A. Aziz, J. Mol. Struct. 979 (2010) 77. 
34. N.C. Mösch-Zanetti, D. Wurm, M. Volpe, G. Lyashenko, B. Harum, F. Belaj, J. 
Baumgartner, Inorg. Chem. 49 (2010) 8914.  
35. A. Rezaeifard, I. Sheikhshoaie, N. Monadi, M. Alipour, Polyhedron 29 (2010) 2703. 
36. V. Vrdoljak, I. Ðilović, M. Rubčić, S.K. Pavelić, M. Kralj, D. Matković–Calogović, I. 
Piantanida, P. Novak, A. Rožman, M. Cindrić, Eur. J. Med. Chem.45 (2010) 38. 
37. Z. Hu, X. Fu, Y. Li, Inorg. Chem. Commun.14 (2011) 497. 
38. R.D. Chakravarthy, K. Suresh, V. Ramkumar, D.K. Chand, Inorg. Chim. Acta 376 (2011) 
57. 
39. M. Kooti, M. Afshari, Catal Lett 142 (2012) 319.  
40. M.E. Judmaier, C. Holzer, M. Volpe, N.C. Mösch-Zanetti, Inorg. Chem.51 (2012) 9956. 
41. J. Feng, X. Lu, G. Wang, S. Du, Y. Cheng, Dalton Trans. 41 (2012) 8697.  
 
 
 
 
31 
 
Chapter 2 
 
 
 
 
 
 
 
 
Mixed-ligand Aroylhydrazone Complexes of Molybdenum: 
Synthesis, Structure and Biological Activity 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Chapter 2 
Mixed-Ligand Aroylhydrazone Complexes of Molybdenum: Synthesis, Structure and 
Biological Activity 
 
Abstract 
Reaction of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L) with [MoO2(acac)2] proceeds 
smoothly in refluxing ethanol to afford an orange complex [MoO2L(C2H5OH)] (1). The substrate 
binding capacity of 1 has been demonstrated by the formation and isolation of two mononuclear 
[MoO2L(Q)] {where Q = imidazole (2a) and 1-methylimidazole (2b)} and one dinuclear 
[(MoO2L)2(Q)] {Q = 4,4'-bipyridine (3)} mixed- ligand oxomolybdenum complexes. All the 
complexes have been characterized by elemental analysis, electrochemical and spectroscopic 
(IR, UV–Vis and NMR) measurements. Molecular structures of all the oxomolybdenum(VI) 
complexes (1, 2a, 2b and 3) have been determined by X-ray crystallography. The complexes 
have been screened for their antibacterial activity against Escherichia coli, Bacillus subtilis and 
Pseudomonas aeruginosa. The minimum inhibitory concentration of these complexes and 
antibacterial activity indicates the compound (2a) and (2b) as the potential lead molecule for 
drug designing. 
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2.1. Introduction 
The coordination chemistry of molybdenum has become a fascinating area of research in recent 
time because of presence of molybdenum in metalloenzymes and its biochemical as well as 
catalytic importance [1–20]. The molybdenum Schiff‘s base complexes have continued to play 
the role of one of the most important models of molybdoenzymes [21–23] due to their 
preparative accessibility. Schiff bases derived from salicylaldehyde and amino alcohols have 
been widely used for the preparation of oxomolybdenum complexes containing the MoO2
2+-core 
[24–26] whereas, Schiff bases obtained by the reactions of aromatic acidhydrazides with           
o-hydroxycarbonyl compounds have rarely been used in molybdenum chemistry. This type of  
ligands are of particular interest because MoO2L or MoOL type of complex possess one or two 
―open‖ coordination sites that can be utilized for substrate binding [23, 27–29] properties and 
these species have frequently been considered as models of enzymatic reaction and catalytic 
sites. On the other hand, hydrazones –NH–N=CRR' (R and R  = H, alkyl, aryl) are versatile 
ligands due to their applications in the field of analytical [30] and medicinal chemistry [31]. 
Hydrazone moieties are the most important pharmacophoric cores of several anti- inflammatory, 
antinociceptive, and antiplatelet drugs [32]. It may be relevant to mention here that though the 
study of antibacterial activity of aroylhydrazones complexes of many transition metals have been 
extensively studied [33–38], that of oxomolybdenum(VI) appears to have remained practically 
unexplored [39–41].  
As part of our group studies on aroylhydrazone complexes [29,33,42], this chapter reports the 
synthesis, X-ray structure and characterization of a new mononuclear Schiff base complex 
MoO2L(C2H5OH)] (1), some mixed–ligand mononuclear [MoO2L(Imz)] (2a),             
[MoO2L(1–MeImz)] (2b) and diimine bridged dinuclear [(MoO2L)2( -4,4'-bipy)] (3)               
cis-dioxomolybdenum(VI) complexes with aroylhydrazone as a primary ligand with special 
reference to their antibacterial activity.  
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2.2. Experimental 
2.2.1. Materials 
[MoO2(acac)2] was prepared as described in the literature [28]. Reagent grade solvents were 
dried and distilled prior to use. All other chemicals were reagent grade, available commercially 
and used as received. Commercially available TBAP (tetra butyl ammonium perchlorate) was 
properly dried and used as a supporting electrolyte for recording cyclic voltammograms of the 
complexes. 
 
2.2.2. Physical Measurements  
Elemental analyses were performed on a Vario ELcube CHNS Elemental analyzer. IR spectra 
were recorded on a Perkin-Elmer Spectrum RXI spectrometer. 1H NMR spectra were recorded 
with a Bruker Ultrashield 400 MHz spectrometer using SiMe4 as an internal standard. Electronic 
spectra were recorded on a Lamda25, PerkinElmer spectrophotometer. Magnetic susceptibility 
was measured with a Sherwood Scintific AUTOMSB sample magnetometer. Electrochemical 
data were collected using a PAR electrochemical analyzer and a PC-controlled 
Potentiostat/Galvanostat (PAR 273A) at 298 K in a dry nitrogen atmosphere. Cyclic 
voltammetry experiments were carried out with a platinum working electrode, platinum auxiliary 
electrode, Ag/AgCl as reference electrode and TBAP as supporting electrolyte. 
 
2.2.3. Synthesis of Ligand (H2L)  
The ligand benzoylhydrazone of 2-hydroxybenzaldehyde (H2L) was prepared by the 
condensation of equimolar ratio of benzoylhydrazide 2.72 g (20.00 mmol) and                                
2-hydroxybenzaldehyde 1.46 g (20.00 mmol) in stirring ethanol (25 ml) for 2 hr. The resulting 
yellowish- white compound was filtered, washed with ethanol and dried over fused CaCl2. M.P. 
160oC. Yield: 2.88g (61%). Anal. Calcd. for C14H12N2O2: C, 69.98; H, 5.03 ; N, 11.65. Found: C, 
70.00; H, 5.01; N, 11.62%. 1H NMR (DMSO-d6,400 MHz):  = 12.14 (s, 1H, OH), 11.32 (s, 1H, 
NH), 8.66 (s, 1H, CH), 7.96–6.91 (m, 9H, Aromatic). 13C NMR (DMSO-d6, 100 MHz):  = 
163.30, 157.94, 148.79, 133.27, 132.45, 131.86, 130.01, 129.02, 128.11, 119.82, 119.13, 116.89, 
114.34, 112.57. 
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2.2.4. Synthesis of precursor complex [MoO2L(C2H5OH)] (1) 
0.24 g (1.00 mmol) of ligand H2L was dissolved in 30 mL ethanol. When 0.32 g (1.00 mmol) of 
MoO2(acac)2 was added to the solution, the color changed to dark orange. The solution mixture 
was then refluxed for 3 hr. After leaving the solution for 2 days at room temperature, fine dark 
orange crystals were isolated and a suitable single crystal was selected for X-ray analysis. Yield: 
0.31g (75%). Anal. Calcd. for C16H16N2O5Mo: C, 46.61; H, 3.91; N, 6.79. Found: C, 46.63; H, 
3.89; N, 6.77%. 1H NMR (DMSO-d6,400 MHz):  = 9.01 (s, 1H, CH), 8.02–6.95 (m, 9H, 
Aromatic), 4.37 (s, 1H, OH), 3.40 (q, 2H, CH2), 1.04 (t, 3H, CH3). 
13C NMR (DMSO-d6,100 
MHz):  = 169.16, 159.83, 156.50, 135.42, 134.77, 132.46, 130.40, 129.28, 128.44, 122.08, 
120.74, 119.03, 114.49, 112.69, 56.50, 19.01. 
 
2.2.5. Synthesis of mixed-ligand complexes [{MoO2L(Q)}, where Q = imidazole (2a), 1-
methylimidazole (2b)] and [{(MoO2L)2(Q)} where Q = 4,4'-bipyridine (3)] 
To a clear orange solution (obtained by refluxing) of 1 (0.50 mmol) in ethanol (30 ml) was added 
corresponding mixed- ligand [0.73 mmol (2a and 2b), 0.30 mmol (3)] and the mixture was 
refluxed for 3 hr. Slow evaporation of the orange filtrate over 2 days produced orange-red 
crystals. 
[MoO2L(Imz)] (2a): Yield: 0.25g (57%). Anal. Calcd. for C17H14N4O4Mo: C, 47.01; H, 3.23; N, 
12.90. Found: C, 47.03; H, 3.20; N, 12.89%. 1H NMR (DMSO-d6, 400 MHz):  = 8.95 (s, 1H, 
CH), 7.99–6.96 (m, 9H, Aromatic), 7.74–7.01 (m, 3H, Aromatic–Imz); 7.67 (br s, 1H, NH–Imz). 
13C NMR (DMSO-d6,100 MHz):  = 169.24, 159.90, 156.52, 135.44, 134.82, 132.48, 130.36, 
129.28, 129.03, 128.42, 128.10, 122.14, 120.75, 119.05, 118.34, 116.45, 113.56.  
 
[MoO2L(1-MeImz)] (2b): Yield: 0.35g (78%). Anal. Calcd. for C18H16N4O4Mo: C, 48.21; H, 
3.59; N, 12.50. Found: C, 48.18; H, 3.60; N, 12.48%.1H NMR (DMSO-d6, 400 MHz):  = 8.96 
(s, 1H, CH), 7.99–7.07 (m, 9H, Aromatic), 7.74–6.87 (m, 3H, Aromatic–1–MeImz), 3.63 (s, 3H, 
CH3–1–MeImz). 
13C NMR (DMSO-d6,100 MHz):  = 169.19, 159.88, 156.54, 138.37, 135.43, 
134.80, 132.48,131.42, 130.37, 129.28, 129.13, 128.43, 128.16, 122.13,121.15, 120.75, 119.03, 
67.87.  
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[(MoO2L)2( -4,4'-bipy)] (3): Yield: 0.54g (60%). Anal. Calcd. for C38H28N6O8Mo2: C, 51.35; H, 
3.15; N, 9.45. Found: C, 51.37; H, 3.13; N, 9.46%. 1H NMR (DMSO-d6,400 MHz):  = 8.96 (s, 
1H, CH), 8.71–7.82 (m, 4H, Aromatic–4,4'–bipy), 7.99–6.96 (m, 9H, Aromatic). 13C NMR 
(DMSO-d6,100 MHz):  = 169.15, 159.82, 156.52, 151.03, 144.78, 135.44, 134.78, 132.48, 
132.06, 130.38, 129.29, 129.13, 128.43, 126.43, 124.62, 122.10, 121.76, 120.73, 119.03. 
 
2.2.6. Crystallography 
Suitable single crystal of 1, 2a, 2b and 3 were chosen for X-ray diffraction studies. 
Crystallographic data and details of refinement are given in Table 2.1. These compounds 
crystallized in the monoclinic space group P21/c (1), orthorhombic space group Pna21 (2a), 
orthorhombic space group Pca21 (2b) and monoclinic space group P21/n (3) respectively. The 
unit cell parameters and the intensity data for all the complexes were collected at ~ 293 K, on a 
Bruker Smart Apex CCD diffractometer using graphite monochromated Mo K  radiation (k = 
0.71073 Å), employing the ω–2θ scan technique. The intensity data were corrected for Lorentz, 
polarization and absorption effects. The structures were solved using the SHELXS97 [43] and 
refined using the SHELXL97 [44] computer programs. The non-hydrogen atoms were refined 
anisotropically. 
 
2.2.7. Antibacterial activity  
Antibacterial activity of the compounds (ligands and complexes) was studied against Escherichia 
coli (E. coli), Bacillus and Pseudomonas aeruginosa by agar well diffusion technique. Mueller 
Hinton-agar (containing 1% peptone, 0.6% yeast extract, 0.5% beef extract and 0.5% NaCl, at 
pH 6.9–7.1) plates were prepared and 0.5–McFarland culture (1.5 x 108 cells/mL) of the test 
organisms were swabbed onto the agar plate (as per CLSI guidelines, 2006). Test compounds 
were dissolved in DMSO at several concentrations ranging from 1000 µg/mL–1.95 µg/mL. 9 
mm wide wells were dug on the agar plate using a sterile cork borer. 100 µg/mL of the solutions 
of the each test compound from each dilution were added into each o f the wells using a 
micropipette. These plates were incubated for 24 h at 35 ± 2 °C. The growth of the test 
organisms was inhibited by diffusion of the test compounds and then the inhibition zones 
developed on the plates were measured [41,45]. The effectiveness of an antibacterial agent in 
sensitivity is based on the diameter of the zones of inhibition which is measured to the nearest 
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millimeter (mm). The standard drug Vancomycin was also tested for their antibacterial activity at 
the same concentration under the conditions similar to that of the test compounds as +ve control. 
DMSO alone was used as a –ve control under the same conditions for each organism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
Table 2.1 Crystal and Refinement Data of Complexes 1, 2a, 2b and 3 
Compound 1 2a 2b 
 
3 
Formula C16H16MoN2O5 C17H14MoN4O4 C18H16MoN4O4 C38H28Mo2N6 O8 
M 412.25 434.26 448.29 888.54 
Crystal symmetry Monoclinic Orthorhombic Orthorhombic Monoclinic  
Space group P21/c Pna21 Pca21 P21/n 
a(Å) 10.4986(7) 7.6276(14) 17.0374(5) 11.1975(3) 
b(Å) 10.4410(7) 16.640(3) 6.7818(2) 13.0914(4) 
c(Å) 15.1561(11) 13.260(3) 32.3366(9) 12.5884(3) 
(°) 90 90 90 90 
β (°) 106.842(2) 90 90 98.875(2) 
(°) 90 90 90 90 
V(Å
3
) 1590.09(19) 1683.0(5) 3736.31(19) 1823.25(9) 
Z 4 4 8 2 
Dcalc(g.cm
-3
) 1.722 1.714 1.594 1.618 
F(000) 832 872 1808 880 
(Mo-K )(mm
-1
) 0.854 0.811 0.733 0.749 
max./min.trans. 0.9505 /0.8826 0.8047 / 0.7757 0.8100 / 0.7939 0.8064 /0.7794 
2 (max)(
o
) 30.5 28 30.50 30.20 
Reflections collected / 
unique 
23567/4900 16063/3880 68324/11367 15801/5495 
R1
a 
 [I>2 (I)] R1 = 0.0281, 
wR2=0.0671 
 
R1 = 0.0360, 
wR2=0.0790 
R1 = 0.0413, 
wR2=0.0817 
R1 = 0.0611, 
wR2=0.1431 
wR2
b
 [all data] R1 = 0.0324, 
wR2=0.0690 
R1 = 0.0455, 
wR2=0.0835 
R1 = 0.0716, 
wR2=0.0920 
 
R1 = 0.1310, 
wR2=0.1742 
S[goodness of fit] 1.079 1.077 1.012 1.037 
min./max. res.(e.Å
-3
) 0.779 / -0.809 0.997 / -0.518 0.413 / -0.571 2.525 / -0.696 
 
a
R1 = Σ FO  - FC / Σ  FO .  
 
b
wR2 = {Σ [w (FO
2
- FC
2
)
2]/Σ [w (FO
2
)
2
]}
1/2 
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2.3. Results and Discussion 
2.3.1. Synthesis  
Reaction of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L) with [MoO2(acac)2]       
(Scheme 2.1) proceeds smoothly in refluxing ethanol to afford a orange complex in a decent 
yield. Though the preliminary characterization data (microanalysis, 1H NMR and IR) indicated 
the presence of the ligand, two oxo, and an ethanol in this complex, they could not point to any 
definite stereochemistry of the complex, as well as the coordination mode of H2L in it. These 
compounds are highly soluble in aprotic solvents, viz. DMF or DMSO and are sparingly soluble 
in alcohol, CH3CN and CHCl3. All these complexes are diamagnetic, indicating the presence of 
molybdenum in the + 6 oxidation state, and are nonconducting in solution.  
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2.3.2. Spectral Characteristics  
Spectral characteristics of compounds 1–3 are listed in Table 2.2. Infrared spectra of all the 
complexes are mostly similar. The ligand exhibit the IR bands of minimum intensity at 3269  
cm–1 [ν(OH)], 3057 cm–1 [ν(NH)], and 1673 cm–1 [ν(C=O)] [27–33] . Characteristic strong bands 
at 1607 cm–1 and 1576 cm-1 region due to ν(C=C/aromatic) and ν(C=N) stretching modes of the 
ligand [23,29] are located in the spectra of both the ligand and the complexes. The Mo=O 
stretching modes occur as a pair of sharp strong peaks in the 937–892 cm–1 range [23,25–29]. 
The representative IR spectra of ligand H2L
 and complex 1 are shown in Figs. 2.1 and 2.2, 
respectively. 
 A number of absorption bands are observed in the UV-vis region. The DMSO solution of all the 
complexes display a shoulder in the 410–402 nm region and two strong absorptions are located 
in the 316–311 and 270–219 nm range, which are assignable to L→Mo(dπ) LMCT and 
intraligand transitions respectively [23,28,29]. Electronic absorption spectra of              
[(MoO2L)2 ( -4,4'-bipy)] (3) is shown in Fig. 2.3 as the representative one. 
The 1H and 13C NMR spectroscopic data of the free ligand and all the complexes are given in the 
experimental section. The 1H NMR spectrum of the free ligand exhibits an –OH (phenolic) 
resonance at δ = 12.14 ppm, –NH resonance at δ = 11.32 ppm and –CH resonance at δ = 8.66 
ppm. All the aromatic proton signals of ligands and complexes are observed in the expected 
region δ = 8.71–6.87 ppm. The signal for the –OH and –NH protons disappeared, indicating the 
deprotonation of the phenolic –OH and –NH groups in the complexes (1-3) [23–29]. The 
chemical shift of the coordinated EtOH of complex 1 exhibits an –OH (enolic) resonance at δ = 
4.37 ppm, –CH2 resonance at δ = 3.43 ppm and –CH3 resonance at δ = 1.05 ppm. These data are 
different compared to the chemical shifts found [46] for free molecule at 4.63, 3.44 and 1.06 ppm 
respectively. The 13C signals expected from coordinated EtOH are clearly observed in the 
expected region. Therefore, the NMR data of complex 1 clearly indicates that the labile solvent 
molecule e.g. EtOH stay coordinated during the solution study. The representative NMR spectra 
of complex 1 and complex 2b are shown in Figs. 2.4 and 2.5, respectively. 
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Table 2.2 Characteristic IR[a] bands and electronic spectral data[b] for the studied ligand and 
complexes 
 
Compounds                                   ν(–OH)    ν(C═N)     v(Mo=O)/cm–1       λmax/nm (ε/dm
3
mol
–1
cm
–1
) 
 
H2L                                                   3269         1576                 --               327 (23614), 217 (15785) 
[MoO2L
 
(C2H5OH)]  (1)                      --           1555           937, 913         402 (9439), 316 (25123), 219 (16352) 
[MoO2L(Imz)] (2a)                              --           1556           935, 892        403 (9569), 316 (26126), 220 (15711) 
[MoO2L(1-MeImz)]  (2b)                    --           1596           912,898         410 (10801), 315 (23470), 266 (16352) 
[(MoO2L)2( -4,4'-bipy)] (3)                --           1556           932, 910        404 (6393), 311 (22768), 270 (16939) 
 
 [a] 
In KBr pellet; 
[b] 
In DMSO 
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Fig. 2.1 IR spectrum of H2L  
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Fig. 2.2 IR spectrum of [MoO2L(EtOH)] (1)  
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 Fig. 2.3 Electronic absorption spectra of [(MoO2L)2 ( -4,4'-bipy)] (3) in DMSO, at 25
0 C 
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Fig. 2.4 1H NMR spectrum of [MoO2L(EtOH)] (1) in DMSO d6. 
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Fig. 2.5 1H NMR spectrum of [MoO2L(1-MeImz)] (2b) in DMSO d6. 
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2.3.3. Electrochemical properties  
Electrochemical properties of the complexes have been studied by cyclic voltammetry in DMF 
solution (0⋅1 M TBAP). Voltammetric data are given in Table 2.3. The CV trace of complex 1 
exhibits one irreversible reductive response at –0.81 V, which may be assigned to MoVI/MoV 
process [23]. But the CV traces of complexes 2a and 2b exhibit two irreversible reductive 
responses within the potential window –0.71 to –0.73 V and –0.92 to –1.00 V, which are 
possibly assigned to MoVI/MoV and MoV/MoIV processes respectively [28].  
The dinuclear complex 3 exhibit three successive irreversible one-electron reductions within the 
potential window –0.79 to –1.61 V versus Ag/AgCl in DMF which are assigned to              
MoVI–MoVI/MoV–MoVI and MoV–MoVI/MoV–MoV processes and the ligand (bridging)-centered 
reduction, respectively [29]. The cyclic voltammogram of MoO2L(C2H5OH) (1) and 
[(MoO2L)2( -4,4'-bipy)] (3) are displayed in Figs. 2.6 and 2.7 as the representative. 
 
Table 2.3 Cyclic voltammetric results for dioxomolybdenum (VI) complexes at 298 K 
 
 
 
Complex                                                Epc [V]
[a]
 
[MoO2L
 
(C2H5OH)]  (1)                         –0.81 
[MoO2L(Imz)] (2a)                                –0.71, –0.92 
[MoO2L(1-MeImz)] (2b)                       –0.73, –1.00 
[(MoO2L)2( -4,4'-bipy)] (3)                  –0.79, –1.35, –1.61 
 
 
                       
[a]
 Solvent: DMF; working electrode: platinum; auxiliary electrode: platinum; reference electrode: 
Ag/AgCl; supporting electrolyte: 0.1 M TBAP; scan rate: 50 mV/s. Epc is the cathodic peak potential.  
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Fig. 2.6 Cyclic voltammogram of [MoO2L(C2H5OH)] (1) in DMF  
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.7 Cyclic voltammogram of [(MoO2L)2( -4,4'-bipy)] (3) in DMF  
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2.3.4. Description of the X-ray structure of complex [MoO2L(C2H5OH)] (1) 
Reaction of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L) with [MoO2(acac)2] proceeds 
smoothly in refluxing ethanol to afford a orange complex in a decent yield. Though the 
preliminary characterization data (microanalysis, 1H NMR and IR) indicated the presence of the 
ligand, two oxo, and an ethanol in this complex, they could not point to any definite 
stereochemistry of the complex, as well as the coordination mode of H2L in it. For an 
unambiguous characterization of this complex, its structure has been determined by X-ray 
crystallography. The structure is shown in Fig. 2.8 and some relevant bond parameters are listed 
in Table 2.4. The structure shows that the ligand is coordinated to MoO2
+2 as a ONO-donor, with 
bite angles of 81.08(5)° [N(1)–Mo(1)–O(1)] and 71.11(5)° [O(2)–Mo(1)–N(1)]. One ethanol 
molecule is also coordinated to the metal center. This complex is therefore formulated as 
[MoO2L(C2H5OH)] (1), where L refers to the benzoylhydrazone of 2-hydroxybenzaldehyde 
ligand coordinated as in Scheme 2.1. The observed microanalytical data are also consistent with 
this composition. In this [MoO2L(C2H5OH)] complex molybdenum is sitting in a NO5 
coordination sphere, which is significantly distorted from ideal octahedral geometry as reflected 
in the bond parameters around the metal center. The Mo=O distance is quite normal [4,23,28,29] 
and so are the Mo–O, Mo–N, C=N and N–N bond lengths within the Mo(L) fragment. The    
Mo–O(C2H5OH) bond lengths in complex 1 is longer than the normal single bond lengths 
[2.362(2) Å against 1.928 (1)–2.020 (1) Å] and that indicates the labile site available for 
substitutions. This possibility is realized in the facile formation of adducts of the general formula 
[MoO2L(Q)] (2a and 2b). 
 
2.3.5. X-ray structures of complexes [MoO2L(Imz)] (2a), [MoO2L(1-MeImz)] (2b) and 
[(MoO2L)2( -4,4'-bipy)] (3) 
The formation of mixed- ligand mononuclear [MoO2L(Q)] complexes have been achieved by the 
reaction of 1 with different Lewis bases {Q = imidazole (2a), 1-methylimidazole (2b)} in 
excellent yield. The dinuclear dioxomolybdenum(VI) complex [(MoO2L)2( -4,4'-bipy)] (3) was 
achieved by the reaction of 1 and 4,4'-bipyridine as exo-bidentate ligand under reflux condition.  
The common characteristic of these structures is the absence of a metal-coordinating solvent 
molecule, and its replacement by a heterocyclic bases through the nitrogen atom. The atom 
numbering schemes for the complexes 2a and 2b are given in Figs. 2.9 and 2.10 with the 
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relevant bond distances and angles collected in Tables 2.5 and 2.6 respectively. The molecular 
structures of complexes, [MoO2L(Imz)] (2a) and [MoO2L(1-MeImz)] (2b) have shown that the 
dinegative hydrazone ligands (H2L) bind to the molybdenum(VI) center by O(1), N(1), O(2)–
donor atoms. The fourth coordination site around molybdenum (VI) is occupied by imidazole 
ligand in complex 2a and by 1-methylimidazole in 2b through its tertiary nitrogen N(3), forming 
distorted octahedral complexes. The rather large Mo(1)–N(3) distance are [2.348(4) Å (2a) and 
2.353(3) Å (2b)] revealed that the imidazole and 1-methylimidazole moiety are also rather 
weakly coordinated to the MoO2
2+ core [4,23,28,29]. The Mo–O (oxo) bond distances of the 
MoO2
2+ group are unexceptional [23,29] and almost equal [1.695(2)–1.706(3) Å] for both the 
complexes (2a and 2b). The ligand coordinates to the MoO2
2+ core in the deprotonated enolate 
form because in complexes 1, 2a and 2b the C–O bond distances [C(8)–O(2)] exhibit values of 
1.311(2), 1.335(4) and 1.325(5) Å respectively and are nearer to a C–O single bond than to a C–
O double bond distance. However, it falls short of the pure C–O single bond distance of 1.42 Å 
because of the delocalization of electrons.  
The dinuclear complex, 3 (Fig. 2.11, Table 2.7) crystallizes in the monoclinic space group P21/n 
with the molecule sitting across a crystallographic center of inversion. Each half of the dinuclear 
complex [(MoO2L)2( -4,4'-bipy)] closely resembles the structure of the other half of the 
complex. The coordination environment around the Mo (VI) center is octahedral and highly 
distorted. The ligand H2L is dianionic and tridentate, with its meridionally situated donor sites  
O(1), N(1), and O(2) lying in the equatorial plane along with the oxo oxygen O(4). The bond 
distances about Mo(1) reveal the magnitude of the distortions, as can be seen in Table 2.7. The 
Mo–O distances range from 1.688(4) Å for the oxo ligand O(3), located in an axial position, to 
1.990(3) Å for the enolate oxygen O(2). The Mo(1)–O(1) (phenolate) distance is slightly shorter 
at 1.923(4) Å. The second axial position is occupied by a nitrogen atom of the bridging 4,4'-
bipyridine ligand, which is significantly farther from the Mo center than the other five ligated 
atoms. Mo(1)–N(3), at 2.487(4) Å, is undoubtedly the weakest of the six Mo–L bonds and 
consequently the most susceptible to ligand exchange [29]. The chelate bite angles for the five- 
and six-membered rings have values within the expected ranges [O(2)–Mo(1)–N(1), 71.61(1) ; 
O(1)–Mo(1)–N(1), 81.2(1) ].  
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Table 2.4 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 1  
Distances 
              Mo(1)-O(1)                       1.928(1)                        Mo(1)-O(2)                      2.020(1) 
              Mo(1)-O(3)                       1.698(2)                        Mo(1)-O(4)                      1.702(1) 
              Mo(1)-O(5)                       2.362(2)                        Mo(1)-N(1)                      2.237(1) 
Angles 
              O(1)-Mo(1)-O(2)               149.09(5)                     O(1)-Mo(1)-O(3)              99.19(7) 
              O(1)-Mo(1)-O(4)               102.65(6)                     O(1)-Mo(1)-O(5)              82.08(5) 
              O(1)-Mo(1)-N(1)               81.08(5)                       O(2)-Mo(1)-O(3)              96.54(6) 
              O(2)-Mo(1)-O(4)               98.39(6)                       O(2)-Mo(1)-O(5)              78.51(5) 
              O(2)-Mo(1)-N(1)               71.11(5)                       O(3)-Mo(1)-O(4)              105.81(7) 
              O(3)-Mo(1)-O(5)               171.06(6)                     O(3)-Mo(1)-N(1)              95.12(7) 
              O(4)-Mo(1)-O(5)               82.41(6)                       O(4)-Mo(1)-N(1)              157.69(6) 
              O(5)-Mo(1)-N(1)               76.28(5) 
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Table 2.5 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 2a 
 
Distances 
              Mo(1)-O(1)                       1.929(4)                        Mo(1)-O(2)                      2.028(3) 
              Mo(1)-O(3)                       1.697(3)                        Mo(1)-O(4)                      1.695(2) 
              Mo(1)-N(1)                       2.251(3)                        Mo(1)-N(3)                      2.348(4) 
Angles 
              O(1)-Mo(1)-O(2)               150.0(1)                       O(1)-Mo(1)-O(3)              100.8(2) 
              O(1)-Mo(1)-O(4)               104.4(1)                       O(1)-Mo(1)-N(1)              81.4(1)                      
              O(1)-Mo(1)-N(3)               83.7(1)                         O(2)-Mo(1)-O(3)              93.2(1) 
              O(2)-Mo(1)-O(4)               97.5(1)                         O(2)-Mo(1)-N(1)              71.6(1)                 
              O(2)-Mo(1)-N(3)               78.5(1)                         O(3)-Mo(1)-O(4)              104.3(2) 
              O(3)-Mo(1)-N(1)               92.4(1)                         O(3)-Mo(1)-N(3)              169.0(1) 
              O(4)-Mo(1)-N(1)               160.7(1)                       O(4)-Mo(1)-N(3)              84.0(1) 
              N(1)-Mo(1)-N(3)               78.3(1) 
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Table 2.6 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 2b 
 
Distances 
              Mo(1)-O(1)                       1.905(3)                        Mo(1)-O(2)                      2.010(3) 
              Mo(1)-O(3)                       1.703(3)                        Mo(1)-O(4)                      1.706(3) 
              Mo(1)-N(1)                       2.239(3)                        Mo(1)-N(3)                      2.353(3) 
Angles 
              O(1)-Mo(1)-O(2)               150.4(1)                       O(1)-Mo(1)-O(3)               100.2(1) 
              O(1)-Mo(1)-O(4)               103.9(1)                       O(1)-Mo(1)-N(1)               82.1(1)                      
              O(1)-Mo(1)-N(3)               81.5(1)                         O(2)-Mo(1)-O(3)               94.3(1) 
              O(2)-Mo(1)-O(4)               96.7(1)                         O(2)-Mo(1)-N(1)               71.9(1)                 
              O(2)-Mo(1)-N(3)               79.6(1)                         O(3)-Mo(1)-O(4)               106.0(1) 
              O(3)-Mo(1)-N(1)               91.0(1)                         O(3)-Mo(1)-N(3)               168.8(1) 
              O(4)-Mo(1)-N(1)               160.4(1)                       O(4)-Mo(1)-N(3)               84.2(1) 
              N(1)-Mo(1)-N(3)               78.2(1) 
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Table 2.7 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 3 
 
Distances 
              Mo(1)-O(1)                       1.923(4)                        Mo(1)-O(2)                      1.990(3) 
              Mo(1)-O(3)                       1.688(4)                        Mo(1)-O(4)                      1.703(4) 
              Mo(1)-N(1)                       2.249(4)                        Mo(1)-N(3)                      2.487(4) 
Angles 
              O(1)-Mo(1)-O(2)               148.5(1)                       O(1)-Mo(1)-O(3)              98.8(2) 
              O(1)-Mo(1)-O(4)               104.2(2)                       O(1)-Mo(1)-N(1)              81.2(1)                      
              O(1)-Mo(1)-N(3)               80.7(1)                         O(2)-Mo(1)-O(3)              99.0(2) 
              O(2)-Mo(1)-O(4)               95.5(2)                         O(2)-Mo(1)-N(1)              71.61(1)                 
              O(2)-Mo(1)-N(3)               77.8(1)                         O(3)-Mo(1)-O(4)              106.2(2) 
              O(3)-Mo(1)-N(1)               94.6(2)                         O(3)-Mo(1)-N(3)              171.3(2) 
              O(4)-Mo(1)-N(1)               157.2(2)                       O(4)-Mo(1)-N(3)              82.2(2) 
              N(1)-Mo(1)-N(3)               76.8(1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.8. ORTEP diagram of [MoO2L(C2H5OH)] (1) with atom labeling scheme  
at 50% probability 
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Fig. 2.9. ORTEP diagram of [MoO2L(Imz)] (2a) with atom labeling scheme  
at 50% probability 
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Fig. 2.10. ORTEP diagram of [MoO2L(1-MeImz)] (2b) with atom labeling scheme  
at 50% probability 
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Fig. 2.11. ORTEP diagram of [(MoO2L)2 ( -4,4'-bipy)] (3) with atom labeling scheme  
at 50% probability 
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2.3.6. Antibacterial activity 
In vitro antimicrobial activity of the synthesized oxomolybdenum(VI) complexes (1–3) have 
been tested against the pathogenic strains of Escherichia coli, Bacillus subtilis and Pseudomonas 
aeruginosa by agar well-diffusion method and in some cases they showed promising results by 
giving the MIC value lesser than the standard drug examined. The results (Table 2.8) also 
indicate that the corresponding oxomolybdenum(VI) complexes showed much better 
antibacterial activity with respect to the individual ligand against the same microorganism under 
identical experimental conditions which is in agreement with the previous results [16,41,45,47–
49]. A possible explanation is that, by coordination, the polarity of the ligand and the central 
metal ion are reduced through the charge equilibration, which favors permeation of the 
complexes through the lipid layer of the bacterial cell membrane [16,41,45,47–49]. 
From the zone of inhibition, it is observed that the complex 2a and 2b showed most promising 
results as compared to the other compounds (1 and 3) of this study and the difference in value 
may be attributed to the nature of compounds synthesized with imidazole as co- ligands [50,51]. 
Imidazole is a five membered planar ring, which is soluble in water and other polar solvent and 
also highly polar due to its dipole moment. Therefore, the liophilicity of the compounds (2a and 
2b) is increased due to these above factors and it may be the possible reasons for increasing the 
zone of inhibition. The result for the octahedral complex (1) is least promising especially for E.coli as 
compared to 2a and 2b, probably due to the presence of ethanol molecule in the coordination sphere. 
Against some of the tested bacterial species the inhibitory action for 3 has no significant effect 
may be because of its dimeric structure. Antibacterial activity of the similar type oxo-metal 
complexes has also been reported by Sharma et al. [52] , Chohan et al. [53] and Prasad et al. [54] 
using agar well diffusion technique against Escherichia coli, Shigella flexenari, Pseudomonas 
aeruginosa, Salmonella typhi, Staphylococcus aureus and Bacillus subtilis and the present results 
are in accordance with the reported values.  
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Table 2.8 Minimum Inhibitory Concentration (MIC) value in µg/mL of the Schiff base ligand 
(H2L), oxomolybdenum(VI) complexes (1–3) and standard drugs against pathogenic strains
 
 
 
                                               E.coli       Bacillus subtilis       Pseudomonas aeruginosa     
 
H2L
    
                    125                             500                            -- 
[MoO2L(C2H5OH)] (1)                       125                             62.5                                       -- 
[MoO2L(Imz)] (2a)                             15.6                            15.6                                     1000 
[MoO2L(1-MeImz)](2b)                     15.6                            125                                      1000 
[(MoO2L)2 ( -4,4'-bipy)] (3)               125                               --                                        500 
Vancomycin                                         30                               30                                          -- 
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2.4. Conclusions 
In summary, this chapter presents the synthesis and structures of a mononuclear Schiff base 
complex (1), some mixed- ligand mononuclear (2a and 2b) and diimine bridged dinuclear (3) 
oxomolybdenum(VI) complexes, and sheds some light on their antibacterial activity. The 
coordinated ethanol of oxomolybdenum(VI) complex [MoO2L(C2H5OH)] (1) with 
aroylhydrazone is found to act as a substrate-binding site, and mixed- ligand six-coordinate 
adducts, like [MoO2L(Imz)] (2a), [MoO2L(1-MeImz)] (2b) and [(MoO2L)2( -4,4'-bipy)] (3) are 
easily formed by the attachment of imidazole, 1-methylimidazole and 4,4'-bipyridine to this 
position as co-ligand respectively. The complexes have been screened for their antibacterial 
activity against Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. The minimum 
inhibitory concentration of these complexes and antibacterial activity indicates the compound 
(2a) and (2b) as the potential lead molecule for drug designing.  
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Chapter 3 
Synthesis, Structural Studies, Biological and Catalytic Activity of Dioxomolybdenum(VI) 
Complexes with Aroylhydrazones of Naphthol-Derivative 
 
Abstract  
Reaction of the salicyloylhydrazone of 2-hydroxy-1-naphthaldehyde (H2L
1), anthranylhydrazone 
of 2-hydroxy-1-naphthaldehyde (H2L
2), benzoylhydrazone of 2-hydroxy-1-acetonaphthone 
(H2L
3) and anthranylhydrazone of 2-hydroxy-1-acetonaphthone (H2L
4; general abbreviation 
H2L) with [MoO2(acac)2] afforded a series of 5- and 6- coordinate Mo(VI) complexes of the type 
[MoO2L(ROH)] [where R = C2H5 (1) and CH3 (2)], and [MoO2L] (3 and 4). The substrate 
binding capacity of 1 has been demonstrated by the formation of one mononuclear mixed- ligand 
dioxomolybdenum complex [MoO2L
1(Q)] {where Q = γ-picoline (1a)}. Molecular structure of 
all the complexes (1, 1a, 2, 3 and 4) is determined by X-ray crystallography, demonstrating the 
dibasic tridentate behaviour of ligands. All the complexes show two irreversible reductive 
responses within the potential window –0.73 to –1.08 V, due to MoVI/MoV and MoV/MoIV 
processes. The complexes have been screened for their antibacterial activity against Escherichia 
coli, Bacillus subtilis, Proteus vulgaris and Klebsiella pneumoniae. Minimum inhibitory 
concentration of these complexes and antibacterial activity indicates 1 and 1a as the potential 
lead molecule for drug designing. Catalytic potential of these complexes was tested for the 
oxidation of benzoin using 30% aqueous H2O2 as an oxidant in methanol. At least four reaction 
products benzoic acid, benzaldehyde-dimethylacetal, methylbenzoate and benzil were obtained 
with the 95-99% conversion under optimized reaction conditions. Oxidative bromination of 
salicylaldehyde, a functional mimic of haloperoxidases, in aqueous H2O2/KBr in the presence of 
HClO4 at room temperature has also been carried out successfully.  
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3.1. Introduction 
Schiff bases, characterized by the azomethine group (–RC=N–), form a significant class of 
compounds in medicinal and pharmaceutical chemistry and are known to have biological 
applications due to their antibacterial [1–6], antifungal [3–6] and antitumor [7,8] activity. The 
incorporation of transition metals into these compounds leads to the enhancement of their 
biological activities and decrease in the cytotoxicity of both the metal ion and Schiff ba se ligand 
[9–11]. On the other hand, aroylhydrazones are excellent multidentate ligands for transition 
metals. They have been shown to exhibit a range of biological e.g. antiamoebic activity [12] and 
DNA synthesis inhibition or antiproliferative behavior [13–15]. For quite some time, our group 
has been engaged in a program aimed at credible synthesis of oxygen and nitrogen co-ordinated 
transition metal compounds in order to approach the biological co-ordination units as potential 
lead molecules for drug designing. Accordingly, our group has synthesized and examined a 
number of transition metal-Schiff base compounds using aroylhydrazone as tridentate ONO– 
donor ligand [16–18]. Their properties can be tuned by modification of either the aromatic 
aldehyde or the hydrazide component. Our aim was to increase lipophilicity using bulky 
aromatic groups and to investigate the influence on the coordination sphere as well as reactivity 
by the use of aroylhydrazone of naphthol-derivatives.  
The coordination chemistry of molybdenum has become a fascinating area of research in recent 
years because of the presence of molybdenum in metalloenzymes [19–25]. Catalytic applications 
of molybdenum complexes in organic transformations, particularly in the epoxidation of alkenes 
have been explored much as evidenced by number of publications [26–39]. The catalytic activity 
of molybdenum complexes are sensitive to the donor/acceptor ability of the ligand, and to steric 
and strain factors. Therefore, we have designed sterically hindered/ bulky ONO donor 
aroylhydrazones of naphthol-derivative (Scheme 3.1) in the light of above factors to prepare 
dioxomolybdenum(VI) complexes. Varying the steric bulk of the aroylhydrazone ligands also 
controls the coordination number of the molybdenum in these complexes. Novel structural 
features, reactivity patterns of these complexes and their catalytic activity for the oxidation of 
benzoin are reported here. Selective transformation of -hydroxyketone to the corresponding -
diketone is one of the most important fundamental reactions in organic chemistry [40–41]. The 
catalytic potential of dioxomolybdenum(VI) complexes for the oxidative bromination of 
salicylaldehyde, as functional mimic of haloperoxidase has also been explored.  
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3.2. Experimental 
 
3.2.1. Materials 
[MoO2(acac)2] was prepared as described in the literature [42]. Reagent grade solvents were 
dried and distilled prior to use. All other chemicals were reagent grade, available commercially 
and used as received. Commercially available TBAP (tetra butyl ammonium perchlorate) was 
dried and used as a supporting electrolyte for recording cyclic voltammograms of the complexes.  
 
3.2.2. Physical Measurements 
Elemental analyses were performed on a Vario ELcube CHNS Elemental analyzer. IR spectra 
were recorded on a Perkin-Elmer Spectrum RXI spectrometer. 1H NMR spectra were recorded 
with a Bruker Ultra shield 400 MHz spectrometer using SiMe4 as an internal standard. Electronic 
spectra were recorded on a Lamda25, PerkinElmer spectrophotometer. Electrochemical data 
were collected using a PAR electrochemical analyzer and a PC-controlled 
Potentiostat/Galvanostat (PAR 273A) at 298 K in a dry nitrogen atmosphere. Cyclic 
voltammetry experiments were carried out with a platinum working electrode, platinum auxiliary 
electrode, Ag/AgCl as reference electrode and TBAP as supporting electrolyte. A Shimadzu 
2010 plus gas-chromatograph fitted with an Rtx-1 capillary column (30 m × 0.25 mm × 0.25 μm) 
and a FID detector was used to analyze the reaction products  and their quantifications were made 
on the basis of the relative peak area of the respective product. The identity of the products was 
confirmed using a GC-MS model Perkin-Elmer, Clarus 500 and comparing the fragments of each 
product with the library available. The percent conversion of substrate and selectivity of products 
was calculated from GC data using the formulae:  
          
% Conversion of substrate
Peak area of a substrate
Total area of substrate + products
X 100100=
% Selectivity of a product =
Peak area of a product
Total area of products
X 100
 
 
3.2.2.1. Product Quantification 
For oxidation of benzoin, the percentage of substrate and oxidation products are usually 
quantified by GC itself from the relative peak area of the respective product. For bromination of 
salicylaldehyde, white products form in solution where HBr, Br2 etc. are present hence it requires 
extraction with CH2Cl2 and the crude mass is dissolved in methanol and then subjected to GC. 
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Some researchers are usually used internal standard, but this is a very tedious method. Therefore, 
the substrate and products both were analysed by GC using the formulae discussed as above. 
 
3.2.3. Synthesis of Ligands (H2L
1–4) 
Schiff base ligands, H2L
1-4 were prepared by the condensation of carbonyl compounds and the 
respective acidhydrazide in equimolar ratio in ethanol medium by a standard procedure [43]. The 
resulting yellowish- white compounds were filtered, washed with ethanol and dried over fused 
CaCl2.  
H2L
1: Yield: 0.22g (72%). Anal. Calcd for C18H14N2O3: C, 70.58; H, 4.61; N, 9.15. Found: C, 
70.59; H, 4.59; N, 9.12%. 1H NMR (DMSO-d6, 400 MHz):  = 12.74 (s, 1H, naphthyl–OH), 
12.07 (s, 1H, NH), 11.87 (s, 1H, aryl-OH), 9.54 (s, 1H, HC═N), 8.33–6.62 (m, 10H, Aromatic) 
ppm. 13C NMR (DMSO-d6, 100 MHz):  = 163.72, 158.51, 157.89, 147.44, 133.78, 132.68, 
131.44, 128.69, 128.55, 127.57, 127.50, 123.33, 120.73, 118.92, 118.65, 117.05, 115.48,108.36.  
 
H2L
2: Yield: 0.19g (62%). Anal. Calcd for C18H15N3O2: C, 70.81; H, 4.95; N, 13.76. Found: C, 
70.78; H, 4.92; N, 13.77%. 1H NMR (DMSO-d6, 400 MHz):  = 12.97 (s, 1H, naphthyl–OH), 
12.04 (s, 1H, NH), 9.47 (s, 1H, HC═N), 8.18–6.64 (m, 10H, Aromatic), 6.61 (s, 2H, NH2) ppm. 
13C NMR (DMSO-d6,100 MHz):  =165.12, 158.33, 150.93, 146.33, 133.18, 132.91, 132.07, 
129.45, 128.57, 128.25, 128.16, 123.96, 120.88, 119.42, 117.12, 115.14, 112.62, 109.06.  
 
H2L
3: Yield: 0.18g (63%). Anal. Calcd for C19H16N2O2: C, 74.98; H, 5.30; N, 9.20. Found: C, 
74.97; H, 5.32; N, 9.18%. 1H NMR (DMSO-d6, 400 MHz):  = 10.31 (s, 1H, naphthyl–OH), 9.55 
(s, 1H, NH), 7.91–7.27 (m, 11H, Aromatic), 2.34 (s, 3H, CH3) ppm. 
13C NMR (DMSO-d6,100 
MHz):  = 153.71, 152.63, 134.24, 131.82, 131.51, 130.21, 129.06, 128.76, 128.36, 128.23, 
127.86, 127.43, 126.99, 123.67, 123.19, 118.99, 118.71, 113.74, 24.30.  
 
H2L
4: Yield: 0.21g (65%). Anal. Calcd for C19H17N3O2: C, 71.47; H, 5.36 ; N, 13.16. Found: C, 
71.45; H, 5.33; N, 13.15%. 1H NMR (DMSO-d6, 400 MHz):  = 10.35 (s, 1H, naphthyl–OH), 
9.17 (s, 1H, NH), 7.91–6.23 (m, 10H, Aromatic), 6.05 (s, 2H, NH2), 2.35 (s, 3H, CH3) ppm.
 13C 
NMR (DMSO-d6, 100 MHz):  =153.98, 152.47, 152.36, 149.84, 132.47, 131.56, 130.22, 
129.09, 128.34, 127.98, 127.67, 123.78, 123.14, 118.94, 117.04, 115.46, 114.69, 113.59, 24.15. 
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3.2.4. Synthesis of complexes (1–4) 
These complexes were prepared modifying a previously published procedure [44–46]. To a 
refluxing solution of ligand, H2L
1–4 (1.0 mmol) in 30 mL of alcohol {ethanol (1 and 2) and 
methanol (3 and 4)}, 1.0 mmol of MoO2(acac)2 was added. The color of the solution changed to 
dark red. The mixture was then refluxed for 3 hr. After leaving the solution for 2 days at room 
temperature, fine red colored crystals were isolated. Crystals of most complexes were suitable 
for single crystal X-ray analysis.  
 
[MoO2L
1(C2H5OH)](1): Yield: 0.29g (60%). Anal. Calcd for C20H18N2O6Mo: C, 50.20; H, 3.76; 
N, 5.85. Found: C, 50.18; H, 3.77; N, 5.84%. 1H NMR (DMSO-d6, 400 MHz):  = 11.41 (s, 1H, 
aryl–OH), 10.07 (s, 1H, HC═N), 8.61–6.99 (m, 10H, Aromatic), 4.36 (s, 1H, OH–ethanol), 3.42 
(q, 2H, CH2–ethanol), 1.05 (s, 3H, CH3–ethanol) ppm.
 13C NMR (DMSO-d6, 100 MHz):  = 
168.19, 160.20, 158.59, 152.76, 136.14, 134.01, 132.51, 129.03, 128.99, 128.89, 128.49, 124.91, 
121.87, 120.25, 119.38, 117.10, 113.21, 111.65, 56.00, 18.54.  
 
[MoO2L
2(CH3OH)] (2): Yield: 0.23g (53%). Anal. Calcd for C19H17N3O5Mo: C, 49.26; H, 3.70; 
N, 9.07. Found: C, 49.25; H, 3.68; N, 9.08%. 1H NMR (DMSO-d6, 400 MHz):  = 9.92 (s, 1H, 
HC═N), 8.57–6.65 (m, 10H, Aromatic), 7.12 (s, 2H, NH2), 4.10 (s, 1H, OH-methanol), 3.15 (s, 
3H, CH3- methanol) ppm.
 13C NMR (DMSO-d6, 100 MHz):  = 169.06, 160.58, 151.88, 150.05, 
135.93, 133.01, 132.91, 130.33, 129.44, 129.25, 128.77, 125.15, 122.16, 120.86, 116.51, 115.18, 
112.26, 109.63, 49.07.  
 
[MoO2L
3](3): Yield: 0.26g (54%). Anal. Calcd for C19H14N2O4Mo: C, 53.04; H, 3.28; N, 6.51. 
Found: C, 53.06; H, 3.26; N, 6.50%. 1H NMR (DMSO-d6, 400 MHz):  = 8.11–7.18 (m, 11H, 
Aromatic), 2.93 (s, 3H, CH3), ppm.
 13C NMR (DMSO-d6,100 MHz):  = 169.36, 165.06, 163.01, 
152.34, 134.25, 132.43, 131.88, 130.98, 130.13, 129.41, 129.24, 128.52, 127.84, 126.07, 125.02, 
120.38, 119.84, 116.46, 24.23.  
 
[MoO2L
4](4): Yield: 0.21g (52%). Anal. Calcd for C19H15N3O4Mo: C, 51.23; H, 3.37; N, 9.43. 
Found: C, 51.24; H, 3.35; N, 9.44%. 1H NMR (DMSO-d6, 400 MHz):  = 8.01–6.87 (m, 10H, 
Aromatic), 7.04 (s, 2H, NH2), 2.86 (s, 3H, CH3) ppm.
 13C NMR (DMSO-d6,100 MHz):  = 
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170.36, 162.91, 162.82, 150.17, 134.03, 133.14, 131.87, 130.36, 130.07, 129.37, 127.77, 126.08, 
124.96, 120.38, 119.82, 116.53, 115.47,110.15, 24.40.  
 
3.2.5. Synthesis of mixed-ligand complex [{MoO2L
1(Q)}, where Q = γ-picoline (1a)]  
To a clear red solution of (1) (0.50 mmol) in CH3CN (30 mL), γ-picoline (0.73 mmol) was added 
and the mixture was refluxed for 3 hr. Slow evaporation of the red filtrate over 2 days produced 
dark red crystals. These were separated by filtration. Yield 0.25g (57%). Anal. Calcd for 
C24H19N3O5Mo: C, 54.85; H, 3.61; N, 8.00. Found: C, 54.86; H, 3.59; N, 8.01%. 
1H NMR 
(DMSO-d6, 400 MHz):  = 11.42 (s, 1H, aryl–OH), 10.08 (s, 1H, HC═N), 8.62–6.99 (m, 10H, 
Aromatic), 7.24–6.97 (m, 4H, Aromatic– –picoline), 2.31 (s, 3H, CH3– –picoline) ppm.
 13C 
NMR (DMSO-d6, 100 MHz):  = 168.69, 160.70, 159.09, 153.26, 149.76, 147.22, 136.62, 
134.49, 133.00, 129.52, 129.47, 129.38, 128.97, 125.38, 125.11, 122.35, 120.73, 119.85, 117.58, 
114.35, 113.71, 112.15, 110.15, 19.02. 
 
3.2.6. Crystallography 
Suitable single crystal of 1, 1a and 2-4 was chosen for X-ray diffraction studies. Crystallographic 
data and details of refinement are given in Table 3.1. The unit cell parameters and the intensity 
data for the complexes (1, 2, 3 and 4) were collected at ~ 293 K, on a Bruker Smart Apex CCD 
diffractometer and complex (1a) was collected at 100 K, on a Bruker Smart Apex II CCD 
diffractometer using graphite monochromated Mo K  radiation (λ = 0.71073 Å), employing the 
ω–2θ scan techniques. The intensity data were corrected for Lorentz, polarization and absorption 
effects. The structures were solved using the SHELXS97 [47] and refined using the SHELXL97 
[48] computer programs. The non-hydrogen atoms were refined anisotropically.  
 
3.2.7. Antibacterial activity  
Antibacterial activity of the compounds (ligands and complexes) was studied against Escherichia 
coli (E. coli), Bacillus subtilis, Proteus vulgaris and Klebsiella pneumoniae by agar well 
diffusion technique. Mueller Hinton-agar (containing 1% peptone, 0.6% yeast extract, 0.5% beef 
extract and 0.5% NaCl, at pH 6.9–7.1) plates were prepared and 0.5–McFarland culture (1.5  
108 cells /mL) of the test organisms were swabbed onto the agar plate (as per CLSI guidelines,  
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 2006) [49]. Test compounds were dissolved in DMSO at several concentrations ranging from 
1000 µg/mL–1.95 µg/mL. 9 mm wide wells were dug on the agar plate using a sterile cork borer. 
A solution of 100 µg/mL of each test compound from each dilution was added into each of the 
well using a micropipette. These plates were incubated for 24 h at 35 ± 2 °C. The growth of the 
test organisms was inhibited by diffusion of the test compounds and then the inhibition zones 
developed on the plates were measured [16,50–51]. The effectiveness of an antibacterial agent in 
sensitivity is based on the diameter of the zones of inhibition which is measured to the nearest 
millimeter (mm). The standard drug Vancomycin and Amoxycillin were also tested for their 
antibacterial activity at the same concentration under the conditions similar to that of the test 
compounds as +ve control. DMSO alone was used as a –ve control under the same conditions for 
each organism. 
 
3.2.8. Catalytic Reactions 
3.2.8.1. Oxidation of benzoin  
In a typical oxidation reaction, benzoin (1.06 g, 5 mmol), aqueous 30% H2O2 (1.71 g, 15 mmol) 
and catalyst (0.0005 g) were mixed in methanol (10 mL). The reaction mixture was heated under 
reflux with stirring for 4 hr. The progress of the reaction was monitored by withdrawing samples 
at different time intervals and samples were extracted with n-hexane and then analysed 
quantitatively by gas chromatography. The effect of various parameters such as amount of 
catalyst, amount of oxidant, and solvent were checked to optimize the conditions for the best 
performance of the catalyst. The identity of the products was confirmed by GC-mass. 
 
3.2.8.2. Oxidative bromination of salicylaldehyde 
Salicylaldehyde (0.610 g, 5 mmol) was added to an aqueous solution (20 mL) of KBr (1.785 g, 
15 mmol), followed by addition of aqueous 30% H2O2 (1.71 g, 15 mmol) in a 100 mL reaction 
flask. The catalyst (0.0005 g) and 70% HClO4 (0.715 g, 5 mmol) were added, and the reaction 
mixture was stirred at room temperature (20 0C). Three additional 5 mmol portions of 70% 
HClO4 were further added to the reaction mixture in three equal portions at 45 minutes intervals 
under continuous stirring. After 3 hr, the separated white products were extracted with CH2Cl2 
and dried. The crude mass was dissolved in methanol and was subjected to gas chromatography. 
The identity of the products was confirmed as mentioned above.  
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Table 3.1 Crystal and Refinement Data of Complexes 1, 1a, 2, 3 and 4 
Compound 1 1a 2 3 4 
Formula C20H18N2O6Mo C24H19N3O5Mo C19H17N3O5Mo C19H14N2O4Mo C19H15N3O4Mo 
M 478.30 525.36 463.30 430.26 445.28 
Crystal 
symmetry 
Triclinic  Monoclinic Triclinic  Monoclinic Monoclinic 
Space group P-1 
P 21/c 
P-1 P21/c P21/n 
a(Å) 7.8196(2) 13.313(2) 8.1198(5) 4.0623(12) 7.8923(3) 
b(Å) 11.1222(3) 8.0476(14) 9.9276(6) 25.842(8) 13.8894(5) 
c(Å) 11.4265(3) 21.357(3) 12.3349(8) 15.761(5) 15.3314(6) 
 (°) 80.0650(10) 90 101.8430(10) 90 90 
β (°) 85.1030(10) 68.156(11) 103.7180(10) 98.332(16) 100.355(2) 
 (°) 82.1190(10) 90 91.6650(10) 90 90 
V(Å
3
) 967.69(4) 2123.9(6) 942.23(10) 1637.1(9) 1653.24(11) 
Z 2 4 2 4 4 
Dcalc(g.cm
-3
) 1.642 1.643 1.633 1.746 1.789 
F(000) 484 1064 468 864 896 
(Mo-K ) 
(mm
-1
) 
0.718 0.661 0.732 0.830 0.827 
max./min.trans. 0.9514 / 0.8999 0.9934 / 0.9804 0.9370 / 0.8981 0.9755 / 0.9366 0.9918 / 0.9598 
2 (max)(
o
) 30.00 25.42 26.00 26.00 25.99 
Reflections 
collected / 
unique 
20284 / 5821 3820 / 3820 9689 / 3671 26708 / 3181 26992 / 3249 
R1
a
[I>2 (I)] R1 = 0.0335, 
wR2=0.0781 
R1 = 0.0670, 
wR2= 0.0974 
R1 = 0.0250, 
wR2 = 0.0669 
R1 = 0.0676, 
wR2 = 0.1673 
R1 = 0.0387, 
wR2 = 0.0881 
wR2
b
[all data] R1 = 0.0432, 
wR2=0.0836 
R1 = 0.1298, 
wR2= 0.1143 
R1 = 0.0267, 
wR2=0.0681 
R1 = 0.0789, 
wR2 = 0.1730 
R1 = 0.0633, 
wR2=0.0992 
S[goodness of 
fit] 
1.044 1.044 1.099 1.157 1.089 
min./max. 
res.(e.Å
-3
) 
0.691 / -0.535 1.041/-0.667 0.333 / -0.233 2.007 / -1.890 0.372 / -0.467 
 
a
R1 = Σ FO  - FC / Σ  FO .  
 
b
wR2 = {Σ [w (FO
2
- FC
2
)
2]/Σ [w (FO
2
)
2
]}
½
. 
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3.3. Results and Discussion 
3.3.1. Synthesis  
Reactions of the selected aroylhydrazones (c.f. Scheme 3.1) with [MoO2(acac)2] in refluxing 
alcohol afforded two different types of MoVI complexes, [MoO2L(ROH)] and [MoO2L]; 
Equations 1 and 2. The formation of mixed-ligand mononuclear complex [MoO2L(Q)] {where Q 
= γ-picoline (1a)} has been achieved by the reaction of 1 with γ-picoline; Equation 3. Proposed 
structures of these complexes (Scheme 3.2) are based on their spectroscopic characterization (IR, 
electronic and 1H NMR spectroscopy), elemental analyses and single crystal X-ray diffraction 
studies. The ligands coordinate through their dianionic (ONO)2– enolate tautomeric forms. 
 
[MoO2(acac)2] + H2L + ROH  [MoO2L(ROH)] + 2Hacac                                        (1) 
[H2L = H2L
1
, R = C2H5: (1) and H2L = H2L
2
, R = CH3: (2)]    
[MoO2(acac)2] + H2L  [MoO2L]n + 2Hacac                                                            (2) 
[H2L = H2L
3, n = ∞: (3) and H2L = H2L
4
, n = 1: (4)] 
[MoO2L
1
(C2H5OH)] + Q  [MoO2L
1
Q] + C2H5OH                                                     (3) 
[Q = γ-picoline: (1a)] 
All these complexes are highly soluble in aprotic solvents, viz. DMF or DMSO and are sparingly 
soluble in alcohol, CH3CN and CHCl3. All these complexes are diamagnetic, indicating the 
presence of molybdenum in the +6 oxidation state, and are nonconducting in solution.  
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Scheme 3.1. Schematic representation of Ligand.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.2. Possible bonding modes of Mo(VI) complexes 
 
 
Ligand X Complex  
 
H2L
1
 
H2L
1
 
H2L
2
 
H2L
3
 
H2L
4
 
 
C2H5OH 
γ-picoline 
CH3OH 
-- 
-- 
 
[MoO2L
1
 (C2H5OH)] (1) 
[MoO2L
1
 (γ -pic)] (1a) 
[MoO2L
2
(CH3OH)] (2) 
[MoO2L
3
]n (3) 
[MoO2L
4
] (4) 
O
N N
R1
O
R
Mo
O
O
X
76 
 
3.3.2. Spectral properties  
Spectral characteristics of compounds are listed in Table 3.2. All the ligands exhibit the bands at 
3368–3323 cm-1 [ν(OH)], 3135–3022 cm-1 [ν(NH)] and 1652–1623 cm-1 [ν(C=O)] region, are 
disappeared in complexes [16, 52-53]. Characteristic strong bands at 1622–1592 cm-1 and 1555–
1605 cm-1 due to ν(C=C/aromatic) and ν(C=N) stretching modes of the ligand are located in the 
spectra of both the ligands and the complexes [16,52–53]. In addition, 1, 1a, 2 and 4 display two 
strong peaks in the range 937–902 cm–1 due to terminal ν(M=Ot) stretch [16,52–54]. There are 
two relatively strong and broad peaks around 863–821 cm-1 due to weakened (Mo–O Mo) for 
oligomeric complex 3, observed. The representative IR spectra of ligand H2L
1 and complex 1 are 
shown in Figs. 3.1 and 3.2 respectively. 
The DMSO solution of all the complexes display a medium intensity band in the 468–423 nm 
region and two strong absorptions in the 340–256 nm range which are assignable to ligand to 
molybdenum (pπ–dπ) charge transfer (LMCT) and intraligand transitions, respectively [16,52–
53]. Electronic spectra of all the complexes are shown in Fig. 3.3. 
The 1H and 13C NMR (DMSO-d6) data of all the free ligands and their corresponding 
dioxomolybdenum(VI) complexes are given in the experimental section. The spectra of the free 
ligands exhibit a resonance at δ = 12.97–10.31 ppm due to naphthyl –OH (H2L
1–4), at δ = 9.54–
9.47 ppm due to –HC=N protons (H2L
1–2) and at δ = 2.35–2.34 ppm due to –CH3 protons (H2L
3–
4), respectively. All the aromatic protons of ligands are clearly observed in the expected region δ 
= 8.33–6.23 ppm. In the NMR spectra of complexes, the absence of signal due to aromatic 
(naphthyl) –OH indicates that the phenolic group is coordinated to the metal centre after proton 
replacement [16,52–53]. Similarly, the absence of signal due to –NH proton in the complexes 
suggests that the ligands are coordinated to the metal center via enolic form. The representative 
NMR spectra of ligand H2L
2 and complex 2 are shown in Figs.3.4 and 3.5 respectively. 
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Table 3.2 Characteristic IR[a] bands and electronic spectral data[b] for the studied complexes (1, 
1a and 2–4) 
 
Compounds                          ν(C═O)        ν(C═N)         v(Mo=O)            λmax/nm (ε/dm
3
 mol
–1
 cm
–1
) 
 
H2L
1                                                               
1621             1570                  --                  327 (2064), 257 (5321) 
H2L
2
                                        1637             1555                  --                  323 (1925), 257 (5246) 
H2L
3
                                        1652             1572                  --                  335 (1854), 256 (5136) 
H2L
4
                                        1652             1583                  --                  337 (1938), 257 (5148) 
[MoO2L
1
(C2H5OH)] (1)            --                1602             937, 913           447 (5890), 340 (1591), 257 (1915) 
[MoO2L
1
(γ-pic)] (1a)                 --               1595             923, 902           446 (5505), 339 (1361), 257 (1770) 
[MoO2L
2
(CH3OH)] (2)              --               1597              931, 902          468 (51649), 329 (12711), 256 (13024) 
[MoO2L
3
]n (3)                            --               1593              863, 821           423 (10701), 329 (23470), 258 (20373) 
[MoO2L
4
] (4)                             --               1590              935, 915           442 (10433), 329 (14886), 258 (27667) 
 
[a] 
In KBr pellet; 
[b] 
In DMSO 
 
 
 
 
 
 
 
 
 
 
 
78 
 
 
 
 
 
 
 
 
 
Fig. 3.1 IR spectrum of H2L
1  
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Fig. 3.2 IR spectrum of [MoO2L
1(C2H5OH)] (1) 
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Fig. 3.3 Electronic absorption spectra of Complexes (1, 1a and 2–4) in DMSO, at 250 C 
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Fig. 3.4 1H NMR spectrum of [H2L
2] in DMSO d6 
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Fig. 3.5 1H NMR spectrum of [MoO2L
2(CH3OH] (2) in DMSO d6 
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3.3.3. Electrochemical properties  
Electrochemical properties of the complexes have been studied by cyclic voltammetry in DMF 
solution (0.1 M TBAP). Voltammetric data are given in Table 3.3 and the cyclic voltamogram of 
MoO2L
2(CH3OH) (2) is displayed in Fig. 3.6 as the representative one. The CV traces of 
complexes (1–5) exhibit two irreversible reductive responses within the potential window –0.73 
to –0.81 V and –1.03 to –1.08 V, which are assigned to MoVI/MoV and MoV/MoIV processes 
respectively.  The lack of anodic response, even at a high scan rate, is clearly due to rapid 
decomposition of the reduced species [16,52–53]. 
 
 
 
Table 3.3 Cyclic voltammetric results for dioxomolybdenum (VI) complexes (1, 1a and 2–4) at 
298 K 
 
 
           Complex                                                 Epc [V]
[a] 
 
 
[MoO2L
1
(C2H5OH)] (1)                                       –0.81, –1.03 
[MoO2L
1
(γ-pic)] (1a)                                           –0.79, –1.06 
[MoO2L
2
(CH3OH)] (2)                                        –0.73, –1.08 
[MoO2L
3
]n (3)                                                      –0.75, –1.07 
[MoO2L
4
] (4)                                                       –0.77, –1.06 
 
[a]
 Solvent: DMF; working electrode: platinum; auxiliary electrode: platinum; reference electrode: 
Ag/AgCl; supporting electrolyte: 0.1 M TBAP; scan rate: 50 mV/s. Epc is the cathodic peak potential 
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Fig. 3.6 Cyclic voltammogram of [MoO2L
2(CH3OH)] (2) in DMF  
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3.3.4. Description of the X-ray structure of complexes [MoO2L
1(C2H5OH)] (1), 
[MoO2L
2(CH3OH)] (2) and [MoO2L
3] (3) 
The molecular structure and the atom numbering schemes for the complex [MoO2L
1(C2H5OH)] 
(1), [MoO2L
2(CH3OH)] (2) and [MoO2L
3] (3) are shown in Figs 3.7–3.9 respectively, with the 
relevant bond distances and angles collected in Table 3.4. The coordination geometry around the 
molybdenum (VI) atom in 1, 2 and 3 reveals a distorted octahedral environment with an NO5 
coordination sphere (Scheme 3.2). Each ligand molecule behaves as dianionic tridentate one 
binding through the phenolate oxygen O(1), the enolate oxygen O(2) and the imine nitrogen 
N(1). In all three complexes, one of the two oxo group O(4) is located trans to the imine nitrogen 
in the same plane. For complexes 1 and 2 the other oxo group O(3) is located in the axial plane 
with the solvent molecule [C2H5OH (1) and CH3OH (2)]. Whereas in complex 3 along with the 
two oxo-oxygens, O(3) and O(4), the three ONO donor points of the ligand complete the five 
coordinate environment around the Mo(VI) acceptor center, the disposition of the donor points 
being roughly square pyramidal. The sixth coordination site, trans to the oxo-oxygen O(3), is 
occupied by an oxo-oxygen O(3!) of the next neighboring complex molecule and this pattern is 
repeated leading to a chain of MoO2L
3 molecules (Fig. 3.10). This may be visualized as an effect 
of stacking of the complex molecules along the z-axis [55]. The length of the Mo–O(3!) bond 
(2.374Å) is considerably longer than the other Mo–O bonds, the longest of which [Mo–O(2)] is 
1.982(5) Å which suggest that this should be explained as oligomeric structure where one of the 
oxygen of one molybdenum weakly interacts with other. The bond between Mo and the 
azomethine nitrogen in the complexes are within a range of 2.225–2.234 Ǻ which is 
comparatively longer than other Mo–N single bonds. This is due to the trans effect generated by 
the oxo group trans to the Mo–N bond [52].  
The angular distortion in the octahedral environment around Mo comes from the bites taken by 
the Schiff base ligand, angles O(1)–Mo(1)–N(1) is [80.56(6)° (1), 80.12(6)° (2), 79.2(2)° (3)] 
and angles O(2)–Mo(1)–N(1) is [72.33(6)° (1), 71.88(6)° (2) and 72.4(2)° (3)]. For the same 
reason the trans angles O(1)–Mo(1)–O(2) and O(4)–Mo(1)–N(1) are significantly reduced from 
the ideal value of 180°, the trans-axial angle O(3)–Mo(1)–O(5) is 172.09(7)° (complex 1) and 
171.46(8)° (complex 2). The two oxo oxygen of MoO2 groups is almost equal [average 1.696(2) 
& 1.697(2)]. The Mo–O(alcohol) bond [2.383(2) Å (1) and 2.294(2) Å (2)] is significantly longer 
than the other Mo–O bonds [1.694(2)–2.001(2) Å (1) and 1.693(2)–1.992(1) (2) Å] indicating 
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that the alcohol molecule is weakly bonded to the MoO2
2+ core and this position holds the 
possibility of functioning as a substrate-binding site of the general formula [MoO2L(Q)]. 
 
3.3.5. Description of the X-ray structure of complex [MoO2L
1(γ-pic)] (1a) 
The atom numbering scheme for the complex 1a is given in Fig. 3.11 with the relevant bond 
distances and angles collected in Table 3.4. The molecular structures of complex,        
[MoO2L
1(γ-pic)] has shown that the dinegative hydrazone ligand (H2L
1) bind to the 
molybdenum(VI) center by O(1), N(1), O(2)–donor atoms. The fourth coordination site around 
molybdenum (VI) is occupied by γ-picoline ligand in complex 1a through its tertiary nitrogen N 
(3), forming distorted octahedral complex. The rather large Mo(1)–N(3) distance is [2.427(5) Å] 
revealed that the γ-picoline moiety is also rather weakly coordinated to the MoO2
2+ core 
[16,19,53]. The Mo–O (oxo) bond distances of the MoO2
2+ group is unexceptional [16,19,53] 
and almost equal [1.698(4)–1.713(3) Å]. The ligand coordinate to the MoO2
2+ core in the 
deprotonated enolate form because, in complexes (1) and (1a) the C–O bond distances [C(12)–
O(2)] exhibit values of 1.314(3) and 1.329(6) Å respectively and are nearer to a C–O single bond 
than to a C–O double bond distance. However, it falls short of the pure C–O single bond distance 
of 1.42 Å because of the delocalization of electrons.  
 
3.3.6. Description of the X-ray structure of complex [MoO2L
4] (4) 
We have employed the steric bulk on aroylhydrazones ligand (H2L
4) (Scheme 3.1) to gain 
control of the coordination number around the Mo(VI) center. Structural studies indicate that, 
with increasing steric bulk, control of the coordination number around the Mo(VI) center is 
achieved by the formation of 5-coordinate dioxomolybdenum(VI) complex of the type [MoO2L
4] 
(4) (Scheme 3.2). The molecular structure and the atom numbering schemes of 4 is shown in 
Fig. 3.12. In this compound (MoO2L
4) the coordination geometry of Mo(VI) is similar to that 
observed earlier [53], which consist of two oxo oxygen atoms, one enolate oxygen, one 
phenolate oxygen, and an azomethine nitrogen atom. This is the rare example of a five–
coordinate Mo(VI) complex [53,56]. No structural evidence for the achievement of 
hexacoordination through Mo–O···Mo bridging is observed. The molecular geometry of 
[MoO2L
4] is best represented as a square-pyramid with one axial oxo oxygen atom [O(3)], and 
three O atoms [O(1,2,4)] and the N(1) atom describing the equatorial plane, which is slightly 
87 
 
distorted from an ideal geometry, as reflected in the bond parameters (Table 3.4) around the 
metal center. The length of the Mo–O(4) bond lying trans to N(1) is practically equal to Mo-
O(3); the position trans to O(3) remains unoccupied. The other Mo–O and Mo–N distances are 
normal, as observed in other structurally characterized complexes of molybdenum containing 
these bonds [52–53]. The bite angles of the ligand at Mo, O(2)–Mo(1)–N(1) and O(1)–Mo(1)–
N(1), are 72.3(1)° and 80.2(1)°, respectively, generating five-membered and six-membered 
chelate rings at the MoVI center.  
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Table 3.4. Selected Bond Distances [Å] and Bond Angles [˚] for Complex 1, 1a, 2, 3 and 4 
 
 
 
 
Complex 1 
 
Complex 1a 
 
Complex 2 
 
Complex 3 
 
 
Complex 4 
 
Bond lengths  
 
 
 
 
 
 
 
 
 
 
Mo(1)-O(1)    1.918(1) 1.915(4) 1.925(1) 1.892(5) 1.924(3) 
Mo(1)-O(2) 2.001(2) 2.015(5) 1.992(1) 1.982(5) 1.992(3) 
Mo(1)-O(3) 1.694(2) 1.698(4) 1.693(2) 1.701(5) 1.689(3) 
Mo(1)-O(4) 1.697(2) 1.713(3) 1.706(2) 1.689(5) 1.700(3) 
Mo(1)-O(5) 2.383(2) -- 2.294(2) -- -- 
Mo(1)-N(1) 
Mo(1)-O(3)#1 
 
Bond Angles 
2.225(2) 
-- 
2.219(4) 
 
2.234(2) 
-- 
2.231(5) 
2.374(5) 
 
2.222(3) 
-- 
O(1)-Mo(1)-O(2) 149.49(6) 148.9(2) 146.78(6) 146.8(2) 147.0(1) 
O(1)-Mo(1)-O(3) 99.78(7) 101.1(2) 99.25(8) 101.0(2) 99.9(1) 
O(1)-Mo(1)-O(4) 102.68(7) 101.9(2) 104.25(7) 100.8(2) 101.7(1) 
O(1)-Mo(1)-O(5) 80.24(6) -- 79.38(7) -- -- 
O(1)-Mo(1)-N(1) 80.56(6) 80.0(2) 80.12(6) 79.2(2) 80.2(1) 
O(2)-Mo(1)-O(3) 97.25(7) 95.9(2) 99.37(7) 99.3(2) 100. 9(1) 
O(2)-Mo(1)-O(4) 96.68(7) 98.4(2) 97.07(7) 98.6(2) 96.3(1) 
O(2)-Mo(1)-O(5) 79.49(6) -- 78.15(6) -- -- 
O(2)-Mo(1)-N(1) 72.33(6) 72.5(2) 71.88(6) 72.4(2) 72.3(1) 
O(3)-Mo(1)-O(4) 105.95(8) 105.4(2) 105.19(8) 105.7(3) 107.1(1) 
O(3)-Mo(1)-O(5) 172.09(7) -- 171.46(8) -- -- 
O(3)-Mo(1)-N(1) 97.11(7) 95.5(2) 92.28(7) 97.5(2) 96.4(1) 
O(4)-Mo(1)-O(5) 81.67(7) -- 83.28(7) -- -- 
O(4)-Mo(1)-N(1) 155.65(7) 158.0(2) 160.84(7) 156.2(2) 155.6(1) 
O(5)-Mo(1)-N(1) 
  O(3)-Mo(1)-O(3)#1 
75.06(6) 
-- 
-- 
-- 
79.18(6) 
-- 
-- 
170.8(2) 
 
-- 
-- 
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Fig. 3.7. ORTEP diagram of [MoO2L
1(C2H5OH)] (1) with atom labeling scheme  
at 50% probability. 
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Fig. 3.8. ORTEP diagram of [MoO2L
2(CH3OH)] (2) with atom labeling scheme   
at 50% probability. 
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Fig. 3.9. ORTEP diagram of asymmetry unit of [MoO2L
3]n (3) with atom labeling scheme  
at 50% probability. 
. 
 
 
 
 
 
 
 
92 
 
 
 
 
 
 
 
 
 
Fig. 3.10. One dimensional polymeric diagram of [MoO2L
3]n (3) 
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Fig. 3.11. ORTEP diagram of [MoO2L
1(γ-pic)] (1a) with atom labeling scheme  
at 50% probability. 
. 
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Fig. 3.12. ORTEP diagram of [MoO2L
4 ] (4) with atom labeling scheme  
at 50% probability. 
.  
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3.3.7. Antibacterial activity 
All synthesized ligands and complexes were evaluated for their in vitro antimicrobial activity 
against the pathogenic strains of Escherichia coli, Bacillus subtilis, Proteus vulgaris and 
Klebsiella pneumoniae by agar well-diffusion method and their MIC values are represented in 
Table 3.5 and Fig.3.13. It is clearly observed that in some cases they showed promising results 
by giving the MIC value lesser than the standard drug examined. The results also indicate that 
the corresponding dioxomolybdenum(VI) complexes showed much better antibacterial activity 
with respect to the individual ligand against the same microorganism under identical 
experimental conditions which is in agreement with the previous results [16,50–51,57–60]. A 
possible explanation is that, by coordination, the polarity of the ligand and the central metal ion 
are reduced through the charge equilibration, which favors permeation of the complexes through 
the lipid layer of the bacterial cell membrane [16,50–51,57–60]. 
From the zone of inhibition, it is observed that the complex 1 and 1a showed most promising 
results as compared to the other compounds (2, 3 and 4) of this study and the difference in value 
may be attributed to their distorted octahedral geometry and nature of compounds synthesized in 
presence of one molecule of ethanol in the coordination sphere of the metallic ion (1) and with  
γ-picoline as co- ligand (1a) [61–62]. The result for the octahedral complex (2) is least promising 
as compared to (1) and (1a), probably due to the presence of methanol in the coordination 
sphere. Against some of the tested bacterial species the inhibitory action for complex (3) and (4) 
are less significant may be because of their polymeric and square pyramidal structure 
respectively. 
Antibacterial activity of the similar type oxo-metal complexes has also been reported by our 
group [16,17] Sharma et al. [63], Chohan et al. [64] and Prasad et al. [65] using agar well 
diffusion technique against Escherichia coli, Shigella flexenari, Pseudomonas aeruginosa, 
Salmonella typhi, Staphylococcus aureus and Bacillus subtilis and the present results are in 
accordance with the reported values. However, the difference in value may be attributed to the 
nature of compounds synthesized with different ligands.  
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Table 3.5 Minimum Inhibitory Concentration (MIC) value in µg/mL of the Schiff base ligand 
(H2L
1–4), dioxomolybdenum (VI) complexes (1, 1a and 2–4) and standard drugs against 
pathogenic strains 
 
 
                                      E.coli      Bacillus subtilis       Proteus vulgari      Klebsiella pneumoniae 
H2L
1    
              --                   62.5                         125                                 -- 
H2L
2                          
--                     --                             --                                   -- 
H2L
3                                                                        
--                    125                         250                                  -- 
H2L
4                                                                        
--
                               
125                         500                                  -- 
[MoO2L
1
(C2H5OH)] (1)            62.5                   15.6                        15.6                              15.6 
[MoO2L
1 (γ-pic)] (1a)               15.6                   62.5                        15.6                              15.6 
[MoO2L
2 
(CH3OH)] (2)               --                     15.6                        125                                 -- 
[MoO2L
3
]n (3)                              --                     62.5                        62.5                                -- 
[MoO2L
4
] (4)                             15.6                   15.6                        62.5                                -- 
Vancomycin                               30                      30                             --                                30 
Amoxycillin                                --                       --                            25                                 -- 
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Fig. 3.13 Minimum Inhibitory Concentration (MIC) of the Schiff base ligand (H2L
1–4), their 
corresponding Mo(VI) complexes (1–4) and standard drugs against pathogenic strains.  
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3.3.8. Catalytic Activity Studies   
3.3.8.1. Oxidation of benzoin 
The oxidation of benzoin has attracted the attention of researchers because one of its oxidized 
product, benzil, is a very useful intermediate for the synthesis of heterocyclic compounds and 
benzylic acid rearrangements [66]. The oxidation of benzoin was successfully achieved with the  
molybdenum complexes using 30% aqueous H2O2 as oxidant. The products mainly obtained 
were benzoic acid, benzaldehyde-dimethylacetal, methylbenzoate and benzil (Scheme 3.3).  
 
 
 
 
Scheme 3.3. Various oxidation products of benzoin. (a) benzoic acid, (b) benzaldehyde-
dimethylacetal, (c) methylbenzoate and (d) benzil.  
 
To optimize the reaction conditions for the maximum oxidation of benzoin, [MoO2L
2(CH3OH)] 
(2) was considered as a representative catalyst. The effect of oxidant was studied by considering 
the substrate to oxidant ratios of 1 : 1, 1 : 2 and 1 : 3 for the fixed amount of catalyst (0.0005 g) 
and substrate (1.06 g, 5 mmol) in 10 mL of refluxing methanol. As shown in Fig. 3.14 and entry 
no. 3 of Table 3.6, a maximum of 96 % conversion of benzoin was achieved at the substrate to 
oxidant ratio of 1:3, in 4 hr of reaction time. Lowering the amount of oxidant decreases the 
conversion. The effect of amount of catalyst on the oxidation of benzoin was studied considering 
three different amounts of [MoO2L
2(CH3OH)] (2) viz. 0.0005, 0.001 and 0.0015 g for the fixed 
amount of benzoin (1.06 g, 5 mmol) and 30% H2O2 (1.7 g, 15 mmol) in 10 mL of methanol and 
reaction was monitored at reflux temperature of methanol. A maximum of 96 % conversion was 
achieved with 0.0005 g of catalyst. This conversion improved only marginally to 98% whereas 
0.0015 g of catalyst gave a maximum conversion of 99 % in 4 hr of reaction time (Fig. 3.15). 
Thus at the expense of catalyst, only 0.0005 g of catalyst can be considered sufficient to optimize 
other reaction conditions. The amount of solvent also influences on the oxidation of benzoin.  It 
was concluded (Fig. 3.16 and entry no. 3, 4 and 5 of Table 3.6) that 10 mL methanol was 
O
OH
OH
O
OO
CH3 CH3
OCH3
O O
O
a b c d
Catalyst
H2O2 / MeOH
99 
 
sufficient to effect maximum conversion under above optimized reaction conditions. Table 3.6 
summarizes conversion of benzoin under different experimental conditions. Thus, from these 
experiments, the best reaction conditions for the maximum oxidation of benzoin as concluded 
are: catalyst [MoO2L
2(CH3OH)] (2) (0.0005 g), benzoin (1.06 g, 5 mmol) and 30% H2O2 (1.7 g, 
15 mmol) and refluxing methanol (10 mL).  
Fig. 3.17 presents the selectivity of products along with the conversion of benzoin as a function 
of time (4 hr) under the optimal experimental conditions as concluded above, i.e. benzoin (1.06 
g, 5 mmol), 30% H2O2 (1.7 g, 15 mmol), [MoO2L
2(CH3OH)] (2) (0.0005 g) and methanol (10 
mL) under reflux condition. It is clear from the plot that all products form with the conversion of 
benzoin. The highest selectivity of benzoic acid (ca. 51%) was observed in the first one hour. 
With the elapse of time its selectivity slowly decreases and finally becomes almost constant and 
reaches 47 % after 4hr. Similar results have been observed in case of methyl benzoate and benzil 
and reach 23 and 16 %, respectively. The selectivity of benzaldehyde-dimethylacetal increases 
continuously from 3 to 14 %. Thus, with the maximum benzoin oxidation of 96 % after 4 hr of 
reaction time, the selectivity of the reaction products varies in the order: benzoic acid (47 %) > 
methyl benzoate (23 %), > benzil (16 %) > benzaldehyde-dimethylacetal (14 %).  
Under these reaction conditions other catalysts were also tested and results are compared in     
Fig. 3.18 while Table 3.7 provides turnover frequency (TOF) and selectivity details. The data 
presented in table show that other complexes are also catalytically active and show equally good 
activity with very high turnover frequency (TOF: 1021–1301 h–1) but the selectivity order of 
various products slightly differs. In the absence of the catalyst, the reaction mixture showed 60% 
conversion where selectivity of different products follows the order: benzil (48%) > benzoic acid 
(27%) > benzaldehyde-dimethylacetal (20%) > methyl benzoate (5%). Thus, these complexes 
not only enhance the catalytic action, they also alter the selectivity of the products.  
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Table 3.6 Conversion of benzoin (1.06 g, 5 mmol) using [MoO2L
2(CH3OH)] (2) as catalyst in    
4 hr of reaction time under different reaction conditions.  
 
Entry No. Catalyst [g] H2O2 [g, mmol] CH3OH [ml] Conversion  [%] 
1 
2 
3 
4 
5 
6 
7 
0.0005 
0.0005 
0.0005 
0.0005 
0.0005 
0.001 
0.0015 
0.57, 05 
1.14, 10 
1.71, 15 
1.71, 15 
1.71, 15 
1.71, 15 
1.71, 15 
10 
10 
10 
15 
20 
10 
10 
83 
88 
96 
89 
81 
98 
99 
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Table 3.7 Effect of different catalysts on the oxidation of benzoin, TOF and product selectivity 
 
Catalyst [g] TOF 
[h
–1
] 
Conversion 
[%] 
Selectivity [%]
[a]
   
a b c d 
[MoO2L
1
(C2H5OH)] (1) 1148 96 29 22 31 18 
[MoO2L
1(γ-pic)] ( 1a) 1301 99 31 26 26 17 
[MoO2L
2
(CH3OH)] (2) 1110 96 47 14 23 16 
[MoO2L
3
]n (3) 1021 95 40 25 22 13 
[MoO2L
4
] (4) 1073 96 40 24 22 14 
Without catalyst  60 27 20 5 48 
[a]
 (a) benzoic acid, (b) benzaldehyde-dimethylacetal, (c) methylbenzoate and (d) benzil.  
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Fig. 3.14. Effect of oxidant amount on the oxidation of benzoin. Reaction conditions: benzoin 
(1.06 g, 5 mmol), catalyst amount (0.0005 g) and methanol (10 mL).  
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Fig. 3.15. Effect of catalyst amount on the oxidation of benzoin. Reaction conditions: benzoin 
(1.06 g, 5 mmol), 30 % H2O2 (1.7 g, 15 mmol) and methanol (10 mL).  
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Fig. 3.16. Effect of solvent (methanol) amount on the oxidation of benzoin. Reaction conditions: 
benzoin (1.06 g, 5 mmol), catalyst amount (0.0005 g) and 30% H2O2 (1.7 g, 15 mmol). 
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Fig. 3.17. Plot showing percentage conversion of benzoin and the selectivity of benzoic acid, 
benzaldehyde dimethylacetal, methyl benzoate and benzil formation as a function of time. 
Reaction condition: benzoin (1.06 g, 5 mmol), H2O2 (1.7 g, 15 mmol), [MoO2L
2(CH3OH)], 2  
(0.0005 g) and 10 mL methanol.  
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Fig. 3.18. Comparison of various catalysts on the oxidation of benzoin. Reaction conditions: 
benzoin (1.06 g, 5 mmol), 30% H2O2 (1.7 gm, 15 mmol), catalyst amount (0.0005 gm) and 
methanol (10 mL). 
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3.3.8.2. Oxidative bromination of salicylaldehyde  
Oxidative bromination of salicylaldehyde, a functional mimic of haloperoxidases, in aqueous 
solution at room temperature has also been carried out successfully. By using these 
dioxomolybdenum(VI) complexes as catalyst precursors in the presence of KBr, HClO4 and 
H2O2 gave mainly three products, namely 5-bromosalicylaldehyde, 3,5-dibromosalicylaldehyde 
and 2,4,6- tribromophenol; (Scheme 3.4). 
 
 
 
 
 
  
Scheme 3.4. Main products obtained upon oxidative bromination of salicylaldehyde.                                  
(a) 5-bromosalicylaldehyde, (b) 3,5-dibromosalicylaldehyde and (c) 2,4,6- tribromophenol. 
 
After several trials (Table 3.8), the best suited reaction conditions obtained for the maximum 
conversion of 5 mmol (0.610 g) of salicylaldehyde were: KBr (1.785 g, 15 mmol), aqueous 30% 
H2O2 (1.71 g, 15 mmol), catalyst (0.0005), aqueous 70% HClO4 (2.86 g, 20 mmol) and water (20 
mL). However, the addition of HClO4 in four equal portions (at t = 0, 45, 90 and 135 min. of 
reaction time) was necessary to improve the conversion of the substrate and to avoid 
decomposition of the catalyst. A total of 3 hr was required to complete the reaction. Under the 
above conditions, a maximum of 96% conversion was achieved with [MoO2L
2(CH3OH)] (2) and 
all three products were identified; Table 3.8. The presence of three equivalent of H2O2 facilitates 
not only the formation of HOBr which ultimately helps in the oxidative bromination of 
salicylaldehyde but also affects on the selectivity of different products. Other catalysts gave 
similar results. Lowering the amount of H2O2 increased the formation of                                       
5-bromosalicylaldehyde. In the absence of the catalyst, the reaction mixture gave ca. 40% 
conversion of salicylaldehyde where selectivity of the formation of 5-bromosalicylaldehyde is 
89%. 
OH
Catalyst
KBr/H2O2/HClO4
O
OH
O
OH
O
OH
Br
Br
Br
Br Br
Br
a b c
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Other complexes have also been tested under similar reaction conditions and the obtained results 
are summarized in Table 3.9. It is clear from the table that all complexes have equally good 
catalytic potential with high turnover frequency. The selectivity of the 5-bromosalicylaldehyde 
(56.5–75%) is much high for most complexes except for [MoO2L
4] (4) which exhibits only 47.5 
% selectivity. The overall selectivity of three products follows the order: 5-bromosalicylaldehyde 
> 2,4,6- tribromophenol > 3,5-dibromosalicylaldehyde.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.5. Mechanism of the catalytic oxidation of benzoin and oxidative bromination of 
salicylaldehyde  
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Table 3.8. Results of oxidative bromination of salicylaldehyde catalyzed by [MoO2L
2(CH3OH)] 
(2) after 3 hr of contact time  
 
Entry no. Catalyst [g] H2O2 [g, mmol] KBr [g, mmol] HClO4 [g, mmol] Conversion [%] 
1 0.0005 0.57, 5 1.78, 15 2.86, 20 66 
2 0.0005 1.14, 10 1.78, 15 2.86, 20 81 
3 0.0005 1.71, 15 1.78, 15 2.86, 20 96 
4 0.0005 1.71, 15 0.59, 5 2.86, 20 57 
5 0.0005 1.71, 15 1.19, 10 2.86, 20 77 
6 0.0005 1.71, 15 1.78, 15 1.43, 10 67 
7 0.0005 1.71, 15 1.78, 15 2.14, 15 89 
8 0.0010 1.71, 15 1.78, 15 2.86, 20 98 
9 0.0015 1.71, 15 1.78, 15 2.86, 20 99 
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Table 3.9. Effect of different catalysts on the oxidative bromination of salicylaldehyde, TOF and 
product selectivity. 
 
Catalyst (g) TOF  
[h
-1
] 
Conversion [%]                    Selectivity [%]
[a]
  
monobromo Dibromo Tribromo 
 
[MoO2L
1
(C2H5OH)] (1) 
 
1555 
 
98 
 
60.6 
 
1.6 
 
37.8 
[MoO2L
1(γ-pic)] ( 1a) 1673 95 75 4.4 20.5 
[MoO2L
2
(CH3OH)] (2) 1482 96 75 12.1 12.6 
[MoO2L
3
]n (3) 1415 99 56.6 1.7 41.7 
[MoO2L
4
] (4) 1470 99 47.5 1.6 51.0 
Without catalyst  40 89 0.2 10.8 
[a]
 (a) 5-bromosalicylaldehyde, (b) 3,5-dibromosalicylaldehyde and (c) 2,4,6- tribromophenol 
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3.3.8.3. Reactivity of complexes with H2O2 
Dioxomolybdenum (VI) complexes are known to react with H2O2 to form the corresponding 
oxoperoxo complexes [67]. In order to throw some light on the reaction mechanism of catalytic 
reactions (Scheme 3.5), complex [MoO2L
2(CH3OH)] (2) dissolved in DMSO was reacted with 
H2O2 and spectral changes were monitored by electronic absorption spectroscopy. Thus, the 
stepwise additions of H2O2 (1.47 g, 13 mmol) of 30% H2O2 dissolved in 5 mL of DMSO to 25 
mL of ca. 6.7 × 10–3 M solution of [MoO2L
2(CH3OH)] (2) in DMSO causes the decrease in the 
intensities of the 468 nm band and finally disappear (Fig. 3.19). Simultaneously, two bands start 
appearing at 369 and 383 nm and become intense after addition of excess of H2O2. The intensity 
of the 337 nm band decreases slowly along with the appearance of a shoulder band at ca. 312 
nm. We have interpreted this result in terms of the formation of the oxoperoxomolybdenum(VI) 
complex. The new bands at 383 and 368 nm may be assigned to LMCT and n–π* transitions, 
respectively. The later one was not visible in [MoO2L
2(CH3OH)] (2) while the band at 312 nm is 
assignable to π – π* transition. Exact mechanism for the catalytic oxidation of benzoin catalysed 
by dioxomolybdenum(VI) complex in presence of H2O2 is not clear at present. However, based 
on the oxidation products obtained and experiments carried out above it is concluded that the 
reaction used the following pathway. Where, [MoO2L
2(CH3OH)] (2)  reacts with H2O2 to give 
Mo(oxo)peroxo [MoO(O2)-] complex which finally catalyses abstraction of hydrogen from 
alcoholic group of benzoin to give benzil. By oxidative cleavage benzil produces benzoic acid 
which on subsequent esterification gives methylbenzoate. The acid produced by hydrogen 
peroxide during catalytic reaction catalyses the esterification [68]. 
During bromination process, molybdenum reacts with 1 or 2 equiv. of H2O2, forming oxoperoxo 
species, which ultimately oxidise bromide, possibly by formation of a hydroperoxo intermediate. 
The oxidised bromine species (Br2, Br3
– and/or HOBr) then brominates the substrate. The 
presence of acid was found to be essential during catalytic oxidative bromination reaction [69]. 
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Fig. 3.19. UV–Vis spectral changes observed during titration of [MoO2L
2(CH3OH)] (2) with 
H2O2. The spectra were recorded after successive additions of 1-drop portions of 30% H2O2 (13 
mmol) dissolved in 5 mL of DMSO to 25 mL of 6.7 × 10-3 M solution in DMSO. 
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3.4. Conclusions 
Synthesis of four new dioxomolybdenum(VI) complexes with aroylhydrazone of naphthol-
derivative (1, 2, 3 and 4) and one mixed- ligand mononuclear complex (1a) have been prepared 
and characterized. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis, Proteus vulgaris and Klebsiella pneumoniae. Minimum 
inhibitory concentration of these complexes and antibacterial activity indicates the complexes (1) 
and (1a) as the potential lead molecule for drug designing. The one labile binding site in these 
complexes has an added advantage as has been shown by reacting complex (2) with H2O2 to give 
corresponding peroxo species without changing original coordinating sites i.e. ONO coordination 
of ligands. Again the labile peroxo group of complexes has an added advantage as they transfer 
oxygen in catalytic oxidation as has been demonstrated for the oxidation, by peroxide, of benzoin 
using these complexes as catalysts. Under optimized reaction conditions benzoin gives 95-99% 
conversion with four reaction products benzoic acid, benzaldehyde-dimethylacetal, methyl 
benzoate and benzil. The functional mimic of haloperoxidase is demonstrated by the oxidative 
bromination of salicylaldehyde where these complexes have shown 95–99% conversion of 
salicylaldehyde to brominated and other products with high turnover frequency.  
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Chapter 4 
Synthesis, Structure and Characterization of Dimeric and Tetrameric 
Dioxomolybdenum(VI) Complexes of N,N'-Disalicyloylhydrazine 
 
Abstract 
The in situ reaction of salicyloylhydrazide and its corresponding hydrazone with [MoO2(acac)2] 
afforded two novel and unusual type dimeric [(MoVIO2)2L] (1) and tetrameric 
[{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) dioxomolybdenum(VI) complexes with            
N,N'–disalicyloylhydrazine (H2L). These binucleating ligands were formed by the self-
combination of acid hydrazide or corresponding hydrazone. The complexes were characterized 
by various spectroscopic techniques (IR, UV and NMR) and also by electrochemical study. The 
molecular structures of both have been confirmed by X-ray crystallography. The above studies 
indicate that the N,N'–disalicyloylhydrazine (H2L) has the normal tendency to form both dimeric 
and tetrameric complexes coordinated through the dianionic tridentate manner.  
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4.1. Introduction 
The coordination chemistry of transition metals with ligands from the hydrazine family has been 
of interest due to different bonding modes shown by them with both electron rich and electron 
poor metals. Acylhydrazones have been extensively investigated by chemists for the synthesis of 
coordination polymers owing to their inherent coordination and hydrogen-bonding 
donor/acceptor functionalities, as well as their biological activities [1,2].  
However, the research on the compounds with symmetrical diaroylhydrazine ligands is limited 
[3–10]. The N,N'–diacylhydrazines have value as structural components of heterocyclic ring 
systems [11], and as tuberculostatic agents [12]. The N,N'–bis-salicylhydrazine [13], which had 
previously been known to chelate a variety of metal ions [13,14], has been shown to exhibit 
potent inhibition of the human immunodeficiency virus (HIV) integrase [15]. This enzyme is a 
potential target for the development of new anti-HIV therapeutics [16]. On the other hand, 
among all the transition metals, the coordination chemistry of high-valent molybdenum(VI) with 
Schiff base ligand has attracted wide interests due to its biochemical significance [17–19], as 
well as for the involvement of molybdenum(VI) compounds as catalysts in several industria l 
processes such as amoxidation of propene, epoxidation of olefins, etc. [20,21]. In this chapter, 
we report the synthesis and structural studies of two novel di- and tetranuclear 
dioxomolybdenum(VI) complexes of N,N'–disalicyloylhydrazine. These complexes are fully 
characterized by various physicochemical techniques.  
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4.2. Experimental 
4.2.1. Materials 
[MoO2(acac)2] and salicyloyl hydrazide were prepared as described in the literature [22,23]. 
Reagent grade solvents were dried and distilled prior to use. All other chemicals were reagent 
grade, available commercially and used as received. Commercially available TBAP (tetra butyl 
ammonium perchlorate) was properly dried and used as a supporting electrolyte for recording 
cyclic voltammograms of the complexes. 
 
4.2.2. Physical Measurements 
Elemental analyses were performed on a Vario ELcube CHNS Elemental analyzer. IR spectra 
were recorded on a Perkin-Elmer Spectrum RXI spectrometer. 1H NMR spectra were recorded 
with a Bruker Ultrashield 400 MHz spectrometer using SiMe4 as an internal standard. Electronic 
spectra were recorded on a Lamda25, PerkinElmer spectrophotometer. Magnetic susceptibility 
was measured with a Sherwood Scientific AUTOMSB sample magnetometer. Electrochemical 
data were collected using a PAR electrochemical analyzer and a PC-controlled 
Potentiostat/Galvanostat (PAR 273A) at 298 K in a dry nitrogen atmosphere. Cyclic 
voltammetry experiments were carried out with a platinum working electrode, platinum auxiliary 
electrode, Ag/AgCl as reference electrode and TBAP as supporting electrolyte. X-band EPR 
measurements were performed on a JEOL JES-FA 200 instrument.  
 
4.2.3. Synthesis of salicyloylhydrazone of acetophenone  
The ligand salicyloylhydrazone of acetophenone was prepared by the condensation of equimolar 
ratio of salicyloylhydrazide 2.72 g (20.00 mmol) and acetophenone 2.38 g (20.00 mmol) in 
stirring ethanol (25 ml) for 2 hr following a standard procedure [24]. The resulting yellowish- 
white compound was filtered, washed with ethanol and dried over fused CaCl2. M.P. 160
oC. 
Yield: 0.18 g (75%). Anal. Calcd. for C15H14N2O2: C, 70.88; H, 5.55; N, 11.08. Found: C, 70.90; 
H, 5.54; N, 11.06%. 1H NMR (400 MHz, DMSO-d6): δ = 11.83 (s, 1H, OH), 11.35 (s, 1H, NH), 
8.03–6.97 (m, 9H, Aromatic), 2.33 (s, 3H, CH3),.
13C NMR (DMSO-d6, 100 MHz): δ = 164.99, 
159.50, 157.99, 149.49, 134.44, 132.08, 129.04, 128.83, 126.89, 119.85, 119.08, 117.77, 116.92, 
116.06, 14.34.  
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4.2.4. Synthesis of complex [(MoVIO2)2L] (1) 
To the refluxing solution of 0.15 g (1.0 mmol) of salicyloylhydrazide in 30 mL of ethanol 0.32 g 
(1.0 mmol) of MoO2(acac)2 was added [25]. The color of the solution changed to dark red. The 
mixture was then refluxed for 3 hr. After leaving the solution for 2 days at room temperature, 
fine dark red colored crystals were isolated and a suitable single crystal was selected for X-ray 
analysis. [(MoVIO2)2L] (1): Yield: 0.36g (68%). Anal. Calcd for C14H8N2O8Mo2: C, 32.08; H, 
1.53; N, 5.34. Found: C, 32.06; H, 1.55; N, 5.37%. 1H NMR (DMSO-d6, 400 MHz): δ = 7.94–
7.02 (m, 4H, Aromatic). 13C NMR (DMSO-d6, 100 MHz): δ = 163.55, 162.00, 135.42, 129.87, 
122.53, 120.03, 115.80.  
 
4.2.5. Synthesis of complex [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) 
0.24 g (1.00 mmol) of salicyloylhydrazone of acetophenone was dissolved in 30 mL ethanol. 
When 0.32 g (1.00 mmol) of MoO2(acac)2 was added to the solution, the color changed to dark 
orange [24]. The solution mixture was then refluxed for 3 hr. After leaving the solution for 2 
days at room temperature, fine dark orange crystals were isolated and a suitable single crystal 
was selected for X-ray analysis. [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2): Yield: 0.19g 
(73%). Anal. Calcd for C36H40N4O20Mo4: C, 35.06; H, 3.27; N, 4.55. Found: C, 35.08; H, 3.25; 
N, 4.56%. 1H NMR (DMSO-d6, 400 MHz): δ = 8.14–7.06 (m, 8H, Aromatic), 4.36 (s, 1H, OH), 
3.42 (q, 2H, CH2), 1.05 (s, 3H, CH3).
 13C NMR (DMSO-d6, 100 MHz): δ = 163.58, 163.46, 
162.42, 162.02, 135.58, 134.67, 129.87, 128.69, 122.67, 121.22, 120.10, 118.87, 115.67, 114.96, 
56.49, 55.95, 19.10, 19.00.  
 
4.2.6. Crystallography 
Suitable single crystal of 1 and 2 were chosen for X-ray diffraction studies. Crystallographic data 
and details of refinement are given in Table 4.1. Both the compounds crystallized in the Triclinic 
space group P-1. The unit cell parameters and the intensity data for the complexes were collected 
at ~293 K, on a Bruker Smart Apex CCD diffractometer using graphite monochromated Mo K  
radiation (k = 0.71073 Å), employing the ω–2θ scan technique. The intensity data were corrected 
for Lorentz, polarization and absorption effects. The structures were solved using the 
SHELXS97 [26] and refined using the SHELXL97 [27] computer programs. The non-hydrogen 
atoms were refined anisotropically.  
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Table 4.1 Crystal and Refinement Data of Complexes 1 and 2  
Compound 1 2 
Formula C14H8Mo2N2O8 C36H40Mo4N4O20 
M 524.10 1232.50 
Crystal symmetry Triclinic  Triclinic 
Space group P -1 P -1 
a(Å) 3.96540(10) 9.5892(3) 
b(Å) 9.5080(2) 10.7151(4) 
c(Å) 10.1683(2) 11.4986(4) 
 (°) 76.167(10) 68.042(10) 
β (°) 87.856(10) 73.353(10) 
 (°) 82.230(10) 81.152(2) 
V(Å
3
) 368.834(14) 1048.39(6) 
Z 1 1 
Dcalc(g.cm
-3
) 2.360 1.952 
F(000) 254 
612 
(Mo-K )(mm
-1
) 1.753 1.256 
2 (max)(
o
) 26.37 25.50 
Reflections collected 
/ unique 
11936/ 1498 9430 / 3870 
R1
a
[I>2 (I)] R1 = 0.0224, 
wR2= 0.0782 
R1 = 0.0413, 
wR2 = 0.0790 
wR2
b
[all data] R1 = 0.0214, 
wR2= 0.0815 
R1 = 0.0285, 
wR2= 0.0736 
S[goodness of fit] 0.793 1.062 
min./max. res.(e.Å
-3
) 0.843/ -0.649 0.920/ -0.873 
 
               a
R1 = Σ │FO│- │FC│/ Σ│ FO│ 
  
              b
wR2 = {Σ [w (FO
2
- FC
2
)
2]/Σ [w (FO
2
)
2
]} 
½ 
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4.3. Results and Discussion 
4.3.1. Synthesis  
Scheme 4.1 summarizes the synthesis of dioxomolybdenum(VI) complexes (1) and (2) from the 
common ligand, N,N'–disalicyloylhydrazine (H2L) employed in the present study. According to 
the demand, to provide the exact stereo and electronic environment for the stability of well 
known penta- and hexa coordinated dioxomolybdenum(VI) complexes, the N,N'–
disalicyloylhydrazine ligand (H2L) was synthesized by the self-combination of 
salicyloylhydrazide and subsequently transformed to the corresponding dioxomolybdenum(VI) 
complexes through in situ reaction of corresponding hydrazide or hydrazone and metal precursor 
MoO2(acac)2. The metal precursor in ethanol may provide the acidic medium (PH = 3.5) required 
for this self-combination. 
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Methods used for synthesis of the precursor hydrazide, hydrazone and dioxomolybdenum 
complexes (1 and 2) are given in experimental section. These compounds are highly soluble in 
aprotic solvents, viz. DMF or DMSO and are sparingly soluble in alcohol, CH3CN and CHCl3. 
Both the complexes are diamagnetic and EPR inactive, indicating the presence of molybdenum 
in the +6 oxidation state, and are nonconducting in solution.  
 
4.3.2. Spectral properties 
Spectral characteristics of precursor salicyloylhydrazone of acetophenone and complexes 1–2 are 
listed in Table 4.2. The IR spectra of the hydrazone ligand exhibits the peak at 3267 cm–1, 
1611cm–1 and 1581 cm–1 due to ν(–OH), ν(C=C/aromatic) and ν(C=N) stretching modes 
respectively. During metallation reaction the hydrazide and its hydrazone are transformed to the 
intermediate ligand N,N'–disalicyloylhydrazine and produce the corresponding 
dioxomolybdenum(VI) complexes (1 and 2). The spectra of complexes exhibit two peaks in the 
range 1602–1601 cm–1and 1579–1549 cm–1due to ν(C=C/aromatic) and ν(C=N) stretching 
modes [24] respectively. New bands at 662–644 cm–1for 1 and 2 are assigned to ν(Mo–N) 
[28,29]. In addition, 1–2 display strong and a moderately strong band in the range 944–943     
cm–1 and 921–918 cm–1 due to terminal ν(M=Ot) stretch [24]. A strong band at 752 cm
–1 for 
complex 2 may be assigned to (Mo–O–Mo) [30]. The representative IR spectra of precursor 
ligand and complex 2 are given in Figs. 4.1 and 4.2, respectively. 
The DMSO solution of all the complexes display a shoulder in the 426–423 nm region and two 
strong absorptions are located in the 314–312 and 274–260 nm range, which are assignable to 
L→Mo(dπ) LMCT and intraligand transitions respectively [24]. The electronic spectrum of 
complex 2 is shown in Fig. 4.3 as the representative one. 
The 1H and 13C NMR data of the precursor ligand and complexes are given in the experimental 
section. The spectrum of the free ligand exhibits an –OH (phenolic) resonance at δ = 11.83 ppm 
and one –NH proton resonance at δ = 11.35 ppm. All the aromatic proton signals of the precursor 
ligand are clearly observed at δ = 8.03–6.97 ppm and the CH3 proton resonance is observed at δ 
= 2.33 ppm. The NMR spectra of the metal complexes show no resonance for –OH proton due to 
coordination. The aromatic protons of 1 and 2 are observed at δ = 8.14–7.02 ppm [31]. The 
chemical shift of the coordinated C2H5OH of complex (2) exhibits an –OH resonance at δ = 4.36 
ppm, –CH2 resonance at δ = 3.42 ppm and –CH3 resonance at δ = 1.05 ppm. The representative 
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NMR spectrum of precursor ligand and [(MoVIO2)2L] (1) is displayed in Figs. 4.4 and 4.5, 
respectively. 
 
Table 4.2 Characteristic IR[a] bands and electronic spectral data[b] for the studied ligand and 
complexes (1–2) 
 
Compounds                                                     ν(C═N)     ν(Mo=O)/cm–1         λmax/nm (ε/dm
3
 mol
–1
 cm
–1
) 
 
 
Salicyloylhydrazone of acetophenone
                          
1581                --               331 (23524), 292 (15624)
 
[(Mo
VI
O2)2L] (1)                                                 1579         944, 918          426 (9439), 314 (25123), 274 (16352)  
[{(C2H5OH)LO3Mo2
VI
}2( -O)2]·C2H5OH (2)    1549         943, 921           423 (9569), 312 (26126), 260 (15711)
  
[a] 
In KBr pellet; 
[b] 
In DMSO 
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Fig. 4.1 IR spectrum of Salicyloylhydrazone of acetophenone 
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Fig. 4.2 IR spectrum of [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) 
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Fig. 4.3. Electronic absorption spectrum of [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) in 
DMSO, at 250 C 
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Fig. 4.4 1H NMR spectrum of Salicyloylhydrazone of acetophenone 
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Fig. 4.5 1H NMR spectrum of [(MoVIO2)2L] (1) in DMSO d6 
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4.3.3. Electrochemical properties  
Electrochemical properties of the complexes have been studied by cyclic voltammetry in DMSO 
solution (0.1 M TBAP). Voltammetric data are given in Table 4.3. The CV traces of complexes 
(1–2) exhibit two irreversible reductive responses within the potential window –0.05 to –0.15 V 
and –1.01 to –1.06 V, which are assigned to MoVI/MoV and MoV/MoIV processes respectively 
[24]. An oxidation wave at positive potentials in the range of +1.45 V to +1.48 V, which is 
assigned to the oxidation of the coordinated ligands [32]. As the Mo(VI) complex cannot 
undergo a metal-centered oxidation, this is attributed to a ligand-centered process [31]. The 
cyclic voltammogram of [(MoVIO2)2L] (1) is displayed in Fig.4.6 as the representative one.  
 
Table 4.3 Cyclic voltammetric results for dioxomolybdenum (VI) complexes (1–2) at 298 K 
 
 
Complexes                                                                                Epc [V]
[a] 
 
 
      [(Mo
VI
O2)2L] (1)                                                                            –0.05, –1.01 
      [{(C2H5OH)LO3Mo2
VI
}2( -O)2]·C2H5OH (2)                               –0.15, –1.06 
 
 
[a] Solvent: DMSO; working electrode: platinum; auxiliary electrode: platinum; reference 
electrode: Ag/AgCl; supporting electrolyte: 0.1 M TBAP; scan rate: 50 mV/s. Epc is the cathodic 
peak potential 
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Fig.4.6 Cyclic voltammogram of [(MoVIO2)2L] (1) in DMSO  
 
 
 
 
 
 
 
134 
 
4.3.4. Description of the X-ray structure of complex [(MoVIO2)2L] (1) and 
[{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2)  
The reaction of salicyloylhydrazide  and its corresponding hydrazone with metal precursor does 
not produce the expected complexes I and II (Scheme 4.2). However, during in situ reaction the 
hydrazide and its hydrazone are being transformed to N,N'–disalicyloylhydrazine (H2L), which 
subsequently reacts with MoO2(acac)2 and produced two novel di- and tetranuclear 
oxomolybdenum(VI) complexes [(MoO2)2L] (1) and [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH 
(2) respectively (Scheme 4.1). 
 
 
 
 
 
 
 
 
 
 
Scheme 4.2 
The molecular structure and the atom numbering schemes for the complex 1 is shown in Fig 4.7, 
with the relevant bond distances and angles collected in Table 4.4. X-ray diffraction indicates 
complex 1 crystallizes in the triclinic system with space group P-1. Each molybdenum atom 
coordinated with ‗NO4‘ chromophore adopts a distorted tetragonal pyramidal geometry.  
Both sides of the ligand behave as a tridentate (ONO) binegative one, where one side of the 
ligand offers two oxygens as donors to the Mo(1) center–one from the enolate oxygen O(1), 
another from the phenolate oxygen O(2) and the last two oxo O(3) and O(4) atoms with bite 
angles of 71.90(7) [O(1)–Mo(1)–N(1)] and 80.50(8) [O(2)–Mo(1)–N(1)] forming one five- and 
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one six-membered chelate ring. The planar structure of the chelating groups of ligand H2L in 
compound 1 favors the delocalization of the double bonds. Due to this, the N(1)–N(1A) bond 
(1.380 Å) is shorter than the standard ordinary nitrogen–nitrogen bond (1.45 Å) [33]. At the 
same time, the C(1)–N(1A) bond length (1.309 Å) is close to the length of the standard double 
carbon–nitrogen bond (1.340 Å) [13]. The lengths of other bonds and the values of bond angles 
in the organic ligands are close to standard values [33].  
Reaction of MoO2(acac)2 with salicyloylhydrazone of acetophenone can lead to  
[{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2), a novel di- -oxo tetrameric structure (Fig.4.8) 
with the relevant bond distances and angles collected in Table 4.5. The molecular structure of 2 
is almost similar to complex 1 and crystallizes in the triclinic system with space group P-1. The 
two halves of 2 are crystallographically equivalent with closely matching structural dimensions 
bridged by two oxygen atoms; hence, the structure of one half of the complex is described in 
detail.  
Both the Mo centers [Mo(1) and Mo(2)] are six coordinated having ‗NO5‘ chromophore, giving a 
distorted octahedral structure. The ligand N,N'–disalicyloylhydrazine coordinates to the 
molybdenum in the same way as complex (1). As expected from its structure, the tridentate 
ligand is bonded to the Mo(1) centre in a planar fashion involving the xy–plane, coordinating 
through the phenolate oxygen O(4), the enolate oxygen O(1), the imine nitrogen atom N(2) and 
an oxo group O(5) lying trans to N(2). The fifth and sixth position of the distorted octahedron is 
occupied by the bridging oxygen O(6) and free ethanol molecule respectively. The coordination 
around Mo(2) centre is same except the sixth position which is occupied by an oxo group O(8). 
The Mo(1)–O(9) (alcohol) bond [2.272(3) Å] is significantly longer than the other Mo(1)–O 
bonds [1.692(3)–2.029(2) Å] indicating that the alcohol molecule is weakly bonded to the 
MoO2
2+ core. The lengths of other bonds and the values of bond angles in the organic ligands are 
close to standard values [33]. In this complex (2) the molecules are bridged by O-H...O hydrogen 
bonds (dashed lines, Fig.4.9) involving the coordinated and solvent molecules of ethanol, 
forming chains propagating along the c axis direction. Detail of the classical hydrogen bonding 
of complex 2 is given in Table 4.6. 
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Table 4.4 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 1  
Distances 
              Mo(1)-O(1)                       2.037(2)                        Mo(1)-O(2)                       1.900(2)  
              Mo(1)-O(3)                       1.728(2)                        Mo(1)-O(4)                       1.693(2)  
              Mo(1)-N(1)                       2.211(2)                        N(1)-N(1A)                       1.380(3) 
              C(1)–N(1A)                       1.309(3) 
 
Angles 
              O(1)-Mo(1)-O(2)               150.01(8)                     O(1)-Mo(1)-O(3)               95.59(9) 
              O(1)-Mo(1)-O(4)               98.08(9)                       O(1)-Mo(1)-N(1)               71.90(7)                                                             
              O(2)-Mo(1)-O(3)               98.85(9)                       O(2)-Mo(1)-O(4)               103.20(9)  
              O(2)-Mo(1)-N(1)               80.50(8)                       O(3)-Mo(1)-O(4)               83.49(9) 
              O(3)-Mo(1)-N(1)               96.15(9)                       O(4)-Mo(1)-N(1)               157.24(9)                        
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Table 4.5 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 2  
Distances 
              Mo(1)-O(1)                       2.029(2)                        Mo(2)-O(2)                      1.920(3) 
              Mo(1)-O(4)                       1.919(3)                        Mo(2)-O(3)                      2.043(3) 
              Mo(1)-O(5)                       1.692(3)                        Mo(2)-O(7)                      1.704(3)   
              Mo(1)-O(6)                       1.715(2)                        Mo(2)-O(8)                      1.694(3)  
              Mo(1)-O(9)                       2.272(3)                        Mo(2)-O(6)#                    2.409(2)  
              Mo(1)-N(2)                       2.204(3)                        Mo(2)-N(1)                      2.199(3) 
 
 
Angles 
             O(1)-Mo(1)-O(4)     150.1(1)                        O(2)-Mo(2)-O(3)     147.9(1) 
 O(1)-Mo(1)-O(5)     97.2(1)                          O(2)-Mo(2)-O(8)     101.4(1) 
 O(1)-Mo(1)-O(6)     96.1(1)                          O(2)-Mo(2)-O(7)     102.0(1) 
 O(1)-Mo(1)-O(9)     82.2(1)                          O(2)-Mo(2)-N(1)     80.3(1) 
 O(1)-Mo(1)-N(2)     72.3(1)                          O(2)-Mo(2)-O(6) #     81.1(1) 
 O(4)-Mo(1)-O(5)     104.3(1)                        O(3)-Mo(2)-O(7)     96.8(1) 
 O(4)-Mo(1)-O(6)     98.0(1)                          O(3)-Mo(2)-O(8)     98.2(1) 
 O(4)-Mo(1)-O(9)     80.5(1)                          O(3)-Mo(2)-N(1)     71.8(1) 
 O(4)-Mo(1)-N(2)     80.2(1)                          O(3)-Mo(2)-O(6) #     75.92(9) 
 O(5)-Mo(1)-O(6)     105.2(1)                        O(7)-Mo(2)-O(8)     105.6(1) 
 O(5)-Mo(1)-O(9)     82.1(1)                          O(7)-Mo(2)-N(1)     154.4(1) 
 O(5)-Mo(1)-N(2)     157.5(1)                        O(7)-Mo(2)-O(6) #     82.1(1) 
 O(6)-Mo(1)-O(9)     172.6(1)                        O(8)-Mo(2)-N(1)     98.8(1) 
 O(6)-Mo(1)-N(2)     95.8(1)                          O(7)-Mo(2)-O(6) #     171.0(1) 
 O(9)-Mo(1)-N(2)     76.8(1)                          N(1)-Mo(2)-O(6) #     73.0(1) 
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Table 4.6 Hydrogen bond distances (A) and angles (o) for Complex 2  
D–H…A                              D–H(Å)        H...A(Å)                 D...A(Å)               <D–H…A (◦) 
 
O9–H90…O10                     0.873(19)              1.81(2)                   2.601(4)                  137.7(19) 
O10–H100…O4                    0.82                        2.27                       2.988(4)                 147 
O10–H100…O9                     0.82                       2.49                       3.189(4)                  143 
Symmetry transformations used to generate equivalent atoms: 
(a) -x, -y, 2-z 
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Fig. 4.7. ORTEP diagram of [(MoVIO2)2L] (1) with atom labeling scheme  
at 50% probability. 
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     Fig. 4.8. PLATON diagram of [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) with atom 
labeling scheme at 50% probability.  
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Fig.4.9. Packing diagram of complex 2 along a axis  
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4.4. Conclusions 
Two novel and unusual type dimeric [(MoVIO2)2L] (1) and tetrameric 
[{(C2H5OH)LO3Mo2
VI}2( –O)2]·C2H5OH (2) dioxomolybdenum(VI) complexes with            
N,N'–disalicyloylhydrazine have been synthesized and fully characterized. These binucleating 
ligands were formed by the selfcombination of acid hydrazide or corresponding hydrazone. The 
complexes were characterized by various spectroscopic techniques (IR, UV-Vis and NMR) and 
also by electrochemical study. The molecular structures of both have been confirmed by X-ray 
crystallography. The above studies indicate that the N,N'–disalicyloylhydrazine (H2L) has the 
normal tendency to form both dimeric and tetrameric complexes coordinated through the 
dianionic tridentate manner. 
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Chapter 5 
Synthesis and Structural Characterization of Novel Dioxomolybdenum(VI) Complexes: 
Unexpected Coordination Due to Ligand Rearrangement Through Metal Mediated 
Interligand C–C Bond Formation 
 
Abstract 
Two novel dioxomolybdenum(VI) complexes containing the MoO2
2+ motif are reported where 
unexpected coordination due to ligand rearrangement through metal mediated interligand C–C 
bond formation is observed. The ligand transformations are probably initiated by molybdenum 
assisted C–C bond formation in the reaction medium. The ligands (H2L
1–2) are tetradentate C–C 
coupled O2N2– donor systems formed in situ during the synthesis of the complexes by the 
reaction of bis(acetylacetonato)dioxomolybdenum(VI) with Schiff base ligands of                      
2-aminophenol with 2-pyridinecarboxaldehyde (HL1) and 2-quinolinecarboxaldehyde (HL2). The 
reported dioxomolybdenum(VI) complexes [MoO2L
1] (1) and [MoO2L
2] (2) coordinated with 
the O2N2– donor rearranged ligand are expected to have better stability of the molybdenum in +6 
oxidation state than the corresponding ON2–donor ligand precursor. Both the complexes are fully 
characterized by several physicochemical techniques and the novel structural features through 
single crystal X-ray crystallography. 
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5.1. Introduction 
The coordination chemistry of transition metal complex with nitrogen-oxygen donor ligands has 
become an interesting area of research in recent times because of their ability to possess unusual 
configurations, be structurally labile and their sensitivity to molecular environments [1]. Many 
transition metal complexes of Schiff base ligands have received considerable attention in 
biological field, as antibacterial [2–4] and anticancer [5] drugs, including DNA-cleavage systems 
[6,7], and also have catalytic applications, such as in polymerization [8], olefin oxidation [6] and 
Suzuki-Miyaura coupling [7]. On the other hand, the coordination chemistry of molybdenum has 
been a subject of enthusiastic research due to the presence of molybdenum in metalloenzymes 
[8–10] and its biochemical as well as catalytic importance [11–25].  
Transition metal complexes of 2-aminophenol based Schiff base ligands have been widely 
reported [26–31]. But the Schiff base ligands with carbonyl compounds such as 2-pyridine 
carboxaldehyde and 2-quinolinecarboxaldehyde have not been reported much [32–34]. These 
ligands are uninegative tridentate one and coordinate with Mo(VI) precursors MoO2(acac)2 
forming the μ-oxomolybdenum compounds [MoO2(L
1)]2(µ-O) [35].   
In this chapter two novel dioxomolybbdenum(VI) complexes containing the MoO2
2+ motif are 
reported where unexpected coordination due to ligand rearrangement through metal mediated 
interligand C–C bond formation is observed. The ligand transformations are probably initiated 
by molybdenum assisted C–C bond formation in the reaction medium. The ligands (H2L
'1–2) are 
tetradentate C–C coupled O2N2– donor systems formed in situ during the synthesis of the 
complexes by the reaction of bis(acetylacetonato)dioxomolybdenum(VI) with Schiff-base 
ligands of 2-aminophenol with 2-pyridine carboxaldehyde (HL1) and 2-quinolinecarboxaldehyde 
(HL2). The reported dioxomolybdenum(VI) complexes coordinated with the O2N2-donor 
rearranged ligand are expected to have better stability of molybdenum in +6 oxidation state than 
the corresponding ON2-donor ligand precursor [36]. Both the complexes are fully characterized 
by several physicochemical techniques and the novel structural features through single crystal X-
ray crystallography. 
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5.2. Experimental 
 
5.2.1. Materials 
[MoO2(acac)2] was prepared as described in the literature [37]. Reagent grade solvents were 
dried and distilled prior to use. All other chemicals were reagent grade, available commercially 
and used as received. Commercially available TBAP (tetra butyl ammonium perchlorate) was 
properly dried and used as a supporting electrolyte for recording cyclic voltammograms of the 
complexes. 
 
5.2.2. Physical Measurements 
Elemental analyses were performed on a Vario ELcube CHNS Elemental analyzer. IR spectra 
were recorded on a Perkin-Elmer Spectrum RXI spectrometer. 1H NMR spectra were recorded 
with a Bruker Ultra shield 400 MHz spectrometer using SiMe4 as an internal standard. Electronic 
spectra were recorded on a Lamda25, PerkinElmer spectrophotometer. Magnetic susceptibility 
was measured with a Sherwood Scientific AUTOMSB sample magnetometer. Electrochemical 
data were collected using a PAR electrochemical analyzer and a PC-controlled 
Potentiostat/Galvanostat (PAR 273A) at 298 K in a dry nitrogen atmosphere. Cyclic 
voltammetry experiments were carried out with a platinum working electrode, platinum auxiliary 
electrode, Ag/AgCl as reference electrode and TBAP as supporting electrolyte.  
 
5.2.3. Synthesis of Ligands (HL1–2) 
Schiff base ligands HL1–2 were prepared by the condensation of 2-aminophenol with 2-pyridine 
carboxaldehyde (HL1) and 2-quinolinecarboxaldehyde (HL2) in equimolar ratio in ethanol 
medium following a standard procedure [38]. The resulting brown compounds were filtered, 
washed with ethanol and dried over fused CaCl2. 
 
HL1: Yield: 0.13 g (65%). Anal. Calcd for C12H10N2O: C, 72.72; H, 5.05; N, 14.14. Found: C, 
72.76; H, 5.07; N, 14.09%. 1H NMR (DMSO-d6, 400 MHz):  = 9.25 (s, 1H, OH), 8.71 (s, 1H, 
CH), 8.69–6.86 (m, 8H, Aromatic). 13C NMR (DMSO-d6, 100 MHz):  = 159.33, 154.49, 
151.37, 149.45, 136.82, 136.80, 128.21, 125.37, 121.49, 119.66, 119.57, 116.31.  
149 
 
HL2: Yield: 0.18 g (72%). Anal. Calcd for C16H12N2O: C, 77.4; H, 4.87; N, 11.28. Found: C, 
77.38; H, 4.89; N, 11.26%. 1H NMR (DMSO-d6, 400 MHz):  = 9.36 (s, 1H, OH), 8.91 (s, 1H, 
CH), 8.58–6.87 (m, 10H, Aromatic). 13C NMR (DMSO-d6,100 MHz):  = 167.79, 157.14, 
154.32, 152.92, 136.86, 134.43, 132.44, 130.90, 129.52, 128.91, 127.88, 127.81, 120.38, 118.34, 
116.29, 115.49.  
 
5.2.4. Synthesis of complexes [MoO2L
1](1) and [MoO2L
2](2) 
To the refluxing solution of 1.0 mmol ligand HL1–2 in 30 mL of ethanol, 1.0 mmol of 
MoO2(acac)2 was added. The color of the solution changed to dark red. The mixture was then 
refluxed for 3 hr. After leaving the solution for 2 days at room temperature, fine yellow colored 
crystals were isolated and suitable single crystals were selected for X-ray analysis. 
 
[MoO2L
1](1): Yield: 0.25g (57%). Anal. Calcd for C17H17N2O5.50Mo: C, 47.13; H, 3.95; N, 6.47. 
Found: C, 47.14; H, 3.94; N, 6.48%. 1H NMR (DMSO-d6, 400 MHz):  = 8.87–6.63 (m, 8H, 
Aromatic), 8.68 (s, 1H, NH), 5.81 (s, 1H, CH), 2.57 (s, 3H, CH3), 2.22 (s, 3H, CH3). 
13C NMR 
(DMSO-d6, 100 MHz):  = 195.90, 173.66, 162.00, 157.43, 148.49, 141.49, 133.32, 129.55, 
126.36, 125.50, 122.49, 121.16, 117.31, 116.29, 63.71, 31.39, 24.42.  
 
[MoO2L
2](2): Yield: 0.31g (65%). Anal. Calcd for C21H18N2O5Mo: C, 53.16; H, 3.83; N, 5.90. 
Found: C, 53.15; H, 3.84; N, 5.90%. 1H NMR (DMSO-d6, 400 MHz):  = 9.27–6.64 (m, 10H, 
Aromatic), 8.79 (s, 1H, NH), 6.03 (s, 1H, CH), 2.59 (s, 3H, CH3), 2.23 (s, 3H, CH3).
 13C NMR 
(DMSO-d6, 100 MHz):  = 195.49, 174.28, 162.43, 158.44, 143.31, 141.18, 132.84, 131.48, 
128.96, 128.44, 128.28, 127.43, 126.59, 125.63, 120.78, 119.58, 116.91, 116.01, 63.71, 30.75, 
23.42.  
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5.2.5. Crystallography 
Suitable single crystals of 1 and 2 were chosen for X-ray diffraction studies. Crystallographic 
data and details of refinement are given in Table 5.1. These compounds crystallize in the 
triclinic space group P -1 (1) and P 1 (2). The unit cell parameters and the intensity data for the 
complexes were collected at ~ 293 K, on a Bruker Smart Apex CCD diffractometer using 
graphite monochromated Mo K  radiation (k = 0.71073 Å), employing the ω–2θ scan technique. 
The intensity data were corrected for Lorentz, polarization and absorption effects. The structures 
were solved using the SHELXS97 [39] and refined using the SHELXL97 [40] computer 
programs. The non-hydrogen atoms were refined anisotropically.  
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Table 5.1 Crystal and Refinement Data of Complexes 1 and 2  
 
Compound 1 2 
Formula C17H17MoN2O5.50 C21H18MoN2O5 
M 433.27 474.31 
Crystal symmetry Triclinic  Triclinic  
Space group P -1 P 1 
a(Å) 8.4739(5) 9.1187(19) 
b(Å) 9.6684(5) 9.6426(19) 
c(Å) 11.5506(7) 11.841(2) 
 (°) 94.10(10) 73.432(8) 
β (°) 109.95(10) 84.460(9) 
 (°) 96.81(10) 66.820(9) 
V(Å
3
) 876.87(9) 917.2(3) 
Z 2 2 
Dcalc(g.cm
-3
) 1.641 1.717 
F(000) 438 
480 
(Mo-K )(mm
-1
) 0.781 0.753 
max./min.trans. 0.9546 / 0.9053 0.9285 / 0.8639 
2 (max)(
o
) 26.00 28.65 
Reflections collected 
/ unique 
9144/ 3434 48181 / 4651 
R1
a
[I>2 (I)] R1 = 0.0274, 
wR2= 0.0787 
R1 = 0.0188, 
wR2 = 0.0492 
wR2
b
[all data] R1 = 0.0294, 
wR2=0.0803 
R1 = 0.0197, 
wR2=0.0498 
S[goodness of fit] 1.074 1.067 
min./max. res.(e.Å
-3
) 0.831 / -0.245 0.435 / -0.409 
 
               a
R1 = Σ │FO│- │FC│/ Σ│ FO│ 
  
              b
wR2 = {Σ [w (FO
2
- FC
2
)
2]/Σ [w (FO
2
)
2
]} 
½
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5.3. Results and Discussion 
5.3.1. Synthesis  
The precursor ligands (HL1–2) were synthesized by Schiff base condensation of equimolar 
amounts of 2-aminophenol and corresponding carbonyl compounds [2-pyridinecarboxaldehyde 
(HL1) and 2-quinolinecarboxaldehyde (HL2)] in absolute ethanol at room temperature      
(Scheme 5.1). Detail methods used for the syntheses of precursor ligands (HL1–2) and 
corresponding dioxomolybdenum(VI) complexes (1–2) are given in the experimental section. 
Reactions of the 2-aminophenol based Schiff base ligands (HL1–2) with MoO2(acac)2 proceed in 
refluxing ethanol and each of these reactions afford yellow color products [MoO2L
1] (1) and 
[MoO2L
2] (2) in decent yield (Scheme 5.2). Both the reactions are also performed catalytically and 
results and yield completely matched well with the original compounds. These compounds are highly 
soluble in aprotic solvents, viz. DMF or DMSO and are sparingly soluble in alcohol, CH3CN and 
CHCl3. All these complexes are diamagnetic, indicating the presence of molybdenum in the +6 
oxidation state, and are nonconducting in solution. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.1. Synthesis of tridentate Schiff base ligands 
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Scheme 5.2. Synthesis of dioxomolybdenum(VI) complexes (1 and 2) 
 
5.3.2. Description of the X-ray structures of [MoO2L
1] (1) and [MoO2L
2] (2)  
The structure of 1 and 2 (Figs. 5.1 and 5.2) reveals an unexpected coordination due to ligand 
rearrangement, which amounts to an interligand C–C bond coupling between two methylenic 
carbon atoms C8 and C9, leading to the formation of novel dioxomolybdenum(VI) complexes. 
The rearranged ligands (H2L
1–2) are formed (Scheme 5.3) due to template reactions between one 
of the metal coordinated acetylacetonate in [MoO2(acac)2] and the corresponding Schiff base 
ligand (HL1–2). These ligand transformations are highly specific and probably initiated by a     
Mo mediated C–C bond formation in the reaction medium. It is checked and confirmed that, the 
reactions using other metal precursors [VO(acac)2 or Cu(acac)2] do not initiate this type of ligand 
rearrangement. 
N
R
MoO2(acac)2 ,
Reflux
EtOH
HL1-2
EtOH MoO2(acac)2 ,
Reflux
O
N
C
N
H
C C
CH3C
O
CH3
O
Mo
O
O
H
R
[MoO2L
1-2(OEt)] (Expected)
HL1 (R = H)
HL2 (R = 3,4-C6H4)
N
OH
H
[MoO2L
'1-2] (Observed)
N
N
O
MoO
O OEt
H
R
154 
 
In the structure of 1 and 2, the corresponding rearranged ligand H2L
1–2 is coordinated to 
molybdenum as a dianionic tetradentate N2O2–donor, forming one six-membered and two five-
membered rings with bite angles of 80.80(4)°−80.89(8)°, 76.32(8)°−77.27(4)° and 
69.40(8)°−70.07(4)° respectively. The complexes (1 and 2) have a six-coordinated distorted 
octahedral geometry where Mo–O(3) and Mo–O(4) bond distances of the MoO2
2+ group are 
unexceptional [11, 36] and almost equal in the range [1.698(2)–1.711(1) Å]. The Mo–O and Mo–
N distances are close to typical values (Table 5.2) [11, 36]. 
 
 
 
Scheme 5.3. Synthesis of C–C σ bonded rearranged ligands  
 
Both the molecules are found to show inter molecular hydrogen bonding. Two [MoO2L
1] (1) 
molecules form a dimeric unit via a pair of reciprocal hydrogen bonds between the N(1)–H 
proton of one molecule and the acetylacetonate oxygen O(5) of other moiety. On the other hand, 
the dimeric unit of 2 is formed through a pair of reciprocal hydrogen bonds between the oxo 
oxygen O(3) of one molecule with the N(1)–H proton of the neighboring molecule. The 
representative hydrogen-bonded dimeric structure of [MoO2L´
1] (1) is shown in Fig. 5.3. 
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Table 5.2 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 1 and 2  
 
 
 
                       Complex 1 
 
Complex 2 
   
  Bond lengths 
  Mo(1)-O(1) 
 
 
  1.946(2) 
 
 
1.941(1) 
  Mo(1)-O(2) 1.980(2) 1.953(9) 
  Mo(1)-O(3) 1.703(2) 1.711(1) 
  Mo(1)-O(4) 1.698(2) 1.703(1) 
  Mo(1)-N(1) 2.325(2) 2.327(2) 
  Mo(1)-N(2) 
   C(7)-C(13)  
   
  Bond Angles 
2.338(2) 
  1.522(3)          
2.417(1) 
1.507(2) 
 
O(1)-Mo(1)-O(2)                           153.00(8)  152.89(5) 
O(1)-Mo(1)-O(3)                               99.91(9) 99.29(5) 
O(1)-Mo(1)-O(4)                               97.72(9) 97.71(5) 
O(1)-Mo(1)-N(1)                               76.32(8) 77.27(4) 
O(1)-Mo(1)-N(2)                          81.86(8) 81.20(4) 
O(2)-Mo(1)-O(3)                          95.97(9) 95.85(5) 
O(2)-Mo(1)-O(4)                        98.4(1) 99.33(5) 
O(2)-Mo(1)-N(1)                               80.89(8) 80.80(4) 
O(2)-Mo(1)-N(2)                          76.67(8) 76.44(4) 
O(3)-Mo(1)-O(4)                          106.8(1)  106.58(5) 
O(3)-Mo(1)-N(1)                           94.15(9) 88.50(5) 
O(3)-Mo(1)-N(2)                             162.69(9)  158.02(5) 
O(4)-Mo(1)-N(1)                             158.92(9) 95.06(5) 
O(4)-Mo(1)-N(2)                           89.85(9)  164.77(5) 
N(1)-Mo(1)-N(2) 
     
                               69.40(8)             70.07(4) 
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Fig. 5.1. ORTEP diagram of [MoO2L´
1] (1) with atom labeling scheme  
at 50% probability 
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Fig. 5.2. ORTEP diagram of [MoO2L´
2] (2) with atom labeling scheme  
at 50% probability 
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Fig. 5.3. The hydrogen-bonded dimer of [MoO2L´
1] (1) (side view) 
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5.3.3. Spectral properties 
Spectral characteristics of both the ligands and compounds (1–2) are listed in Table 5.3. Both the 
ligands exhibit the IR band of minimum intensity in the 3197–3164 cm–1 region due to ν(OH) 
stretching [27–33]. Characteristic strong bands at 1622–1611 cm–1 and 1583–1581cm–1 region 
due to ν(C=C/aromatic) and ν(C=N) stretching modes of the ligands [11,36] are located in the 
spectra of both the ligands and the complexes. In addition, complexes (1 and 2) display a pair of 
sharp strong peaks in the range 931–924 cm–1 and 910–907 cm–1 due to terminal ν(M=Ot) stretch 
[11,36]. The representative IR spectra of ligand HL1 and complex 1 are shown in Figs. 5.4 and 
5.5 respectively.  
The DMSO solution of both the complexes display a shoulder in the 423–417 nm region and two 
strong absorptions in the 329–252 nm range which are assignable to LMCT and intraligand 
transitions, respectively [11,36]. The electronic spectrum of complex 2 is shown in Fig. 5.6 as 
the representative one. 
The 1H and 13C NMR data of the free ligands and dioxomolybdenum(VI) complexes are given in 
the experimental section. The spectrum of the free ligands exhibits a resonance in the range    δ = 
9.36–9.25 ppm due to phenolic OH and at δ = 8.71–8.91 ppm due to –CH protons. All the 
aromatic protons from ligands are clearly observed in the expected region δ = 8.69–6.85 ppm. 
The spectra of complexes 1–2 display two singlets in the range δ = 2.23–2.22 ppm and δ = 2.59– 
2.57 ppm [41]. These are assigned to the protons of the two methyl groups present in the 
acetylacetone fragment of the rearranged ligand. The –NH and –CH= proton resonance are 
observed in the range of δ = 8.86–8.79 and δ = 6.03–5.81 ppm, respectively [41]. In the NMR 
spectra of complexes, the aromatic –OH proton disappeared due to the deprotonation of phenolic 
group [11,36]. The representative NMR spectra of ligand HL2 and complex 2 are shown in Figs. 
5.7 and 5.8, respectively. 
 
 
 
 
 
160 
 
Table 5.3 Characteristic IR[a] bands and electronic spectral data[b] for the studied ligands and 
complexes (1–2) 
 
Compounds                         ν(–OH)      ν(C═N)      v(Mo=O)/cm–1          λmax/nm (ε/dm
3
 mol
–1
 cm
–1
) 
 
 
HL
1                                                               
3197 
              
  1583                 --                      355 (20154), 256 (15625)
 
HL
2                                                               
3164 
                  
1581                --                      366 (20184), 256 (15463)
 
[MoO2L
1
] (1)                           --               1604            924, 907              417 (30124), 320 (25123), 252 (16352)  
[MoO2L
2
] (2)                           --               1593            931, 910              423 (30125), 329 (25126), 257 (16350)  
[a] 
In KBr pellet; 
[b] 
In DMSO 
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Fig. 5.4. IR spectrum of [HL1]  
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Fig. 5.5. IR spectrum of [MoO2L
1] (1) 
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Fig. 5.6. Electronic absorption spectrum of [MoO2L
2] (2) in DMSO, at 250 C 
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Fig. 5.7. 1H NMR spectrum of [HL2] in DMSO d6. 
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Fig. 5.8. 1H NMR spectrum of [MoO2L
2] (2) in DMSO d6. 
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5.3.4. Electrochemical properties  
Electrochemical properties of the complexes have been studied by cyclic voltammetry in DMF 
solution (0.1 M TBAP). Voltammetric data are given in Table 5.4 and the cyclic voltamogram of 
[MoO2L´
1] (1) is displayed in Fig.5.9 as the representative one. The CV traces of complexes (1–
2) exhibit two irreversible reductive responses within the potential window –1.05 to –1.14 V and 
–1.58 to –1.69 V, which are assigned to MoVI/MoV and MoV/MoIV processes respectively [11].  
An oxidation wave at positive potentials in the range of +1.14 to +1.23 V is assigned to the 
oxidation of the coordinated ligands [11]. As the Mo(VI) complex cannot undergo a metal-
centered oxidation, this is attributed to a ligand-centered process [11].  
 
Table 5.4 Cyclic voltammetric results for dioxomolybdenum (VI) complexes (1–2) at 298 K 
 
 
      Complex                                                     Epc [V]
[a] 
 
 
                [MoO2L´
1
] (1)                                                   –1.14, –1.69 
                [MoO2L´
2
] (2)                                                   –1.05, –1.58  
 
[a]
 Solvent: DMF; working electrode: platinum; auxiliary electrode: platinum; reference electrode: 
Ag/AgCl; supporting electrolyte: 0.1 M TBAP; scan rate: 50 mV/s. Epc is the cathodic peak potential 
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Fig. 5.9. Cyclic voltammogram of [MoO2L´
1] (1) in DMF  
 
 
 
 
 
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0
1.23
-1.69
-1.14
Potential (V)
168 
 
5.4. Conclusions 
Two novel dioxomolybdenum(VI) complexes (1 and 2) containing C–C coupled rearranged 
ligand have been synthesized and successfully characterized. The C–C σ bond formation is 
highly specific and dependent on the metal precursor [MoO2(acac)2] as suggested from the 
tentative reaction mechanism. It is checked and confirmed that, the reactions using other metal 
precursors [VO(acac)2 or Cu(acac)2] do not initiate this type of ligand rearrangement. Both the 
complexes (1 and 2) are diamagnetic and electrically non-conducting in solution. The 
microanalysis, electrochemical study and spectroscopic characteristics are consistent with their 
molecular formula. The molecular structures of both have been confirmed by X-ray 
crystallography.  
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Chapter 6 
 
Crystal Engineering with Aroyl Hydrazones of Acetylacetone – Molecular and 
Supramolecular Structures of Some Oxomolybdenum(VI) Complexes in Relation to 
Biological Activity 
 
Abstract 
In this chapter we present a detailed account of the synthesis, structure, spectroscopic, 
electrochemical properties and study of biological activity of some oxomolybdenum(VI) 
complexes with special reference to their H–bonded molecular and supramolecular structures. 
Reaction of bis(acetylacetonato)dioxomolybdenum(VI) with three different hydrazides 
(isonicotinoyl hydrazide, anthraniloyl hydrazide and 4-nitrobenzoyl hydrazide) afforded two di-
oxomolybdenum(VI) complexes {[MoO2L
1(CH3OH)] (1) and [MoO2L
3] (3)} and one mono-
oxomolybdenum(VI) complex {[MoOL2(O–N)] (2)} (where L = Intermediate in situ ligand 
formed by the reaction between acetyl acetone and the corresponding acid hydrazide, and O–N =     
4-nitrobenzoylhydrazide). All the complexes have been characterized by elemental analysis, 
electrochemical and spectroscopic (IR, UV–Vis and NMR) measurements. Molecular structures 
of all the complexes (1, 2 and 3) have been determined by X-ray crystallography. The complexes 
have been screened for their antibacterial activity against Escherichia coli, Bacillus subtilis and 
Pseudomonas aeruginosa. The Minimum inhibitory concentration of these complexes and 
antibacterial activity indicates 1 as the potential lead molecule for drug designing.  
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6.1. Introduction 
Crystal engineering and the design of solid-state architectures has become an area of increasing 
interest over recent years [1–4]. Much study has been centered upon the use of supramolecular 
contacts, particularly hydrogen-bonding, between suitable molecules to generate multi-
dimensional arrays or networks [1–3]. Variation in the ligand architecture coupled with a change 
in the geometric disposition of the ligands induced by metal nodes may give rise to a number of 
one-, two- and three-dimensional infinite frameworks, such as diamondoid [5,6], helix [7,8], 
brick wall [9,10], ladder [9–13], honeycomb [9,10], square grid and parquet [14], and other 
three-dimensional frameworks. Some supramolecular assemblies are also known to exhibit 
interesting redox, magnetic and optical [15,16] properties.  
In some previous work [17,18], our group have reported several supramolecular architecture of 
oxovanadium(V) aroyl hydrazone and mixed-ligand Ni(II) thiosemicarbazone complexes by 
slight modification of the substituents attached to the ligand framework. In this chapter, I would 
like to examine the possible change in the coordination behavior of the ligands and its 
concomitant effect on the solid state supramolecular assembly of the complexes, when alipha tic 
carbonyl functionality is used instead of the aromatic carbonyls that were used for Schiff base 
formation in the previous studies [17–19]. Chattopadhyay et al. has recently highlighted the 
special role of aroyl hydrazones by systematic variation in the H-bond forming abilities of their 
aroyl moiety. Which can influences the formation of supramolecular assembly of transition metal 
complexes in generating varied molecular architectures [20–22]. 
Keeping this in mind, we have synthesized Schiff bases of ace tyl acetone with isonicotinoyl 
hydrazide, benzoyl hydrazide and anthraniloyl hydrazide to study the supramolecule forming 
abilities of these Schiff bases. These aroyl hydrazones have been chosen in such a way that the 
aroyl moiety varies from being a H–bond donor (anthraniloyl), a H-bond acceptor (isonicotinoyl) 
and one which has no H–bond donor and acceptor ability (benzoyl). We shall show below that 
such a systematic variation of the H–bond forming ability has a profound effect on the 
supramolecular structures of these molecules (Scheme 6.1). 
The hydrazone compounds along with their metal complexes have been extensively investigated 
for their versatile coordination modes [23–25] with prospective biological activities [26–28]. On 
the other hand, the coordination chemistry of molybdenum has been a subject of enthusiastic 
research due to its proven role of catalytic activity [29–42] in various biological and industrial 
174 
 
processes, and the potential medicinal effect as therapeutic agents such as antiamoebic activity 
[43] and DNA synthesis inhibition [44–46]. Our group has been studying the coordination 
complexes of penta- and hexavalent molybdenum with aroyl hydrazones derived from various 
acid hydrazides over the past several years [47–50]. Accordingly, in this chapter we present a 
detailed account of the synthesis, structure, spectroscopic, electrochemical properties and study 
of biological activity of some dioxomolybdenum(VI) complexes with special reference to their 
H–bonded molecular and supramolecular structures.  
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Scheme 6.1. Possible H-bond donor acceptor sites on the ligand  
containing aroyl moiety 
C
N
H
N
C
CH3
CH2
C
CH3O
N H
H
O
N
C
N
H
N
C
CH3
CH2
C
CH3O
H
O
C
N
H
N
C
CH3
CH2
C
CH3O
H
O
A
D
D
C
N
H
N
C
CH3
CH2
C
CH3O
H
O
A
A
The aroyl moiety has no H-bonding ability
H2L
3:The aroyl moiety is a H-bond donor only
H2L
1:The aroyl moiety is a H-bond acceptor only
H2L
2:The aroyl moiety is a H-bond acceptor only
O2N
176 
 
6.2. Experimental 
6.2.1. Materials 
[MoO2(acac)2] and acid hydrazides were prepared as described in the literature [51,52]. Reagent 
grade solvents were dried and distilled prior to use. All other chemicals were reagent grade, 
available commercially and used as received. Commercially available TBAP (tetra butyl 
ammonium perchlorate) was properly dried and used as a supporting electrolyte for recording 
cyclic voltammograms of the complexes.  
 
6.2.2. Physical Measurements 
Elemental analyses were performed on a Vario ELcube CHNS Elemental analyzer. IR spectra 
were recorded on a Perkin-Elmer Spectrum RXI spectrometer. 1H NMR spectra were recorded 
with a Bruker Ultra shield 400 MHz spectrometer using SiMe4 as an internal standard. Electronic 
spectra were recorded on a Lamda25, PerkinElmer spectrophotometer. Magnetic susceptibility 
was measured with a Sherwood Scientific AUTOMSB sample magnetometer. Electrochemical 
data were collected using a PAR electrochemical analyzer and a PC-controlled 
Potentiostat/Galvanostat (PAR 273A) at 298 K in a dry nitrogen atmosphere. Cyclic 
voltammetry experiments were carried out with a platinum working electrode, platinum auxiliary 
electrode, Ag/AgCl as reference electrode and TBAP as supporting electrolyte.  
 
6.2.3. Synthesis of complexes (1–3) 
To the refluxing solution of 1.0 mmol of hydrazides [Isonicotinoylhydrazide (1),                         
4-nitrobenzoylhydrazide (2) and anthraniloylhydrazide (3)] in 30 mL of methanol, 1.0 mmol of 
MoO2(acac)2 was added [53]. The color of the solution changed to dark red. The mixture was 
then refluxed for 3 hr. After leaving the solution for 2 days  at room temperature, fine dark red 
colored crystals were isolated and a suitable single crystal was selected for X-ray analysis. 
  
[MoO2L
1(CH3OH)
 ](1): Yield: 0.25g (66%). Anal. Calcd for C12H15N3O5Mo: C, 38.21; H, 4.01; 
N, 11.14. Found: C, 38.23; H, 4.02; N, 11.12%. 1H NMR (DMSO-d6, 400 MHz): δ = 8.70–7.79 
(m, 4H, Aromatic), 5.53 (s, 1H, CH), 4.11 (s, 1H, OH–methanol), 3.16 (s, 3H, CH3–methanol), 
2.35 (s, 3H, CH3), 2.01 (s, 3H, CH3). 
13C NMR (DMSO-d6, 100 MHz): δ = 170.87, 165.30, 
162.93, 150.78, 138.38, 121.79, 115.48, 110.28, 103.31, 49.05, 24.07, 20.57.  
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[MoOL2(O–N)](2; O-N = 4-nitrobenzoylhydrazide): Yield: 0.32g (57%). Anal. Calcd for 
C19H16N6O8Mo: C, 41.31; H, 2.91; N, 15.21. Found: C, 41.28; H, 2.93; N, 15.17%. 
1H NMR 
(DMSO-d6, 400 MHz): δ = 8.71 (s, 1H, NH), 8.10–8.33 (m, 8H, Aromatic), 5.84 (s, 1H, CH), 
2.58 (s, 3H, CH3), 2.16 (s, 3H, CH3).
 13C NMR (DMSO-d6, 100 MHz): δ = 170.89, 166.28, 
165.24, 162.94, 150.52, 149.25, 136.97, 136.82, 131.18, 129.28, 124.34, 124.22, 121.67, 120.42, 
119.48, 117.28, 103.37, 24.07, 20.61.  
  
[MoO2L
3](3): Yield: 0.23g (64%). Anal. Calcd for C12H13N3O4Mo: C, 40.11; H, 3.62; N, 11.69. 
Found: C, 40.08; H, 3.64; N, 11.67%. 1H NMR (DMSO-d6, 400 MHz): δ = 6.60–7.67 (m, 4H, 
Aromatic), 6.84 (s, 2H, NH2), 5.56 (s, 1H, CH), 2.42 (s, 3H, CH3), 2.06 (s, 3H, CH3).
 13C NMR 
(DMSO-d6, 100 MHz): δ = 169.52, 165.79, 161.91, 149.26, 132.33, 130.08, 116.24, 115.38, 
110.60, 103.12, 23.97, 21.08.  
 
6.2.4. Crystallography 
Suitable single crystal of 1, 2 and 3 were chosen for X-ray diffraction studies. Crystallographic 
data and details of refinement are given in Table 6.1. Details of the classical hydrogen bonding 
are given in Table 6.2. The compound 1 crystallized in monoclinic space group C 1 c 1 and 
compounds 2 and 3 crystallized in triclinic space group P 1 and P21/c respectively. Single 
crystal X-ray diffraction data collection and analysis were performed on a Bruker SMART 
APEX II diffractometer with a sealed tube, Kα Mo source (λ=0.71073 A), graphite 
monochrometer and CCD detector. An Oxford 700 Cryostream N2 open-flow temperature 
system was used. The unit cell refinement and the integration of the diffraction frames were done 
with Bruker SAINT. Intensity data were corrected for Lorentz and polarization effects. 
Absorption corrections were applied using SADABS, and the structures were solved by direct 
methods and refined using least squares with the SHELXL–97 [54] software program. 
 
6.2.5. Antibacterial activity  
Antibacterial activity of the complexes was studied against Escherichia coli (E. coli), Bacillus 
subtilis and Pseudomonas aeruginosa by agar well diffusion technique. Mueller Hinton-agar 
(containing 1% peptone, 0.6% yeast extract, 0.5% beef extract and 0.5% NaCl, at pH 6.9–7.1) 
plates were prepared and 0.5–McFarland culture (1.5 x 108 cells /mL) of the test organisms were 
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swabbed onto the agar plate (as per CLSI guidelines, 2006) [55]. Test compounds were dissolved 
in DMSO at several concentrations ranging from 1000 µg/mL–1.95 µg/mL. 9 mm wide wells 
were dug on the agar plate using a sterile cork borer. 100 µg/mL of the solutions of each test 
compound from each dilution were added into each of the wells using a micropipette. These 
plates were incubated for 24 h at 35 ± 2 °C. The growth of the test organisms was inhibited by 
diffusion of the test compounds and then the inhibition zones developed on the plates were 
measured [18,19,56,57]. The effectiveness of an antibacterial agent in sensitivity is based on the 
diameter of the zones of inhibition which is measured to the nearest millimeter (mm). The 
standard drug Vancomycin was also tested for their antibacterial activity at the same 
concentration under the conditions similar to that of the test compounds as +ve control. DMSO 
alone was used as a –ve control under the same conditions for each organism.  
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Table 6.1 Crystal and refinement data of complexes 1, 2 and 3 
Compound 1 2 3 
Formula C12H15MoN3O5 C19H16MoN6O8 C12H13MoN3O4 
M 377.21 552.32 359.19 
Crystal symmetry Monoclinic Triclinic  Monoclinic  
Space group C 1 c 1 P 1   P21/c 
a(Å) 14.1081(10) 7.5791(3) 6.7999(5) 
b(Å) 7.5782(10) 11.4060(4) 13.2638(8) 
c(Å) 13.9670(10) 13.2523(4) 15.5050(8) 
 (°) 90.00 73.825(2) 90.00 
β (°) 111.59 84.423(2) 116.012(2) 
 (°) 90.00 81.4190(10) 90.00 
V(Å
3
) 1388.5(2) 1086.09(7) 1256.78(14) 
Z 4 2 4 
Dcalc(g.cm
-3
) 1.804 1.689 1.898 
F(000) 760 556                 720 
(Mo-K )(mm
-1
) 0.970 0.664 1.061 
max./min.trans. 0.8005 / 0.6530 0.8516 / 0.6914 0.999 / 0.829  
2 (max)(
o
) 26.99  28.25 25.50 
Reflections collected 
/ unique 
24336/ 3031 8574 / 5105 3275 / 2933 
R1
a
[I>2 (I)] R1 = 0.0128, 
      wR2 = 0.0514 
R1 = 0.0379,  
    wR2 = 0.0960 
R1 = 0.0283,  
      wR2 = 0.0527 
wR2
b
[all data] R1 = 0.0128, 
      wR2 = 0.0512 
R1 = 0.0515, 
    wR2 = 0.1022 
R1 = 0.0238,  
      wR2 = 0.0514 
S[goodness of fit] 0.506 1.048 0.990 
min./max. res.(e.Å
-3
) 0.233/  -0.430 0.580 / -0.617 0.534/-0.578 
 
               a
R1 = Σ │FO│- │FC│/ Σ│ FO│ 
  
              b
wR2 = {Σ [w (FO
2
- FC
2
)
2]/Σ [w (FO
2
)
2
]} 
½ 
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Table 6.2 Hydrogen bond distances (A) and angles (o) for 1 & 3 
D–H…A                              D–H(Å)        H...A(Å)                 D...A(Å)               <D–H…A (◦) 
 
[MoO2L
1
(CH3OH)
 
](1) 
O5–H5…N3                      0.915(18)            1.742(19)                2.655(2)                  175.2(16)  
Symmetry transformations used to generate equivalent atoms: 
(a) x, y, z' ; (b) 'x, -y, z + 1/2'; (c) 'x + 1/2, y + 1/2, z'; (d) 'x + 1/2, -y + 1/2, z + 1/2' 
 
 [MoO2L
3
] (3) 
N3–H3B…N2                    0.873(19)              2.02(2)                   2.734(3)                  137.7(19) 
C1–H1C…O3                     0.96                       2.57                        3.491(3)                  162 
C5–H5B…O1                     0.96                       2.56                        3.443(3)                  154 
C5–H5C…O4                     0.96                       2.58                        3.144(3)                  117 
C11–H11…O1                    0.93                       2.44                        3.224(3)                  142 
Symmetry transformations used to generate equivalent atoms: 
(a) x, y, z ; (b) -x, 1/2 + y, 1/2 - z ; (c) -x, -y, -z ; (d) x, 1/2 - y, 1/2 + z 
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6.3. Results and Discussion 
6.3.1. Synthesis  
The potentially tridentate diprotic ONO donor ligands used in the present work are generally 
abbreviated as H2((L
n)2–). The ligands ((Ln)2–) are thus formed due to template reactions between 
one of the metal coordinated acetylacetonate in [MoO2(acac)2] and the corresponding acid 
hydrazide. The in situ ligands are formed as intermediate during the metallation reactions. 
Methods used for syntheses of the oxomolybdenum complexes (1–3) are given in experimental 
section. Reactions of the selected acidhydrazide with MoO2(acac)2 proceed in refluxing methanol 
and each of these reactions (Scheme 6.2) afford dark red color products in decent yields. These 
compounds are highly soluble in aprotic solvents, viz. DMF or DMSO and are sparingly soluble 
in alcohol, CH3CN and CHCl3. All these complexes are diamagnetic, indicating the presence of 
molybdenum in the + 6 oxidation state, and are nonconducting in solution.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6.2 
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6.3.2. Spectral properties 
Spectral characteristics of all the compounds (1–3) are listed in Table 6.3. Infrared spectra of the 
complexes in KBr disks do not display the characteristic bands associated with the C═O and the 
N–H functionalities of the free Schiff base system H2L
n. Thus in each complex both the 
acetylacetone and the amide fragments of the metal coordinated tridentate ligand ((Ln)2–) are in 
enolate form. All the complexes display a strong band within 1579–1554 cm–1. This band is 
attributed to the C═N–N═C fragment of the in situ ligand [53]. Complexes 1 and 3 display a 
strong and a moderately strong band in the range 939–931 cm–1 and 909–899 cm–1 respectively 
due to terminal ν(M═Ot) stretch [45–50]. Whereas, the complex 2 exhibits only one such peak at 
950 cm–1, which is because of monooxo species. The infrared spectrum of the complex 1 is 
shown in Fig. 6.1 as the representative one. 
The DMSO solution of all the complexes display a shoulder in the 436–422 nm region and two 
strong absorptions in the 327–264 nm range which are assignable to L→Mo(dπ) (LMCT) and 
intraligand transitions respectively [45–50]. The electronic spectrum of complex 2 is shown in 
Fig. 6.2 as the representative one. 
The 1H and 13C NMR spectroscopic data of all the complexes are given in the experimental 
section. NMR spectrum of complex 3 is shown in Fig. 6.3 as the representative one. The NMR 
spectra of 1–3 display two singlets in the ranges δ = 2.16–2.01 ppm and δ = 2.58–2.35 ppm [53]. 
These are assigned to the protons of the two methyl groups present in the acetylacetone fragment 
of the tridentate ligand [53]. The –CH= proton of the acetylacetone fragment appears as a singlet 
within δ = 5.84–5.53 ppm [53]. The complex 2 exhibits one –NH proton resonance at δ =8.71 
ppm, due to the coordination of the hydrazide moiety (co- ligand). The aromatic protons are 
observed in the range δ = 8.70–6.60 ppm. The chemical shift of the coordinated CH3OH of 
complex 1 exhibits an OH resonance at δ = 4.11 ppm and CH3 resonance at δ = 3.16 ppm [45–
50].  
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Table 6.3 Characteristic IR[a] bands and electronic spectral data[b] for the studied complexes (1-
3) 
 
Complex                                        ν(C═N)        v(Mo=O)/cm–1        λmax/nm (ε/dm
3
 mol
–1
 cm
–1
) 
 
 
[MoO2L
1
(CH3OH)] (1)                     1579             939, 909            422 (9439), 314 (25123), 269 (16352)  
[MoOL
2
(O–N)] (2)                            1575            950                    436 (9434), 267 (16350)  
[MoO2L
3
] (3)                                     1554            931, 899            431 (9569), 327 (26126), 264 (15711) 
[a] 
In KBr pellet; 
[b] 
In DMSO 
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Fig.6.1. IR spectrum of [MoO2L
1(CH3OH)] (1) 
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Fig.6.2. Electronic absorption spectra of [MoOL2(O–N)] (2) in DMSO, at 250 C 
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Fig.6.3. 1H NMR spectra of [MoO2L
3] (3) in DMSO d6. 
 
 
 
 
 
187 
 
6.3.3. Electrochemical properties  
Electrochemical properties of the complexes have been studied by cyclic voltammetry in DMSO 
solution (0.1 M TBAP). Voltammetric data are given in Table 6.4 and the cyclic voltamogram of 
MoO2L
1(CH3OH) (1) is displayed in Fig.6.4 as the representative one. The CV traces of 
complexes (1–3) exhibit two irreversible reductive responses within the potential window –0.17 
to –0.25 V and –1.02 to –1.08 V, which are assigned to MoVI/MoV and MoV/MoIV process 
respectively [48]. An oxidation wave at positive potentials in the range of +1.43 V to +1.47 V, 
which is assigned to oxidation of the coordinated ligands [48]. As the Mo(VI) complex cannot 
undergo a metal-centered oxidation, this is attributed to a ligand-centered process [48].  
 
 
 
 
Table 6.4 Cyclic voltammetric results for dioxomolybdenum (VI) complexes (1–3) at 298 K 
 
 
Complex                                                         Epc [V]
[a] 
 
 
                [MoO2L
1
(CH3OH)] (1)                                    –0.17, –1.02 
                [MoOL
2
(O–N)] (2)                                           –0.20, –1.06 
                 [MoO2L
3
] (3)                                                   –0.25, –1.08 
 
 
[a] Solvent: DMSO; working electrode: platinum; auxiliary electrode: platinum; reference 
electrode: Ag/AgCl; supporting electrolyte: 0.1 M TBAP; scan rate: 50 mV/s. Epc is the cathodic 
peak potential 
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Fig. 6.4. Cyclic voltammogram of [MoO2L
1(CH3OH)] (1) in DMSO  
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6.3.4. Description of the X-ray structure of complex [MoO2L
1(CH3OH)](1) and           
[MoOL2(O–N)](2) 
The molecular structure and the atom numbering schemes for the complex [MoO2L
1(CH3OH)] 
(1) and [MoOL2(O–N)] (2) are shown in Figs 6.5 and 6.6 respectively, with the relevant bond 
distances and angles collected in Table 6.5. In each complex, the tridentate intermediate in situ 
ligand coordinates the metal ion via the enolate –O, the imine –N and the deprotonated amide –O 
atoms, with bite angles of 72.68(4)–74.26(8) [N(1)–Mo(1)–O(3)] and 82.20(6)–83.50(9)    
[N(1)–Mo(1)–O(4)] forming one five- and one six-membered chelate ring. The coordination 
geometry around the molybdenum(VI) atom in 1 and 2 reveals a distorted octahedral 
environment with an NO5 and N2O4 coordination sphere respectively.  
In complex 1, one of the two oxo group O(2) is located trans to the imine nitrogen in the same 
plane and the other oxo group O(1) is located in the axial plane with the solvent molecule 
[CH3OH (1)]. The common characteristic of the structure 2 is the absence of one oxo group and a 
metal–coordinating solvent molecule, and these are replaced by a co- ligand (O–N = 4-
nitrobenzoylhydrazide). The fifth and sixth coordination sites are occupied by this co- ligand 
through the enolate oxygen –O(2) and amine nitrogen –N(4) atoms (Scheme 6.2), forming a 
distorted octahedral complex (Fig 6.6) with the bond distances 2.138(2) [Mo(1)–O(2)] and 
1.983(2) [Mo(1)–N(4)] respectively. The bond between Mo and the azomethine nitrogen in the 
complexes are within a range of 2.127–2.225 Ǻ which is comparatively longer than the Mo–N(4) 
single bond in 2. This is due to the trans effect generated by the oxo group trans to the Mo–N 
bond [49]. The C(6)–O(3) bond lengths for complex 1 and 2 are 1.324–1.330 Ǻ, which is closer 
to single bond length rather than C=O double bond length. However, the short bond length 
compared to C–O single bond may be attributed to extended electron delocalization in the 
ligands. Similarly shortening of C(6)–N(2) length in complex 1 and 2 are 1.291–1.294 Ǻ instead 
of normal 1.385Ǻ.  
The angular distortion in the octahedral environment around Mo comes from the bites taken by 
the Schiff base ligand. For the same reason the trans angles O(3)–Mo(1)–O(4) and O(2)–Mo(1)–
N(1) are significantly reduced from the ideal value of 180°; the trans-axial angle O(1)–Mo(1)–
O(5) is 172.36(5)° (complex 1). The bond length of two oxo oxygen of MoO2 group (complex 1) 
is unexceptional and almost equal [1.697(1) & 1.708(1)]. The Mo–O(5) (alcohol) bond [2.330(1) 
Å (1)] is significantly longer than the other Mo–O bonds [1.697(1)–2.011(8) Å] indicating that 
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the alcohol molecule (complex 1) is weakly bonded to the MoO2
2+ core and this position holds 
the possibility of functioning as a substrate-binding site [19]. 
Both the molecules (1 & 2) are found to show inter molecular hydrogen bonding and it is 
observed in this complexes that due to variation in the H-bond donor acceptor properties of the 
ligands leads to considerable diversity in their supramolecular architecture [17,18,20–22]. 
Complex 1 form a polymeric unit via a hydrogen bond between the isonicotinoyl nitrogen N(3) 
of one molecule and the methanolic proton O(5)–H(5) of another moiety. Complex 2 is also 
found to show such supramolecular arrangement via a pair of reciprocal hydrogen bonds 
between the N(4)–H proton of one molecule and the imine nitrogen N(5) of other moiety. Some 
of the drawings of the corresponding H-bonded supramolecular arrangement of complex 1 & 2 
as example of novel features of crystal engineering are shown in Figs. 6.7–6.13. 
 
6.3.5. Description of the X-ray structure of complex [MoO2L
3] (3) 
The molecular structure and the atom numbering schemes of 3 is shown in Fig. 6.14 with the 
relevant bond distances and angles collected in Table 6.5. The crystallographic analysis of a 
suitable crystal of 3 revealed a five-coordinate mononuclear complex, one structural type quite 
uncommon for dioxomolybdenum(VI) complexes [58], that are generally six-coordinate showing 
a distorted octahedral coordination sphere. For related dioxomolybdenum(VI) species bearing a 
tridentate ligand, the sixth position is typically occupied by a donor ligand [59–61]. In some 
cases, the supposed five-coordinate mononuclear complexes are weakly associated by 
unsymmetrical Mo–O…Mo interactions to give an essentially ‗‗binuclear‖ structure [62] or a 
‗‗linear polymeric‖structure [61]. The molecular geometry of MoO2L
3 is best represented as a 
square-pyramid with one axial oxo oxygen atom O(1), and three O atoms [O(2,3,4)] and the N(1) 
atom describing the equatorial plane, which is slightly distorted from an ideal geometry, as 
reflected in the bond parameters around the metal center. The length of the Mo–O(2) bond lying 
trans to N(1) is practically equal to Mo–O(1); the position trans to O(1) remains unoccupied. 
The other Mo–O and Mo–N distances are normal, as observed in other structurally characterized 
complexes of molybdenum containing these bonds [19,47–50].  
Complex 3 is found to show both inter and intra molecular hydrogen bonding. [MoO2L
3] (3) 
molecules form a supramolecular three-dimensional network via four different intermolecular 
hydrogen bonds (Fig.6.15). A pair of  intermolecular hydrogen bonds between the enolic oxygen 
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O(4) and O(3) of one molecule and the methyl (CH3) proton C(5)–H(5C) and C(1)–H(1C) of 
another moiety, respectively. Another pair of intermolecular hydrogen bonds between the oxo 
oxygen O(1) of one molecule and the methyl (CH3) proton C(5)–H(5B) and C(11)–H(11) of 
another moiety. Another hydrogen bonding interaction between the imine nitrogen N(2) and the 
amine (NH2) hydrogen, N(3)–H(3B), is also observed to constitute an intramolecular hydrogen 
bond (Fig. 6.14). 
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Table 6.5 Selected Bond Distances (Å) and Bond Angles (˚) for Complex 1, 2 and 3  
 
 
 
 
Complex 1 
 
Complex 2 
 
Complex 3 
 
   
  Bond lengths 
  Mo(1)-O(1) 
 
 
  1.697(1) 
 
 
1.671(2) 
 
 
1.700(2) 
  Mo(1)-O(2) 1.708(1) 2.138(2) 1.648(2) 
  Mo(1)-O(3) 2.011(8) 2.011(2) 2.079(1) 
  Mo(1)-O(4) 1.960(2) 1.986(2) 2.034(1) 
  Mo(1)-O(5) 2.330(1) -- -- 
  Mo(1)-N(1) 
  Mo(1)–N(4)   
  Bond Angles 
2.225(1) 
            -- 
2.127(2) 
1.983(2) 
 2.110(2) 
                    -- 
O(1)-Mo(1)-O(2)  105.81(5) 159.87(9) 107.94(9) 
O(1)-Mo(1)-O(3)         97.45(4) 100.2(1) 97.10(8) 
O(1)-Mo(1)-O(4)         98.33(6) 99.9(1) 100.57(8) 
O(1)-Mo(1)-O(5)         172.36(5) -- -- 
O(1)-Mo(1)-N(1) 97.29(5) 108.3(1) 96.58(9) 
O(2)-Mo(1)-O(3) 95.98(4) 83.59(8) 95.26(8) 
O(2)-Mo(1)-O(4)  102.02(6) 83.33(8) 99.91(8) 
O(2)-Mo(1)-O(5)         81.68(4) -- -- 
O(2)-Mo(1)-N(1)  155.51(5) 91.78(8) 154.53(8) 
O(3)-Mo(1)-O(4)  151.77(6) 153.74(9) 151.83(7) 
O(3)-Mo(1)-O(5) 80.01(4) -- -- 
O(3)-Mo(1)-N(1) 72.68(4) 74.26(8) 74.47(7) 
O(4)-Mo(1)-O(5) 81.27(6) -- -- 
O(4)-Mo(1)-N(1) 82.20(6) 83.50(9) 81.83(7) 
O(5)-Mo(1)-N(1) 
     
        75.08(4)             -- -- 
 
 
 
193 
 
 
 
Fig.6.5. ORTEP diagram of [MoO2L
1(CH3OH)] (1) with atom labeling scheme  
at 50% probability 
. 
 
 
 
 
 
 
 
 
 
Fig. 6.6. ORTEP diagram of [MoOL2 (O–N)] (2) with atom labeling scheme  
at 50% probability 
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. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.7. H-bonded supramolecular single stranded helix of complex 1 view along c axis 
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Fig.6.8. Spider net like packing of complex 1 view along c axis  
 
Fig.6.9. Cylindrical packing of complex 1 view perpendicular to c axis 
 
 
 
 
 
 
Fig.6.10. Chain like packing of complex 1 view perpendicular to c axis 
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Fig.6.11. Two interpenetrating one-dimensional zig-zag chains through complementary pairs of 
hydrogen bonding in 2 view along the c axis. 
 
 
 
 
Fig.6.12. Four interpenetrating one-dimensional zig-zag chains through complementary pairs of 
hydrogen bonding in 2 view along the c axis. 
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Fig.6.13. Staircase like packing arrangement of complex 2 view along a axis 
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Fig.6.14. PLATON diagram of [MoO2L
3] (3) with atom labeling scheme 
at 50% probability 
. 
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Fig.6.15. Packing diagram of [MoO2L
3] (3) along b axis 
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6.3.6. Antibacterial activity 
The synthesized oxomolybdenum(VI) complexes (1-3) were screened for antimicrobial activity 
against the pathogenic strains of Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa 
by agar well-diffusion method and their MIC values are represented in Table 6.6 and Fig. 6.16. 
In some cases they showed promising results by giving the MIC value lesser than the standard 
drug examined. The results also indicate that the corresponding oxomolybdenum(VI) complexes 
showed much better antibacterial activity with respect to the individual hydrazide against the 
same microorganism under identical experimental conditions which is in agreement with the 
previous results [18,19,63–67]. A possible explanation is that, by coordination, the polarity of 
the ligand and the central metal ions are reduced through the charge equilibration, which favors 
permeation of the complexes through the lipid layer of the bacterial cell membrane [18,19,63–
67]. 
From the zone of inhibition, it is observed that the complex 1 showed most promising results 
especially for E.coli compared to the other compounds (2 and 3) of this study and the difference 
in value may be attributed to the nature of compounds synthesized [68]. Antibacterial activity of 
the similar type oxo-metal complexes has also been reported by Sharma et al. [69] , Chohan      
et al. [70] and Prasad et al. [71] using agar well diffusion technique against Escherichia coli, 
Shigella flexenari, Pseudomonas aeruginosa, Salmonella typhi, Staphylococcus aureus and 
Bacillus subtilis and the present results are in accordance with the reported values. However, the 
difference in value may be attributed to the nature of compounds synthesized with different 
ligands.  
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Table 6.6 Minimum Inhibitory Concentration (MIC) value in µg/mL of the oxomolybdenum(VI) 
complexes (1–3) and standard drugs against pathogenic strains 
 
 
                                               E.coli          Bacillus subtilis        Pseudomonas aeruginosa     
 
[MoO2L
1
(CH3OH)] (1)                       15.6                             62.5                                   -- 
[MoOL
2
(O–N)] (2)                               --                                   --                                    -- 
[MoO2L
3
](3)                                        31.2                             31.2                                 250 
Vancomycin                                         30                                30                                     -- 
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Fig.6.16. Minimum Inhibitory Concentration (MIC) of Mo(VI) complexes (1–3) and  
standard drug 
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6.4. Conclusions 
The synthesis of three new oxomolybdenum(VI) complexes (1, 2 and 3) with aroyl hydrazones 
has been achieved in excellent yield and is characterized by various spectroscopic techniques, 
electrochemistry and X-ray crystallography. The special role of different hydrazones by 
systematic variation in the H-bond forming abilities of their aroyl moiety is successfully 
highlighted by the formation of supramolecular assembly of oxomolybdenum complexes in 
generating varied molecular architectures. The complexes have been screened for their 
antibacterial activity against Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. 
Minimum inhibitory concentration of these complexes and antibacterial activity indicates the 
compound 1 as the potential lead molecule for drug designing.  
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A Brief Resume of the Work Embodied in this Dissertation and Concluding 
Remark  
The aim of this dissertation was to explore in depth certain aspects of the chemistry of 
oxomolybdenum(VI) ligated to a few selected multidentate NO- and/or ONO- donor systems. 
Major emphasis was given to the study of chemical, electrochemical, biological and catalytic 
activity of the complexes and structural characterization of the synthesized complexes and the 
products obtained from the precursor. Works described in chapter 2-6 reveal the results of the 
attempt to fulfill the objectives. The following chapter-wise summary of the work presented in 
this dissertation reveals the extent to which the above-mentioned objectives are fulfilled.  
 
    Chapter 2 contains synthesis and characterization of the oxomolybdenum(VI) complex 
[MoO2L(C2H5OH)] (1) of benzoylhydrazone of 2-hydroxybenzaldehyde (H2L). The substrate 
binding capacity of 1 has been demonstrated by the formation and isolation of two mononuclear 
[MoO2L(Q)] {where Q = imidazole (2a) and 1-methylimidazole (2b)} and one dinuclear 
[(MoO2L)2(Q)] {Q = 4,4'-bipyridine (3)} mixed- ligand oxomolybdenum(VI) complexes. All the 
complexes have been characterized by elemental analysis, spectroscopic (IR, UV–Vis and NMR) 
and cyclic voltammetry measurements. Molecular structures of all the oxomolybdenum(VI) 
complexes (1, 2a, 2b and 3) have been determined by X-ray crystallography. The complexes 
have been screened for their antibacterial activity against Escherichia coli, Bacillus subtilis and 
Pseudomonas aeruginosa. The minimum inhibitory concentration of these complexes and 
antibacterial activity indicates the compound 2a and 2b as the potential lead molecule for drug 
designing.  
 
.Chapter 3 deals with the synthesis, characterization and reactivity of a series of 5- and 6- 
coordinated oxomolybdenum(VI) complexes of the type [MoO2L(ROH)] [where R = C2H5 (1) 
and CH3 (2)], and [MoO2L] (3 and 4) of four different ONO donor ligands: salicyloylhydrazone 
of 2-hydroxy-1-naphthaldehyde (H2L
1), anthranylhydrazone of 2-hydroxy-1-naphthaldehyde 
(H2L
2), benzoylhydrazone of 2-hydroxy-1-acetonaphthone (H2L
3) and anthranylhydrazone of 2-
hydroxy-1-acetonaphthone (H2L
4; general abbreviation H2L). The substrate binding capacity of 1 
has been demonstrated by the formation of one mononuclear mixed- ligand dioxomolybdenum 
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complex [MoO2L
1(Q)] {where Q = γ-picoline (1a)}. Molecular structure of all the complexes (1, 
1a, 2, 3 and 4) is determined by X-ray crystallography, demonstrating the dibasic tridentate 
behavior of ligands. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis, Proteus vulgaris and Klebsiella pneumoniae. The minimum 
inhibitory concentration of these complexes and antibacterial activity indicates 1 and 1a as the 
potential lead molecule for drug designing. Catalytic potential of these complexes was tested for 
the oxidation of benzoin using 30% aqueous H2O2 as an oxidant in methanol. At least four 
reaction products benzoic acid, benzaldehyde-dimethylacetal, methylbenzoate and benzil were 
obtained with the 95-99% conversion under optimized reaction conditions. Oxidative 
bromination of salicylaldehyde, a functional mimic of haloperoxidases, in aqueous H2O2/KBr in 
the presence of HClO4 at room temperature has also been carried out successfully.  
 
   Chapter 4 describes the report of synthesis and characterization of two novel dimeric 
[(MoVIO2)2L] (1) and tetrameric [{(C2H5OH)LO3Mo2
VI}2( -O)2]·C2H5OH (2) dioxomolybdenum 
(VI) complexes with N,N'-disalicyloylhydrazine (H2L), which is formed by the self combination 
of acid hydrazide. Both the complex was characterized by various spectroscopic techniques (IR, 
UV–Vis and NMR) and also by electrochemical study. The molecular structures of both the 
complexes have been confirmed by X-ray crystallography. All these studies indicate that the 
N,N'-disalicyloylhydrazine (H2L) has the normal tendency to form both dimeric and tetrameric 
complexes coordinated through the dianionic tridentate manner.  
 
      In chapter 5 two novel dioxomolybbdenum(VI) complexes containing the MoO2
2+ motif are 
reported where unexpected coordination due to ligand rearrangement through metal mediated 
interligand C–C bond formation is observed. These ligand transformations are probably initiated 
by molybdenum assisted C–C bond formation in the reaction medium. It is checked and 
confirmed that, the reactions using other metal precursors [VO(acac)2 or Cu(acac)2] do not 
initiate this type of ligand rearrangement. The ligands (H2L ) are tetradentate C–C coupled O2N2– 
donor systems formed in situ during the synthesis of the complexes from 
bis(acetylacetonato)dioxomolybdenum(VI) with Schiff base ligands of 2-aminophenol with       
2-pyridinecarboxaldehyde (HL1) and 2-quinolinecarboxaldehyde (HL2). The reported 
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dioxomolybdenum(VI) complexes [MoO2L
1] (1) and [MoO2L
2] (2) coordinated with the O2N2– 
donor rearranged ligand are expected to have better stability of the +6 oxidation state of 
molybdenum than the corresponding ONN– donor ligand precursor. Both the complexes are 
fully characterized by several physicochemical techniques and the novel structural features 
through single crystal X-ray crystallography. 
   The essence of the work presented in chapter 6 is the detailed account of the synthesis, 
structure, spectroscopic, electrochemical properties and study of biological activity of some 
oxomolybdenum(VI) complexes with special reference to their H–bonded molecular and 
supramolecular structures. Reaction of bis(acetylacetonato)dioxomolybdenum(VI) with three 
different hydrazides (isonicotinoyl hydrazide, anthraniloyl hydrazide and 4-nitrobenzoyl 
hydrazide) afforded two dioxomolybdenum(VI) complexes {[MoO2L
1(CH3OH)] (1) and 
[MoO2L
3] (3)} and one mono-oxomolybdenum(VI) complex {[MoOL2(O-N)] (2)} (where L = 
Intermediate in situ ligand formed by the reaction between acetyl acetone and the corresponding 
acid hydrazide, and O–N = 4-nitrobenzoylhydrazide). All the complexes have been characterized 
by elemental analysis, magnetic and spectroscopic (IR, UV–Vis and NMR) measurements. 
Molecular structures of all the complexes (1, 2 and 3) have been determined by X-ray 
crystallography. The complexes have been screened for their antibacterial activity against 
Escherichia coli, Bacillus subtilis and Pseudomonas aeruginosa. The minimum inhibitory 
concentration of these complexes and antibacterial activity indicates 1 as the potential lead 
molecule for drug designing. 
 
The author is very much aware of the fact that some portions of the work described in the prese nt 
dissertation left scope for future work especially the biological and catalytic studies. All the 
reported complexes can be used for the study of several other catalytic and bio activities. This 
dissertation also left scope for further qualitative improvement by the utilization of some relevant 
instrumental data, which could have been really helpful in arriving at completely unambiguous 
conclusions. As those instrumental facilities were not available to us, we were rather helpless. 
However, the above discussion on the entire work presented in chapter 2-6 reveals that the aims 
and objectives of the present dissertation are mostly fulfilled.  
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